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The current thesis describes the evaluation of a microsphere-based scaffold that may be used as 
an early intervention therapy for treating focal cartilage and bone-cartilage interface defects. This 
scaffold is comprised of extracellular matrix materials, which serve as ‘raw materials,’ 
encapsulated in a biodegradable polymer for differentiation of progenitor or resident cells into 
bone and cartilage. The work in the thesis initially evaluated the in vitro performance of raw 
material encapsulating microsphere-based scaffolds fabricated using a high molecular weight 
polymer as a first step to establish their clinical efficacy. Subsequently, concentrations of raw 
materials were increased in microsphere-based scaffolds to stimulate in vitro osteogenesis and 
chondrogenesis in stem cells. Lastly, a novel combination of raw materials, demineralized bone 
matrix (DBM) and decellularized cartilage (DCC), encapsulated in a continuously graded 
scaffold design was tested for in vivo regeneration potential in a rabbit model. Results from the 
body of in vitro studies suggested that raw material encapsulation in microsphere-based scaffolds 
can potentially facilitate neo-tissue synthesis. The encapsulated raw materials readily enhanced 
biochemical production, stimulated gene expression, and tissue synthesis. Additionally, 
biochemical and gene expression evidence highlighted the benefits of using gradient-based 
strategies for regenerating bone and cartilage. The in vivo study demonstrated the feasibility and 
applicability of DBM and DCC gradient microsphere-based scaffolds in the New Zealand White 
rabbit knee defect. The results of the study indicated toward some benefits of using DCC and 
DBM and emphasized on the need to further refine the technology. The important next steps 
would be to investigate polymer degradation rate and its effect on tissue regeneration, and further 
attune raw material concentrations to augment osteochondral regeneration. Ultimately, this thesis 
demonstrated the benefits of raw material encapsulation in microsphere-based scaffolds, in 
	 iv	
addition to opening new areas of investigation with regard to transitioning this technology for 
clinical use.  
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CHAPTER 1: INTRODUCTION TO THESIS 
The overall goal of this thesis is to evaluate a novel microsphere-based scaffold consisting of 
extracellular matrix (ECM) components encapsulated in a biodegradable polymer that can be 
used to treat small cartilage and bone-cartilage defects. The ECM materials were selected to 
serve as ‘raw materials,’ providing both bioactive signals and building blocks, thus enhancing 
the differentiation of surrounding progenitor cells toward bone- and cartilage-like cells. The 
overall progression was to first investigate in vitro response of encapsulating ECM materials (or 
raw materials) in clinically relevant microsphere-based scaffold systems, refine concentrations of 
raw materials for in vitro osteogenesis and chondrogenesis, and finally to evaluate preliminary in 
vivo performance of a gradient microsphere-based scaffold consisting of a unique combination of 
raw materials. Therefore, this thesis included three specific aims: (1) evaluate in vitro potential 
of gradients of raw materials in microsphere-based scaffolds of relevance to large animal models 
or human patients, (2) refine composition of raw materials for stimulating in vitro osteogenesis 
and chondrogenesis in homogenous microsphere-based scaffolds, and (3) assess the in vivo 
performance of a novel microsphere-based gradient scaffold incorporating opposing gradients of 
raw materials.  
The first aim evaluated the in vitro potential of two raw materials, chondroitin sulfate 
(CS) and β-tricalcium phosphate (β-TCP), encapsulated in microsphere-based scaffolds 
comprised of high molecular weight poly(D,L-lactic acid-co-glycolic acid) (PLGA). The second 
aim was divided into two parts, with the goal being to identify raw material combinations for 
future iterations of continuously graded microsphere-based scaffold design. The first part of the 
second aim investigated the use of calcium phosphate mixtures of β-tricalcium phosphate (β-
TCP) and hydroxyapatite (HAp) to enhance osteogenesis in vitro. The second part compared the 
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use of DCC and CS in driving chondrogenesis in vitro. The third and final aim evaluated the in 
vivo efficacy of a novel microsphere-based scaffold consisting of opposing gradients of 
decellularized cartilage (DCC) and demineralized bone matrix (DBM) in rabbit osteochondral 
knee defects. The subsequent chapters reflect the chronological progression of these aims, which 
provided valuable information that guided the direction of subsequent phases of the work. The 
organization of these chapters is as follows: 
Chapter 2 provides a historical context on microsphere-based scaffolds for tissue 
engineering and regenerative medicine, highlights the different methods for microsphere 
fabrication and sintering, and discusses how these methods influence the microsphere and overall 
scaffold properties. This chapter emphasizes the versatility of the microsphere-based scaffolds 
regarding fabrication materials, encapsulated factors, and abilities to provide physicochemical 
gradients and shape-specific grafts, with the goal of enticing the researchers across the 
regenerative medicine field toward microsphere-based scaffolds. Chapter 2 thus lays the 
foundation for this thesis, and provides the motivation for developing a clinically relevant 
biomimetic scaffold for treating focal cartilage and bone-cartilage defects.  
Chapter 3 addresses the first aim of investigating whether the encapsulated raw materials 
(CS and TCP) in high molecular weight PLGA scaffolds can provide building blocks and 
facilitate differentiation of the seeded cells simultaneously in the direction of bone- and 
cartilage-like cells. The outcome analyses included morphological analysis, osteogenic and 
chondrogenic gene expression, biochemical output, and mechanical properties of constructs 
cultured with rat bone marrow stromal cells (rBMSCs). The findings of this chapter provided 
validation for the use of raw materials in microsphere-based scaffolds. 
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Chapter 4 addresses the first part of the second aim by employing TCP and HAp mixtures 
to stimulate osteogenesis in homogenous microsphere-based scaffolds. Mechanical, biochemical 
output, gene expression, and histological data evaluated as a function of scaffolds with 30 wt% 
TCP and HAp encapsulated in two different ratios (7:3 and 1:1, TCP:HAp), seeded with 
rBMSCs. The results of this chapter yielded vital information on how to use TCP/HAp 
combinations in future iterations of gradient microsphere-based scaffolds.  
Chapter 5 addresses the second part of the second aim i.e., comparing CS and DCC for 
influencing chondrogenesis in microsphere-based scaffolds. Homogenous microsphere-based 
scaffolds were fabricated either encapsulating CS or DCC at a concentration of 30 wt%. 
Biochemical content, gene expression, and histological results of engineered constructs 
suggested that incorporation of CS and DCC could enhance cellularity and have a modulatory 
effect on seeded rBMSCs thus, highlighting the benefits of employing ECM materials for driving 
chondrogenesis in microsphere-based scaffolds.  
Chapter 6 further addresses the third aim by evaluating the in vivo regeneration potential 
of a microsphere-based scaffold incorporating of opposing gradients of decellularized cartilage 
(DCC) and demineralized bone matrix (DBM). Scaffolds were implanted into the medial femoral 
condyles of New Zealand White rabbits. After sacrificing the animals at 12 weeks, gross 
morphological, mechanical, and histological analyses were performed to evaluate bone and 
cartilage tissue regeneration. The results of this study provided an insight into parameters that 
can have profound implications during subsequent in vitro and in vivo experiments. 
Chapter 7 serves as the conclusion for this thesis. It summarizes key internal findings 
from a global perspective, and provides recommendations with regard to future generations of 
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experiments, which attempt to address the limitations of the physicochemical microsphere-based 
scaffold design.  
Altogether, the work conducted in this thesis proposed a translational and clinically 
relevant solution for treating focal cartilage (chondral) and bone/cartilage (osteochondral) defects 
that can be implanted in a single surgery, which avoids a three-stage approach for autologous 
chondrocyte graft harvest, cell isolation and culture, and reimplantation, or the two-incision 
approach of mosaicplasty with osteochondral plug harvest site morbidity. Other treatments 
available are products such as Arthrex’s Biocartilage® and Cartiform® that are composed of 
living, human chondral or osteochondral tissue. These treatments not only require viable donated 
tissues, of which availability of donors is a concern, but they still lack the ability to regenerate 
fully functional tissue. Therefore, using biodegradable polymers combined with ECM materials 
that can act as raw materials for the regenerating tissue is an attractive solution. The work within 
this thesis not only highlights the benefits in efficacy of using raw materials alone, but also 
imparts tremendous clinical significance to microsphere-based scaffolds, as scaffolds that do not 
include growth factors may be strategically positioned for a more streamlined regulatory 
approval. Moreover, avoidance of high cost associated with the growth factors will translate into 
higher profit margins for investors; thus furthering the prospects of the raw material 
microsphere-based scaffolds for translation to the clinic.  
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CHAPTER 2: MICROSPHERE-BASED SCAFFOLDS IN TISSUE ENGINEERING AND 
REGENERATIVE MEDICINE† 
ABSTRACT 
Microspheres have long been used in drug delivery applications because of their controlled 
release capabilities. Recently, they have started to gain attention for fabricating tissue-
engineering scaffolds because of their other structural attributes like rigidity in shape, ability to 
provide porous network, and uniform mechanical properties. Moreover, they offer versatility in 
terms of methods for fabrication and sintering thus, further warranting their use as scaffolds for 
regenerating tissues. Furthermore, the microspheres can provide physicochemical gradients via 
spatio-temporal release of bioactive factors and nano-phase ceramics thereby making them 
suitable candidates for engineering complex tissues and biological interfaces. Lastly, these 
microspheres can be injected through most clinical needles and can be assembled into intricate 
geometries to treat irregular- and complex-shaped defects. Hence, these microspheres have the 
ability to provide patient-specific biological grafts for clinical utilities. Therefore, it is essential 
to study the factors that affect the properties of the microspheres and microsphere-based 
scaffolds. This review describes various methods for microsphere fabrication and sintering, and 
discusses how these methods influence the microsphere and scaffold properties. Furthermore, 
key applications of the microspheres and microsphere scaffolds in regenerating different tissue 
types will also be reviewed. By summarizing the methods for microsphere fabrication and 
                                                
† To be submitted as Gupta V, Khan Y, Berkland CJ, Laurencin CT, Detamore MS, 
Microspheres As Scaffolds In Tissue Engineering And Regenerative Medicine, Annual Review of 
Biomedical Engineering, 2015 
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sintering and highlighting their use in tissue engineering, our goal is to inspire researchers to use 
microspheres as tissue engineering scaffolds so that their full potential could be realized. 
 
INTRODUCTION 
In the last few decades, the field of tissue engineering and regenerative medicine has come into 
limelight because of its ability to provide patient specific biological substitutes overcoming 
limitations, like donor shortage and graft rejection, posed by conventional methods for treating 
damaged tissue or organs. The main tissue engineering approach involves transplantation of cells 
onto engineered matrices, called scaffolds. These scaffolds provide a temporal and spatial 
environment for cellular in-growth and are also capable of supporting the regenerating tissue. An 
ideal scaffold: (a) provides a three-dimensional architecture with a desired volume, shape, and 
mechanical strength, (b) has a highly porous and well interconnected open pore structure to 
allow high cell seeding density and tissue in-growth (c) possesses chemical compositions such 
that its degradation products are biocompatible causing minimal immune or inflammatory 
response, and (d) its degradation rate is tuned in a pattern that it provides sufficient support until 
the full re-growth of impaired tissues has occurred.43 Many scaffold fabrication techniques such 
as solvent casting, particulate leaching, phase separation, electrospinning, fiber mesh, fiber 
bonding, etc. are employed for tissue engineering applications192, 221 but recently microsphere-
based scaffold fabrication techniques have gained importance because these scaffolds provide 
excellent initial mechanical properties and also allow for controlled release of bioactive 
molecules to promote tissue regeneration.206 
Microspheres (aka microparticles) are organic or inorganic spherical free flowing 
particles of size range 1-1000 mm with drugs or bioactive molecules either entrapped or 
	 7	
encapsulated in them. They have been extensively used in drug delivery/targeting applications 
because of their ability to enhance the efficacy of the encapsulated drug by providing a large 
surface area to volume ratio for its release and exerting a spatial and temporal control over its 
release.  
Besides their ability to serve as excellent controlled release vehicles, these microspheres 
are rigid in shape and can be packed together alone or in combination with other materials to 
yield porous three-dimensional structures that can serve as tissue engineering scaffolds. The 
microsphere-based tissue engineering scaffolds can broadly be divided into two categories: - i) 
microsphere encompassing scaffolds (MESs) and ii) microsphere scaffolds (MSs).  In MESs, 
microspheres act either as controlled release/delivery vehicles15, 20, 31, 33, 48, 52, 95, 100, 104, 109, 111, 112, 
119, 129-131, 133, 143-148, 153, 159, 165, 182, 194, 195, 197, 198, 219, 220, 236, 241, 243, 244, 248, 259, 264, 265 or pore 
generating entities (porogens).49, 53, 54, 92, 231, 232 As delivery vehicles in scaffolds (Table 2.1), 
microspheres are used for encapsulating peptides/proteins15, 20, 31, 33, 48, 52, 100, 104, 109, 111, 129-131, 143-
148, 159, 182, 194, 195, 198, 220, 236, 241, 243, 244, 248, 259, 264, hormones or antimicrobials119, 153, 165, 219 and 
nucleotides95, 112, 133, 197 to direct fate of the transplanted (or seeded) cells. It has been shown that 
the release profile of encapsulated bioactive molecules from the microspheres depends on the 
properties of scaffolding materials as well as on the properties of the microspheres themselves52, 
265. Moreover, the release profile from these microspheres exhibits a three-stage profile: an initial 
burst period, a lag period and an increased release period afterwards. During the initial phases, 
the release profile is primarily governed by diffusion from within the microsphere matrix and 
afterwards by degradation of the microsphere materials264. Additionally, it has been shown that 
the biological activity of the encapsulated molecule is not significantly altered during the 
microencapsulation process130. Furthermore, multiple bioactive molecules have been released 
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simultaneously from MESs via the use of different microsphere systems. The loading and release 
profiles from these multiple systems were distinct and depend on the nature of the carrier 
matrices used and also on the microencapsulation process244. Another way of incorporating 
microspheres into MESs for controlled release is to apply them as surface coatings78, 265. Francis 
et al. (Table 2.1) developed a multi-functional Bioglass-based ceramic scaffold for bone tissue 
engineering that could deliver an antimicrobial, gentamycin, via the immobilization of 
gentamycin encapsulating poly(3-hydroxybutyrate) microspheres on the scaffold surface78.  
Microspheres in MESs also serve to act as porogens, generating a network of pores into 
the interior of a scaffold that would facilitate cellular in-growth and transportation of nutrients 
and wastes in and out of the scaffold. Certain scaffold fabrication techniques like solvent casting, 
phase separation, rapid prototyping, etc. are limited in their ability to create pores within the 
scaffold; therefore, microspheres are incorporated into such scaffolds to create macro- or micro-
sized pores. Dellinger et al.53, 54 incorporated polymethylmethacrylate (PMMA) microspheres 
into hydroxyapatite (HA) scaffolds, which burnt out during subsequent calcination process thus, 
creating macro- and micro-sized pores in the scaffolds. Using microspheres as porogens an 
ordered, uniform and interconnected network of pores could be created within the scaffolds with 
porosity values as high as 95%231, 232. Moreover, generated pores influence the physical and 
mechanical properties of the scaffolds that could in turn affect the cell growth kinetics within a 
scaffold92.  
Microsphere encompassing scaffolds possess some inherent advantages over scaffolds 
fabricated via conventional techniques in the sense that they allow control over the release of the 
encapsulated molecules and structural properties (porosity and mechanical) of the fabricated 
scaffold. However, they also suffer from some limitations. Fabrication of a MES is a multi-step 
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tedious process involving creation of a scaffold matrix, microspheres, and then combining them 
into a single structure. Moreover, the matrix and microspheres are usually fabricated from 
different materials leading to difference in mechanical properties at the microsphere-matrix 
interface that in turn may cause undesirable results. Therefore, to overcome problems associated 
with MESs, microspheres are themselves used as building blocks for fabricating scaffolds. Such 
scaffolds known as microsphere scaffolds (MSs) are advantageous in terms that they possess 
uniform mechanical properties, provide porous network, allow for controlled release or surface 
modifications via bioactive factors, can be assembled into different shapes, and can also be 
injected via small incisions in minimally invasive surgeries. The MSs can further be classified as 
sintered microsphere scaffolds (SMSs) and injectable microsphere scaffolds (IMSs). In SMSs, 
microspheres are sintered or bonded together to form a three-dimensional structure whereas in 
IMSs the microspheres are not sintered and only act as cell growth substrates or cell/cell-matrix 
carriers.  
Borden et al.25 first reported the use of MSs (SMSs) in 2002 for bone tissue engineering 
applications. Since then, a lot of research groups have started employing MSs for regenerating a 
variety of tissues and rapid progress has been made in the field of MSs especially in the past 5-6 
years (Figure 2.1). In a review, Shi et al. discussed the use of SMSs fabricated via heat and 
solvent sintering for drug delivery and tissue engineering applications 206. Huang et al. in an 
another review examined the use of these scaffolds in bone tissue engineering applications where 
they discussed different material approaches being applied to fabricate such scaffolds101.  
The objective of this review is to recapitulate the use of the microsphere scaffolds (MSs) 
in the tissue-engineering field with emphasis on the methods and materials used for microsphere 
fabrication and sintering. Moreover, the influence of these parameters on scaffold properties will 
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also be discussed. Lastly, the use of MSs in regenerating different tissue types will be reviewed 
and some key emerging applications will also be highlighted. 
 
MICROSPHERE FABRICATION METHODS 
Microspheres are fabricated via a variety of methods (Figure 2.2) for use in MSs. The type of 
method used for microsphere fabrication greatly influences their properties. Therefore, the 
following section describes the different methods used for microsphere fabrication and how they 
affect their size and morphology.  
 
EMULSION BASED METHODS 
The emulsion-based methods (Figures 2.3 – 2.7) are the most commonly and widely used 
methods for microsphere fabrication (Table 2.2) as they are relatively less time consuming, don’t 
require complex apparatus and can be applied to multiple systems4, 11, 14, 25, 26, 29, 39, 41, 42, 44, 46, 47, 51, 
69, 70, 82, 90, 91, 94, 99, 100, 105-109, 112, 115-118, 121-125, 135, 137, 138, 140, 149-151, 158, 160, 168, 178-180, 183, 184, 186, 187, 190, 
200, 208, 210, 228, 233, 239, 242, 246, 247, 255, 257, 260-263. These methods can broadly be divided into a) 
emulsion solvent evaporation, b) emulsion gas foaming, c) emulsion microgel fabrication, and d) 
cryogenic double emulsion methods. 
 
EMULSION SOLVENT EVAPORATION 
Microsphere fabrication by emulsion solvent evaporation/extraction (ESE) consists of four major 
steps (Figures 2.3 & 2.4): - (A) dissolution or dispersion of the bioactive compound often in an 
organic solvent containing the microsphere matrix (usually a polymer); (B) emulsification of this 
organic phase in a second continuous (frequently aqueous) phase immiscible with the first one; 
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(C) extraction of the solvent from the dispersed phase by the continuous phase, which is 
optionally accompanied by solvent evaporation, either one transforming the droplets into solid 
microspheres; (D) harvesting and drying of the microspheres79. Based on the number of 
emulsions used in the fabrication, the ESE method can be classified either as a) a single emulsion 
solvent evaporation (SESE) or b) a double emulsion solvent evaporation (DESE). In SESE, the 
microsphere matrix (containing either dissolved or dispersed bioactive molecule) is emulsified 
into the aqueous phase followed by microsphere hardening through solvent evaporation and 
polymer precipitation (Figure 2.3). On the other hand, in DESE an aqueous solution of the 
bioactive compound is first dispersed in the matrix solution forming primary emulsion, which is 
then further emulsified to form secondary emulsion followed by microsphere hardening (Figure 
2.4).  
Microspheres with smooth, rough and porous surface morphologies can be fabricated via 
ESE methods. Smooth morphology is obtained when a homogenous organic phase is emulsified 
into the aqueous phase during microsphere fabrication. Jiang et al. fabricated smooth poly(lactic 
acid-glycolic acid) (PLAGA) microspheres using a SESE method. However, they observed that 
addition of chitosan to the PLAGA organic phase led to formation of microspheres with a rough 
morphology, which was due to the presence of chitosan particles on the microsphere surface. 
During solvent evaporation and microsphere hardening, only a small amount of loaded chitosan 
particles got incorporated into the interior of the microspheres because of chitosan’s tendency to 
disperse in water and partition onto the microsphere surface thereby imparting a rough 
appearance115. Moreover, addition of inorganic minerals such as hydroxyapatite or titanium 
dioxide107, 160, 246 also led to fabrication of rough microspheres. Microspheres with minute pores 
on their surface could be fabricated when an aqueous inner phase was first dispersed in the 
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organic phase during microsphere fabrication. The pores form due to water leaching from the 
inner aqueous phase amid microsphere hardening via solvent evaporation. Additionally, pores 
could also be generated with the use of a porogen in microsphere matrix material. Hong et al.94 
prepared novel microspheres of polycaprolactone (PCL) with a porous surface by introducing 
camphene as a porogen in the organic phase. PCL and camphene were first dissolved in the co-
solvent chloroform. In the course of solidification, camphene and PCL phases separated to form 
an interconnected structure. Since camphene sublimes (below 400C) easily, the camphene part 
disappeared leaving a porous structure within the PCL microspheres. Microsphere morphology 
and porosity are also influenced by rate and conditions of drying process used to obtain a free-
flowing powder as it is responsible for removal of the continuous phase, wash fluid adhering to 
the microspheres’ surface, and traces of solvents and continuous phase from the interior of the 
microparticles. 
In emulsion solvent extraction methods the factors that influence the size of the 
fabricated microspheres include: - (a) matrix/polymer concentration in the organic phase, (b) 
concentration of the stabilizer/surface active agent used, (c) shear forces produced either by 
homogenizer, sonicator or whirl mixer during the emulsification step and lastly, (d) rate of 
solvent evaporation during microsphere hardening. Increasing the viscosity of the bioactive 
molecule/matrix dispersion increases the diameter of the microspheres, as higher shear forces are 
needed to break the dispersed phase into droplets. Such increase in the dispersion viscosity, 
typically caused by higher concentration or molecular weight of the matrix material, may be 
desirable to improve the encapsulation of the bioactive molecule. To prevent coalescence of the 
bioactive molecule/matrix dispersion droplets, a surface-active or viscosity-enhancing stabilizer 
such as polyvinyl alcohol (PVA) is generally added to the continuous phase and it has been 
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observed that increasing the stabilizer concentration frequently leads to decrease in size of the 
fabricated microspheres. Higher stabilizer concentrations yield an excess of material that adsorbs 
on the surface of newly formed droplets, thus preventing coalescence. Moreover, with increase in 
concentration of stabilizers, the viscosity of the continuous phase also increases, amplifying (for 
a given stirring rate) the shear forces acting upon the bioactive molecule/matrix dispersion 
droplets and thus minimizing their size. Furthermore, it is observed that increasing the shear 
forces by increasing the mixing speed generally also results in decreased microsphere mean size 
as it produces smaller emulsion droplets through stronger shear forces and increased turbulence. 
In addition to a smaller mean diameter, more rapid mixing also resulted in lower microsphere 
polydispersity. The ideal rate of solvent evaporation depends on a variety of factors like the type 
of matrix material, encapsulated bioactive molecule and solvent as well on the desired release 
profile of the microspheres. Increasing the temperature can lead to higher solvent evaporation 
rates thus producing larger microspheres because of rapid microsphere solidification with 
insufficient mixing time to reduce droplet size. As an alternative to elevated temperatures, 
reduced pressure also has a similar effect on the size of the microspheres79.  The parameters 
affecting the microsphere size in ESE methods offer limited control over the microsphere size; 
therefore fabricated microspheres are largely polydisperse. In other words, microspheres 
fabricated via ESE methods have varied sizes that could be undesirable in certain tissue 
engineering applications where a tight control over microsphere size is required.  
 
EMULSION GAS FOAMING 
The emulsion gas foaming method (Figure 2.5) is similar to the DESE method with the exception 
that an effervescent salt is dissolved in the organic phase. The dissolved salt acts as a gas 
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foaming agent, generating gas bubbles when the primary emulsion contacts the secondary 
aqueous phase, thereby creating open porous morphology within the microspheres 41, 42, 122, 123, 136, 
168, 257. Kim et al.136 fabricated porous poly(lactic-co-glycolic acid) (PLGA) microspheres using 
ammonium bicarbonate in the inner aqueous phase as the gas foaming agent. An aqueous 
solution containing ammonium bicarbonate was homogenized into an organic phase of PLGA-
dissolved methylene chloride. The primary emulsion solution was re-emulsified into an aqueous 
solution of PVA for a double emulsion and subsequent solvent evaporation. The inner aqueous 
phase containing ammonium bicarbonate gradually generated carbon dioxide and ammonia gas, 
blowing up their droplet volumes within the embryonic PLGA microspheres during the solvent 
removal process. As a result, porous microspheres with highly inter-connected, open pore 
channels were produced. Moreover, the evolved gas bubbles also stabilized the primary emulsion 
droplets against coalescence during solvent evaporation. Furthermore, it was observed that 
increasing amount of ammonium bicarbonate not only led to a more porous structure but also 
increased the diameter of the microspheres themselves. This was due to internal gas foaming 
effect that expanded the dimension of gas evolving primary aqueous droplets in the solidifying 
polymer phase. The generation of gas within the primary aqueous droplets caused the 
surrounding solidifying PLGA phase to enlarge its original volume during solvent evaporation in 
the second emulsification step.  
 
EMULSION MICROGEL FABRICATION 
Emulsion microgel fabrication involves production of micron or sub-micron sized gel spheres 
(microgels) using hydrophilic materials via ionic crosslinking14, chemical crosslinking90, 100, 247, 
262 and co-precipitation39, 179 in an emulsion (Figure 2.6). Barrias et al. fabricated alginate 
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microgels encapsulating calcium titanium phosphate (CTP) to drive the osteogenic 
differentiation of human osteoblastic cells. CTP was first mixed at a ratio of 0.4 with 2% w/v 
sodium alginate aqueous solution and homogenized to form a paste. Afterwards, this CTP-
alginate paste was extruded drop-wise into a 0.1M CaCl2 crosslinking solution, in which 
spherical-shaped particles instantaneously formed. The size of the microspheres was controlled 
by regulating the extrusion flow rate using a syringe pump and also by applying a coaxial air 
stream. At completion of the gelling period, microspheres were recovered, dried and heated at 
1100°C for 1 h to burn off the polymer causing the CTP granules to become associated. It was 
observed that the CTP microspheres retained their spherical morphology and possessed a rough 
surface14. In an another type of gelation method, Zhu et al., Habraken et al., Watanabe et al., and 
Huang et al. fabricated gelatin microgels using a water-in-oil emulsion process followed by 
chemical (glutaraldehyde) crosslinking90, 100, 247, 262. They noticed that the swelling ratio (ratio 
between wet and dry volumes) of microgels was influenced by the concentration of the 
crosslinker used however; it did not affect their size. Lastly, Chesnutt et al. and Nguyen et al. 
produced composite microgels from chitosan and hydroxyapatite (HA) by employing a co-
precipitation gelation method. Deacetylated chitosan powder was first dissolved in 2 wt % acetic 
acid and then ten milliliter of 1M CaCl2 in 2% acetic acid and 6 mL of 1M NaH2PO4 in 2% 
acetic acid was added to the chitosan solution. The final solution was then extruded through a 
syringe fitted with a needle and placed on a syringe pump into a precipitation solution consisting 
of 20% sodium hydroxide, 30% methanol, and 50% water (pH=13). The precipitation solution 
caused the chitosan drops to precipitate into solid beads that were left in the basic solution to 
allow crystalline HA to develop from unstable brushite and amorphous calcium phosphate. 
Finally, the fabricated beads were washed with DI water until they reached a neutral pH of 7.0–
	 16	
7.5. Scanning electron microscopy (SEM) revealed that the fabricated beads were approximately 
spherical with a textured surface, which could be attributed to the presence of nano-scale calcium 
phosphate particles on the surface of the microspheres.   
The emulsion microgel fabrication method differs from other emulsion-based methods in 
the aspect that it involves the use of hydrophilic materials as microsphere matrices whereas the 
other methods primarily use relatively hydrophobic materials as matrices. However, it is similar 
to them in the fact that the size of the microspheres is majorly controlled by the emulsion 
parameters as observed in the other emulsion-based methods as well.  
 
CRYOGENIC DOUBLE EMULSION 
Cryogenic double emulsion or cryopreparation is a method commonly employed for preparing 
DNA or nucleotide encapsulating microspheres5, 112. The use of conventional DESE method to 
encapsulate DNA causes it to lose its native supercoiled state thus, resulting in loss of its 
bioactivity. Therefore, cryopreparation was developed as an improvement over the DESE 
method to encapsulate DNA into the microspheres.  
Cryopreparation involves lowering the temperature of the DNA-containing primary 
emulsion below the freezing point of the aqueous inner phase resulting in a solid particulate 
suspension prior to homogenization to form the secondary emulsion (Figure 2.7). 
Homogenization can cause shear stress induced DNA degradation. The shear stress within a solid 
is zero; therefore, plasmid DNA frozen in the inner phase is exposed to minimum shear stress 
during homogenization, thus preserving the supercoiled state of the plasmid DNA. Furthermore, 
cryopreparation also enhances the overall encapsulation efficiency of the plasmid DNA by 
preventing its diffusion out of the microsphere during homogenization.  
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Similar to DESE, the size of microspheres fabricated via cryopreparation is governed by 
parameters such as concentration of the organic phase, stabilizer or surface-active agent, mixing 
speed and rate of solvent evaporation. Moreover, the morphology of the fabricated microspheres 
is also similar to those fabricated via DESE. Cryopreparation differs from other emulsion-based 
methods using temperature as a variable parameter in regard that it involves only selective 
freezing of the aqueous inner emulsion whereas other methods freeze or gel the entire 
microsphere.  
Emulsion based methods were among the first methods to be used for microsphere 
fabrication. Although they have evolved a lot in terms of number of systems to which these can 
be applied yet they are limited in certain aspects. These methods offer minimal control over 
microsphere size; resulting in low encapsulation efficiency of the encapsulated molecule and also 
can lead to its denaturation during the encapsulation process. Therefore, to overcome these 
limitations new methods have been developed that offer better control over microsphere size and 
lead to high encapsulation efficiencies of encapsulated molecules without the loss of their 
bioactivity.  
 
THERMALLY INDUCED PHASE SEPARATION (TIPS) 
Before being applied to fabricate microspheres, thermally induced phase separation (TIPS) was 
used for making monoliths for tissue-engineering purposes. In TIPS, a solvent with a low boiling 
point that easily sublimes is used. Solvent dissolved matrix material (usually a polymer) droplets 
are either preformed via an emulsion or directly dropped (via a syringe or sprayed through a 
nozzle) into the cooling solution to generate porous microspheres (Figure 2.8). When the 
temperature of the polymer solution gets below the freezing point of the solvent, it separates into 
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a polymer-rich phase and a polymer-lean phase due to crystallization of the solvent. The polymer 
is expelled from the crystallization front to form a continuous polymer-rich phase and the solvent 
is sublimed to leave the pores, which are a three-dimensional fingerprint of the geometry of the 
solvent crystals21. The droplet forming parameters control the size of the microspheres fabricated 
by TIPS whereas the polymer concentration, solvent and the quenching temperature control the 
microstructure of the pores and walls.  
TIPS offers certain advantages over other microsphere fabrication techniques 
(particularly emulsion based) such as versatility, repeatability, and simplicity. Moreover, it also 
allows control over pore morphology and porosity within the microspheres. Furthermore, it 
permits the inclusion of drug and particulates with high encapsulation efficiency, as the 
encapsulation process is rapid. Additionally, the encapsulated molecules are not exposed to 
solvent phase for prolonged time thereby preventing their degradation. Lastly, the fabricated 
microspheres are exposed to an aqueous continuous phase for a short period thus only a small 
concentration of the encapsulated molecule diffuses out of the microsphere matrix. 
 
PROLEASE 
Originally described by Gombotz et al.32, in this process microspheres are produced by first 
dissolving a polymer/matrix in a solvent together with an active agent that can either be 
dissolved in the solvent or dispersed in it. The polymer/active agent mixture is then atomized 
into a vessel containing a liquid non-solvent, alone or frozen and overlaid with a liquefied gas, at 
a temperature below the freezing point of the polymer/active agent solution. When the 
combination with the liquefied gas is used, the atomized droplets freeze into microspheres upon 
contacting the cold liquefied gas, then sink onto the frozen non-solvent layer. The frozen non-
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solvent is then thawed. As the non-solvent thaws, the microspheres that are still frozen sink into 
the liquid non-solvent. The solvent in the microspheres then thaws and is slowly extracted into 
the non-solvent, resulting in hardened microspheres containing active agent either as a 
homogeneous mixture of the polymer and the active agent or as a heterogeneous two phase 
system of discrete zones of polymer and active agent. If a cold solvent is used alone, the 
atomized droplets freeze upon contacting the solvent, and sink to the bottom of the vessel. As the 
non-solvent for the polymer is warmed, the solvent in the microspheres thaws and is extracted 
into the non-solvent, resulting in hardened microspheres (Figure 2.9). Microspheres with 
different sizes can be made by either using nozzles with different diameters or by changing the 
viscosity of the polymer solution. An advantage of this method is that it doesn’t require the use 
of surface-active agents, as required in the most other processes for making microspheres that 
could interfere with release of encapsulated molecule or cause an undesirable reaction. Moreover, 
it results in minimal loss of the bioactive molecule during encapsulation (high encapsulation 
efficiency) and also preserves its biological activity. 
 
PRECISION PARTICLE FABRICATION 
Precision particle fabrication (PPF) is another method that offers better control on microsphere 
size as compared to other fabrication methods. In PPF, a solution containing the microsphere 
matrix, and any other molecule to be encapsulated, is passed through a small nozzle to form a 
smooth cylindrical jet. A piezoelectric transducer driven by a wave generator at a frequency 
tuned to match the flow rate and the desired drop size vibrates the nozzle. The mechanical 
excitation launches a wave of acoustic energy along the liquid jet generating periodic instabilities 
that, in turn, breaks the liquid jet into a train of uniform droplets. To further control the sphere 
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size, an annular flow of a non-solvent phase around the matrix jet is employed that is pumped at 
a linear velocity greater than that of the matrix stream. The frictional contact between the two 
streams generates an additional downward force that effectively pulls the microsphere solution 
away from the orifice of the nozzle. The microsphere matrix stream is accelerated by this force 
and, therefore, thinned to a degree depending on the difference in linear velocities of the two 
streams. The emanated microspheres are flowed into a beaker containing non-solvent phase with 
a surfactant to prevent them from coalescing (Figure 2.10). To extract the solvent, incipient 
microspheres are stirred for 3–4 hours and subsequently, the hardened microspheres are filtered 
and lyophilized18, 19, 59, 60, 62, 64, 66, 114, 169, 171, 213, 215, 216. 
PPF allows a user to control the microsphere size by varying the process parameters that 
include: (a) the nozzle diameter, (b) flow rate of matrix material, (c) flow rate of non-solvent 
phase, (d) frequency, and (e) amplitude of acoustic energy employed. Using PPF, predetermined 
mono-disperse microspheres can be fabricated within 10-20% range of the set target size. Such a 
precise control over microsphere size can have critical implications in the field of tissue 
engineering. The ability to fabricate mono-disperse microspheres can lead to improved systems 
to explore the effects of microsphere size on microsphere-based scaffolds. Scaffolds made of 
uniform microspheres can be employed to study the influence of microsphere size on the 
degradation patterns and rates within scaffolds. In addition, uniform size microspheres can pack 
closely compared to randomly sized microspheres, providing better control over the pore sizes 
and porosity of the scaffold, and may considerably aid the mechanical integrity of the scaffolds. 
Moreover, local release of molecules from the microspheres in a bulk scaffold is related to size 
of an individual microsphere and its material properties. Reproducibility and predictability 
associated with uniform microsphere-based scaffolds can make them suitable for a systematic 
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study of physical and chemical effects in order to achieve control over local release of growth 
factors within such a scaffold215.  
 
FLAME SPHEROIDIZATION 
Lakhkar et al. demonstrated the successful production of titanium phosphate glass microspheres 
using an inexpensive, efficient and easily scalable process called flame spheroidization. The 
microsphere fabrication apparatus comprised of: - (a) a blowtorch, (b) feed and (c) collectors 
(Figure 2.11). The blowtorch assembly consisted of a gas torch fitted to a gas cylinder. The 
blowtorch assembly was positioned such that the flame of the gas torch was horizontal. The feed 
assembly comprised of an aluminum trough with the edge of one end positioned ∼10 mm above 
the outlet of torch at a slight angle to the horizontal. A DC motor was attached to the other end of 
the trough and was connected to a programmable power supply. A metal screw connected to the 
axle of the motor served as an offset to generate vibration when the motor was in operation so 
that the particle feed for microsphere production was distributed over the surface of the trough 
before the particles entered the flame. The collectors consisted of four rectangular glass boxes 
with their longer edges in contact with each other. The first collector was placed directly below 
the flame so as to collect particles that did not pass through the flame. During operation, glass 
microparticles placed at one end of the trough travelled to the other end under the influence of 
vibratory forces exerted by the DC motor. At the other end, the particles passed into the flame 
and then travelled along the flame axis. As they passed through the flame, they underwent 
spheroidization due to surface tension forces and were then collected in the glass boxes placed 
one after the other below the flame.  
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Flame temperature and the particle residence time in the flame are the only factors that 
affect the size of the microspheres in flame spheroidization process142. The advantages of the 
method include that it is: - (a) inexpensive, (b) efficient as the microspheres can be produced 
very quickly, and (c) easily scalable to make kilograms of microspheres. All of these attributes 
are highly desirable from the standpoint of developing viable commercial applications.  
 
Summary Of Microsphere Fabrication Methods 
In summary, there are merits and demerits associated with each microsphere fabrication method. 
Emulsion based methods are relatively simple and can be used to fabricate microspheres from a 
variety of materials however; they yield particles with non-uniform size and broad size 
distribution. On the other hand, processes like Prolease, PPF and Flame spheroidization can 
fabricate uniform size with narrow size distribution but they are complex and require special 
apparatus. Moreover, the processing parameters involved in the microsphere fabrication hugely 
impact the microspheres’ characteristics. Therefore, the choice of method for microsphere 
fabrication will largely depend on the desired characteristics, composition, and amount of 
microspheres; on the release profile of the encapsulated protein; and lastly on the intended 
application of the microspheres. 
 
METHODS OF MICROSPHERE SINTERING 
Once fabricated, microspheres can either be used as cell/cell-matrix delivery vehicles (IMSs) or 
packed and joined to create three-dimensional structures (SMSs), which can provide mechanical 
support to the regenerating tissue and can also present the surrounding cells with differentiation 
cues to go down a specific lineage. The injectable scaffolds will be discussed separately along 
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with the applications of the MSs in regenerating different type of tissues. In this section, various 
methods used for coupling (aka sintering) microspheres will be described in detail highlighting 
the effects of sintering process parameters on scaffold properties (porosity, mechanical 
characteristics, etc.). Furthermore, merits and demerits of each sintering process will also be 
listed.      
 
HEAT SINTERING 
Heat sintering is the most widely used method to sinter microspheres (Table 2.2) for fabricating 
SMSs4, 11, 25, 26, 44, 46, 47, 105-108, 115-117, 137, 138, 140, 151, 158, 160, 190, 228, 239, 242, 246, 255. Briefly, prefabricated 
dried polymeric microspheres are poured into a mold and heated to a specific temperature above 
the glass transition temperature (Tg) of the polymeric matrix for several hours resulting in the 
melting of the surface layer on the microspheres and thus inducing them to bond with their 
adjacent neighbors forming a three-dimensional porous scaffold (Figure 2.12).  
Microspheres are the building blocks of SMSs therefore; their characteristics in turn 
govern the properties of the fabricated scaffolds irrespective of the method used to fabricate 
scaffolds. Borden et al.26 fabricated PLAGA microspheres heat sintered scaffolds and observed 
that decreasing the microsphere size increased the compressive modulus of the sintered scaffolds. 
This phenomenon was due to the increase in surface area that further increased the number of 
fusion points between the spheres thereby leading to stronger bonding between the spheres. 
Moreover, decreasing the size led to smaller pore size but did not affect the overall porosity of 
the scaffolds. Other than microsphere size, sintering temperature and sintering time are 
recognized as two crucial factors influencing the mechanical properties and porosities of the heat 
sintered scaffolds. A higher sintering temperature and a longer sintering time have equivalent 
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effects on the properties of the scaffolds. In general, a higher sintering temperature results in an 
elevated compressive modulus and compressive strength, a greater median pore size, and 
decreased pore volume. This is because elevated sintering temperature results in greater fusion 
between the microspheres, which contributes to the increase in the compressive properties of the 
scaffolds. At the same time, greater fusion between microspheres results in possible closure of 
pores among three or more microspheres in contact, which decreases the overall pore volume of 
the scaffolds. On the contrary, lower sintering temperature and shorter sintering time induce 
weaker coalescent bonds among the adjacent microspheres that results in lower capability of 
SMSs to resist outside forces.  
The heat sintering method has several advantages compared to other sintering methods 
especially solvent-based methods. Heat sintering method is simple and efficient, as it requires 
moderate temperatures whereas methods like solvent vapor sintering requires an organic solvent 
and also in some cases high temperatures as well. Moreover, heat sintering offers flexible time 
constraints (on the order of several minutes) that make fabricating scaffolds with consistent 
mechanical properties relatively easy. On the other hand, time constraints offered by solvent-
based methods are more stringent (on the order of a few seconds). If a scaffold is left for too long 
during solvent sintering, it could result in significantly reduced porosity of the structure thus, 
simultaneously compromising the mechanical properties of the scaffold. Lastly, a large number 
of scaffolds can be fabricated via heat sintering (in an oven) at one particular time whereas 
methods like solvent sintering requires exposure of the scaffolds to solvent (or its vapors) in a 
confined space thereby limiting the number of scaffolds that can be sintered at any given time 253. 
The biggest drawback of using heat sintering for fabricating SMSs is that it makes encapsulation 
of bioactive molecules difficult. The sintering temperatures and durations of heat exposure used 
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in some previous studies were 650C for 4 h, 700C for 4 h and 620C for varied times of 4, 24, 48, 
and 72 h215. Such high temperatures for extended durations may lead to reduction or complete 
loss in bioactivity of the encapsulated proteins. Furthermore, properties such as Tg, viscosity, 
crystallinity and surface tension of the polymer, as well as heating conditions (heating 
temperature and heating time), must be taken into consideration when fabricating SMSs utilizing 
heat sintering therefore; it is not applicable across a broad spectrum of polymer types due to its 
dependence on those parameters.  
 
SOLVENT BASED METHODS 
Solvent-based sintering strategy is another widely used approach for fabricating SMSs (Table 
2.2) because only two factors must be taken into account in solvent based strategies: (i) species 
of solvent and (ii) sintering time. Solvent-based sintering methods can further be divided into 
three categories: - (a) solvent vapor sintering 109, 110, (b) poor solvent sintering 39, 59, 60, 62, 64, 66, 169, 
171, 179, 208, 213, 215, and (c) solvent/non-solvent sintering 29, 30, 184, 186, 200.  
 
SOLVENT VAPOR SINTERING 
In solvent vapor sintering, the scaffold fabrication process relies on diffusion of solvent vapors 
into the microspheres, which lowers the polymer glass transition temperature, thus softening the 
microspheres and allowing them to fuse (Figure 2.12). Jaklenec et al.110 fabricated bovine serum 
albumin (BSA) loaded PLGA SMSs via dichloromethane (DCM) vapor sintering and studied the 
effects of sintering time and protein loading on the extent of fusion. They observed that the rate-
limiting step in scaffold fusion was the saturation of fusion chamber with DCM vapors. Once the 
chamber reached the saturation vapor pressure for DCM, the further reaction was rather fast. 
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After 4 min, the microspheres started to fuse together and after 4 min and 30 s the scaffold was 
over fused, finally turning into a film after 5 min. At that point, the dichloromethane had 
sufficiently penetrated throughout the entire microsphere matrix reducing the polymer Tg, 
whereas at earlier time stages only the microsphere surface was affected. Additionally, it was 
observed that the fusion time increased with scaffold mass. This was because the fusion process 
was governed by dichloromethane vapor diffusion and added mass generally indicated longer 
diffusion time. Furthermore, microspheres containing the least amount of BSA fused the most 
while those with the highest amount of BSA fused the least, showing that when fusion time and 
mass were held constant, the fusion process was more pronounced for samples with less BSA. 
This phenomenon was a function of BSA, which acted as reinforcement for the soft 
microspheres, thus requiring more vapors for fusion.  
The biggest advantage of solvent vapor sintered microsphere scaffolds is that growth 
factors or proteins can be encapsulated and released from these scaffolds in bioactive form. 
Jaklenec et al.109 showed that both insulin growth factor-I (IGF-I) and transforming growth 
factor-β1 (TGF-β1) were released in bioactive form for up to 70 days from PLGA SMSs sintered 
via DCM vapors. Moreover, the method allows control over scaffold morphology, composition, 
spatial distribution, pore size, and protein release kinetics. Changing the process parameters can 
vary these scaffold attributes. However, it can be argued that presence of residual solvent can 
potentially have deleterious effects. Furthermore, stringent time constraints and consistency 
issues add to the limitations of the technique.   
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POOR SOLVENT SINTERING 
With the use of poor solvent sintering technique, bioinductive microsphere scaffolds can be 
fabricated consisting of growth factor or protein encapsulating microspheres. In this technique, a 
poor solvent for microsphere matrix is used as the sintering agent. The stacked microspheres are 
treated with the poor solvent causing Tg of the matrix material to drop, which results in softening 
of the microspheres near the surface generating a skin layer around them. These skin layers then 
adjoin resulting in formation of sintering junctions among the adjacent microspheres (Figure 
2.12).  
Singh et al.215 fabricated PLGA microsphere scaffolds employing poor solvent ethanol 
for PLGA sintering. They observed that the duration of the ethanol soak was an important 
process parameter, as longer durations led to increase in the extent of interconnection between 
the microspheres due to increased thicknesses of the surface film layer formed by the diffusion 
of ethanol into the microspheres. Moreover, it was observed that increased durations of ethanol 
exposure led to increased deformation of the microspheres from spherical morphology. In 
addition to ethanol soak time, polymer properties such as molecular weight and crystallinity also 
affected the extent of sintering between the microspheres. Furthermore, mechanical test results 
indicated that the average elastic modulus of scaffolds soaked with ethanol for 60min was 
significantly higher than the moduli of the scaffolds soaked for 30min and 240min. The observed 
phenomenon was due to the fact that scaffolds prepared by a 30min soak did not have well-
integrated microspheres resulting in poor mechanical properties whereas, the reduction in 
mechanical integrity for scaffolds sintered for 240min might be because of increased 
morphological distortion of the microspheres from a spherical shape resulting in a poor packing 
of the microspheres. On the other hand, changing the ethanol soak time resulted in only slight 
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variation in the overall porosity of the scaffold. The mean theoretical porosities of scaffolds 
soaked for 30min, 60min, 120min and 240min were 41.1%, 38.8%, 32.8%, and 40.4%, 
respectively. The porosity for the 240min group was higher than that for the 60min and 120mi 
groups; however, no statistically significant differences were noticed among the groups. In 
addition to affecting the scaffold properties, ethanol treatment was found to affect the polymer 
properties215 and the release of the encapsulated proteins60. The ethanol treatment during the 
fabrication of scaffolds resulted in a drop of 14% in Tg of the PLGA when compared to the raw 
polymer215. This was due to the plasticization effect of ethanol on PLGA.  Dormer et al.60 
noticed considerable differences in protein release from microspheres treated with ethanol. It was 
observed that the ethanol-treated groups released more proteins from PLGA microspheres 
because of a pre-solubilization effect of ethanol on the polymer that allowed for diffusion of 
proteins from the innermost layers of the microspheres towards the perimeter. When placed in 
release medium, the outermost layers of the microspheres were primed with proteins, hence 
dumping large quantities of proteins in the first week of release.  
In contrast to solvent vapor sintering method, poor solvent sintering employs a relatively 
milder organic solvent that can be easily removed via subsequent processing methods like 
freeze-drying thus preventing any deleterious effects caused by the residual solvent. The poor 
solvent sintering method requires long exposure to the solvent (due to use of a poor solvent) 
thereby increasing the time required for scaffold fabrication. However, the time required for 
scaffold fabrication is still comparable (often less) to the time required in heat sintering thus 




Solvent/non-solvent sintering is similar to the poor solvent sintering method except for that it 
involves the use of a solvent and a non-solvent, which are selected based on the following 
parameters: the solvent is more volatile (higher vapor pressure at room temperature and pressure) 
than the non-solvent, the solvent and non-solvent are miscible, and there exists no azeotropes 
across the range of solvent/non-solvent ratio. The solvent/non-solvent sintering method sinters a 
range of different polymers based on Flory–Huggins solution theory, which states that a greater 
affinity between the solvent and polymer will allow the solvent to dissolve progressively longer 
chains of the polymer. The solvent in the solvent/non-solvent mixture allows polymer chains on 
the surface of the microspheres to swell and intertwine with each other. The sintering is 
completed when the more volatile solvent begins to evaporate at a greater rate than the less 
volatile non-solvent, which decreases the affinity of solvent/non-solvent mixture for the surface 
chains and causes polymer precipitation resulting in bonding between the microspheres29.  
Parameters such as solvent/non-solvent sintering solution composition and submersion 
time affect the sintering process. If the solvent concentration becomes too high, dissolution will 
occur freeing the smaller surface chains and leading to the occlusion of the pores and flattening 
of the resulting scaffold. The submersion time appears to affect the bonding region only slightly 
and has a more profound effect on the morphology of the microspheres. Presumably this slight 
correlation between submersion time and bonding region is caused by quickly reaching a steady 
state between the solvent/non-solvent sintering solution and the microsphere surface. The long 
submersion time allows diffusion of the sintering solution throughout the microsphere allowing 
interior polymer chains to move in relation to each other resulting in a change in the spherical 
morphology of the microsphere29. 
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Brown et al.29 studied the versatility of the solvent/non-solvent sintering process with six 
different biodegradable polymers and compared it to heat sintering. They observed that the 
microsphere scaffolds fabricated via solvent/non-solvent sintering exhibited porosities similar to 
those observed with heat sintered scaffolds and produced average pore diameters that are in the 
range necessary for in vitro cell culture as well as in vivo scaffold implantation. The porosities 
and pore diameters of the poly[bis(ethyl alaninato)phosphazene] (PNEA) and poly[bis(ethyl 
phenylalaninato) phosphazene] (PNEPhA) scaffolds showed a significant dependence on the 
solvent/non-solvent sintering solution composition with the overall trend being a decrease in 
porosity and pore diameter at high solvent compositions. The higher solvent compositions 
created a greater bonding region, which occluded some of the porosity while decreasing the 
diameter of the resulting pore. The poly[bis(methyl valinato)phosphazene], (PNMV) scaffolds 
had the opposite trend with respect to the total porosity, which was thought to be caused by an 
exposure of the interior porosity of the microspheres due to fracturing or dissolution of the 
surface chains covering the interior pores. Additionally, the compressive modulus of the 
PNEPhA scaffolds showed a significant correlation with solvent/non-solvent sintering solution 
composition. The highest modulus observed was found at the middle solvent concentration. The 
increase in modulus from the low to mid was expected due to increase in the bonding region. 
However, the decrease in modulus from the mid to the high composition was unexpected. This 
decrease could be attributed to dissolution of the surface chains on the porous PNEPhA scaffolds 
resulting in a loss of integrity of the individual microspheres leading to premature failure of the 
individual microspheres as opposed to failure of the bonding region between the spheres. On the 
other hand, the mechanical properties of PNMV microspheres showed no dependence on 
solvent/non-solvent sintering solution composition, which suggested that the observed modulus 
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corresponded with the bulk material or the individual microsphere and not the bonding region 
between the microspheres. 
The advantages of the solvent/non-solvent sintering method include that it can be used 
regardless of the physiochemical properties of a polymer, and can be tailored to produce the 
desired degree of microsphere interconnectivity by varying the concentration of the solvent/non-
solvent sintering solution, and to a lesser extent by varying the submersion time. Moreover, 
being a milder method, the solvent/non-solvent sintering technique could potentially allow 
preloading of bioactive factors within the scaffold for controlled/sustained release. Lastly, the 
solvent/non-solvent sintering technique does not require specific mold geometry, therefore a 
large number of different scaffold geometries can be fabricated29. The major limitation of the 
method is that it involves considerably large amounts of organic solvents which if not completely 
removed can have undesirable effects on the seeded cells and surrounding tissues. Moreover, 
some of the solvents used in the sintering method involve methylene chloride, chloroform, 
hexanes, etc., which can alter the secondary structure of encapsulated proteins and thereby affect 
their biological activity.  
 
SUBCRITICAL CO2 SINTERING 
Subcritical CO2 sintering is a straightforward method to fabricate cell-seeded, shape-specific 
microsphere scaffolds in a single step (Figure 2.12). These SMSs retain their advantages of 
spatiotemporal control for creating three-dimensional signal and stiffness gradients for interfacial 
tissue engineering within a single scaffold. Compared to the other methods of microsphere-based 
scaffold fabrication, the CO2 sintering method is a more benign process. Moreover, it is also 
suitable for producing cell-containing matrices under relatively mild conditions. The ability to 
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create cell-loaded scaffolds and patches can have important implications in tissue engineering, 
where growth factor-encapsulated microspheres can be used to design cell-loaded controlled 
release vehicles in a single step.  
 
The subcritical CO2 sintering method for manufacturing SMSs is a modification of the 
conventional gas-foaming technique used for fabricating porous structures, where saturation of 
the polymer with CO2 is performed at either supercritical pressures (≥ 7MPa) or subcritical 
pressures (< 7MPa) with equilibration periods of 24hrs and 2hrs respectively. Afterwards, rapid 
depressurization then leads to the nucleation of the gas thereby forming pores in the material. To 
prepare sintered microsphere scaffolds, the equilibration of CO2 in the polymer is performed 
with subcritical CO2 with significantly reduced exposure times. These conditions lead to a 
comparatively reduced plasticized state or a relatively less swollen state of the polymer limited to 
the surface of the microspheres. This state allows microspheres to retain their shape, while 
subsequent adhesion (and/or reptation) leads to sintering of the adjoining microspheres. The 
advantage of subcritical CO2 sintering over the conventional gas foaming technique is that the 
subcritical sintering is less time consuming and allows for incorporation of bioactive factors and 
moreover, leads to open pore structures with interconnected pores. 
 
The conditions (time and pressure) of CO2 exposure are the primary factors responsible 
for promoting the mutual penetration, increasing the chain mobility at the interfaces of adjoining 
microspheres and the subsequent adhesion of the microspheres. In addition, the rate of 
depressurization is an important factor that governs the basic morphology of the scaffolds. Singh 
et al.216 fabricated PLGA SMSs via CO2 sintering using a pressure of 1.5 MPa and the duration 
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of CO2 exposure was restricted to 1hr. They observed that a moderate rate of depressurization 
(0.014–0.021MPa s-1) was optimal for the production of sintered matrices whereas, instantaneous 
depressurization (in less than 5 s) or depressurization at very slow rates (< 0.007MPa s-1) led to 
foaming of the prepared scaffolds. Moreover, the extent of sintering also depended on the 
microsphere size and properties of the polymer. Jeon et al.114  fabricated PLGA microsphere 
scaffolds using subcritical (or dense phase) CO2 and studied the effects of polymer properties, 
porogen concentration and sintering process parameters on the mechanical properties and 
morphologies of the scaffolds. They observed that the optimal range of CO2 pressure was 1.5–
2.5MPa for fabricating scaffolds. Scaffolds prepared at 2.5MPa with lower lactic acid ratios and 
without porogen particles had a higher stiffness, while the constructs made at 1.5MPa, with 
lower glycolic acid content, and with porogen granules had lower elastic moduli. Furthermore, 
no statistically significant differences were observed in scaffold porosities with increase in 
applied CO2 pressure and with increase in lactide:glycolide ratio. However, porogen 
concentration (at a given applied pressure) significantly affected the scaffold porosities with 
increasing concentration resulting in higher porosities. 
 Though subcritical CO2 possess key advantages but it also suffers from some limitations. 
The process requires complex apparatus and at high pressures for long durations the technique 
may not be cytocompatible due to known sterilization efficacy of CO2 caused by lowering the 
cytoplasmic pH by the formation of carbonic acid and by the shear forces of intercellular bubble 
formation upon depressurization. 
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SELECTIVE LASER SINTERING (SLS) 
In recent years conventional microsphere sintering methods have been much improved and have 
been widely used for making scaffolds to regenerate a variety of tissues, however they can only 
produce scaffolds with simple architecture, irregular pores and pore sizes in a manual and 
inconsistent manner. Therefore, to overcome the limitations associated with the conventional 
methods, rapid prototyping (RP), also known as solid free-form fabrication (SFF), has been 
developed that can produce three-dimensional scaffolds with complex shapes and architecture in 
a layer-by-layer manner using data generated by computer-aided design (CAD) systems, by 
computer-based medical imaging techniques such as computer tomography (CT) or magnetic 
resonance imaging (MRI), and by digitizers. Among various RP technologies, selective laser 
sintering (SLS) has been found to be advantageous for tissue engineering scaffolds due to its 
ability to process a wide range of biocompatible and biodegradable materials. In the SLS process, 
3D computer images are first sectioned into thin 2D layers (~0.1 mm thick) and then the 
scaffolds are built layer-by-layer to the required size, shape and internal structure by laser-
induced (usually a CO2 laser) fusion of microspheres (Fig. 12). The interaction of the laser beam 
with the microspheres elevates the polymer temperature to reach the glass-transition temperature, 
causing surfaces in contact to deform and fuse together. 
The potential advantages of SLS in production of scaffolds include: (i) fewer design 
constraints, (ii) customization (patient-specific), (iii) faster manufacture speed, (iv) functionally 
graded materials, (v) free of toxic solvents and (vi) controllable and reproducible structures and 
porosity. Although SLS is a promising technology for TE scaffold fabrication, so far it is not 
economical to use because commercial SLS machines require large quantities of biomaterial thus, 
making the process very expensive. Moreover, the biomaterials are not available in the 
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appropriate powder form to be processed by these machines. Therefore, Zhou et al.260 modified a 
commercial SLS system (Sinterstation® 2000) in order to produce scaffolds using small 
quantities of biomaterial powders. Porous scaffolds were sintered from poly(L-lactide) (PLLA) 
microspheres and PLLA/carbonated hydroxyapatite (CHAp) nanocomposite microspheres using 
the modified SLS machine. In order to reduce the consumption of biomaterial powders a 
miniature sintering platform consisting of a miniature build cylinder and two powder supply 
chambers, were designed, fabricated and installed in the build cylinder of the existing SLS 
machine. The miniature build cylinder had a diameter of 49mm and the movement of its base 
was directly linked to the base of the existing build cylinder of the Sinterstation® 2000 system. 
Two additional stepping motors beneath the miniature-sintering platform drove the two powder 
supply chambers. In the sintering processes, the original powder supply tanks of the 
Sinterstation® 2000 system were empty and small amounts of biomaterial powder were fed from 
the miniature powder supply chambers. The roller positions were sensed and the signals were fed 
to a control panel, which controlled the movement of stepping motors and the temperature of the 
small build cylinder. Other sintering parameters were controlled by the existing Sinterstation® 
2000 system. Though they were able to successfully fabricate three-dimensional scaffolds using 
the modified SLS system, however they did not study the effects of SLS processing parameters 
on the properties of fabricated scaffolds. Duan et al. studied the effects of various SLS 
parameters on the properties of sintered scaffolds where they fabricated poly(hydroxybutyrate-
co-hydroxyvalerate) (PHBV) and calcium phosphate (Ca–P)/PHBV nanocomposite scaffolds. 
They applied three-factor three-level complete factorial design to investigate the effects of the 
three factors (laser power, scan spacing, and layer thickness) on scaffold quality and to optimize 
SLS parameters for producing good-quality PHBV scaffolds and Ca–P/PHBV scaffolds. The 
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optimization results showed that all the three factors had significant effects on the integrated 
response, which was concerned with the structure and handling stability, dimensional accuracy 
and compressive properties of the fabricated scaffolds. Furthermore, based on the regression 
equation, optimized PHBV scaffolds and Ca–P/PHBV scaffolds were fabricated using the 
optimized values of SLS parameters69. The compressive strength and modulus for optimized Ca–
P/PHBV scaffolds were 0.24 ± 0.02 and 3.96 ± 0.64MPa, respectively, and for PHBV scaffolds, 
the corresponding values were 0.19 ± 0.02 and 2.38 ± 0.29MPa. Although the compressive 
properties of both types of scaffolds were lower than those of human trabecular bone however, 
they could be potentially used to regenerate bone in non-load bearing areas, such as calvarial 
reconstruction.  
 
Summary Of Microsphere Sintering Methods 
To summarize, a number of microsphere sintering techniques have been developed so far to 
fabricate SMSs with simple shapes and architecture. An important future step from a tissue 
engineering perspective will be the advancement of these techniques to form 3D scaffolds with 
intricate geometries. Techniques like SLS and subcritical CO2 sintering hold great promise to 
create shape specific scaffolds. However, their inability to create scaffolds with finer resolutions 
and dependence on mold geometries (subcritical CO2 sintering) may postpone their widely 
accepted use in the tissue engineering community. Hence an ideal method to fabricate SMSs 
should: - allow control over scaffold properties, be free of organic solvents, preserve the 
bioactivity of encapsulated proteins, provide the ability to create scaffold with complex 
architectures, and allow simultaneous seeding of cells in a single step.  
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The musculoskeletal organ system is responsible for providing structure, stability, support and 
movement to the body. Thus, diseases and conditions affecting the system can severely reduce its 
function and effectiveness thereby, impairing the quality of life. These musculoskeletal disorders 
(MSDs) are an increasing healthcare issue globally and are the second leading cause of 
disability13. For instance, in the U.S. alone the total cost for treating MSDs is estimated to be 
more than $125 billion per year and the musculoskeletal-related procedures constituted 24.2% of 
all operating room procedures performed during hospital stays81, 249. Therefore, there is an urgent 
need to explore new treatment strategies for the steadily growing number of MSD patients. 
Tissue engineering offers an attractive alternative to treat MSDs by providing patient specific 
biological grafts overcoming limitations, like donor shortage and graft rejection associated with 
the currently employed surgical grafts.  Of the various types of scaffolds employed in tissue 
engineering strategies microsphere scaffolds (MSs) have gained importance lately due to their 
ease of fabrication, ability to discretely control particle physicochemical properties and 
versatility for controlling the release kinetics of encapsulated bioactive molecules. Besides their 
ability to provide controlled release, MSs also possess excellent mechanical properties that 
further make them suitable candidates for regenerating musculoskeletal tissue. In the following 
section, various microsphere-scaffolding strategies used in regenerating different 




When trauma or a degenerative disease causes the loss of significant portion of bone, the 
remaining tissue may have difficulty in repairing itself. A graft/scaffold must be placed at the 
defect site in order to allow the adjacent bone to bridge the gap created by the defect. To date, 
autologous trabecular bone grafts taken from the patient’s iliac crest serve as the gold standard in 
such bone grafting procedures. Due to its osteoconductive nature and well-organized three-
dimensional pore structure, the autologous graft plays an important role in healing by serving as 
an effective scaffold for new bone regeneration. It allows for the infiltration of osteogenic and 
perivascular cells at the defect site, thus allowing healing to occur. Moreover, the graft houses 
growth factors that allows for differentiation of surrounding cells, initiation of osteogenesis and 
graft revascularization. The revascularization facilitates the migration of additional osteogenic 
cells to the graft site, thereby resulting in thickening of the internal structure of the graft and 
significant increase in its mechanical integrity. Upon union with the host bone (osteointegration) 
and the transfer of stress to the graft site, the internal graft structure undergoes a remodeling 
phase in which bone is resorbed and formed in response to mechanical stimuli25.  
As seen from the mechanism of bone regeneration within autologous trabecular bone, 
graft incorporation is dependent on osteoconductive bone growth and revascularization. Using 
tissue-engineering principles, several polymeric scaffolds have been designed specifically with 
the hope of supporting and promoting bone repair and regeneration. In 2001, Borden et al.25 
evaluated the osteoconductive properties of a PLAGA microsphere sintered matrix in an in vitro 
environment. They evaluated the cellular response of osteoblasts and fibroblasts on the structure 
of the matrix. It was observed that both osteoblasts and fibroblasts grew over the PLAGA 
matrices and were capable of bridging the gaps in the structures. Moreover, these cells exhibited 
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a unique behavior that helped their proliferation on the matrices. After their initial attachment, 
electron microscopy (EM) revealed that these cells formed extensions between adjacent 
microspheres. These cytoplasmic connections, along with cell–cell signaling, served as a guide-
wire for additional cellular bridging. Another interesting finding of the EM was that these cells 
proliferated in concentric rings around the pores within the matrix. Over time, the diameter of the 
pores slowly decreased as the cells grew in concentric rings. In terms of clinical healing, the 
consequence of this type of cellular organization may be advantageous to the eventual 
remodeling of an implant site. The natural structure of trabecular bone consists of mineralized 
sheets of collagen organized in concentric rings about a central Haversian canal. By promoting 
cells to arrange in concentric layers throughout the pore system of the matrix, the regenerating 
tissue may organize in a manner similar to that of trabecular bone. Furthermore, trabecular bone 
typically consists of 30% bone and 70% void volume. The sintered matrices were found to have 
porosities (30-40%) similar to the percent bone found in trabecular bone. Due to the porous 
microsphere structure, the sintered matrices can serve as a negative template for trabecular bone 
regeneration. Lastly, with the compressive modulus ranging from 137.44 to 296.87MPa, the 
sintered microsphere structure appeared to be capable of sustaining loads in the mid-range of 
trabecular bone26.  
Though the PLAGA sintered matrices are biocompatible and possess some 
osteoconductive properties, the utility of these matrices for bone regeneration may be limited by 
the lack of functional groups to which bioactive molecules may be attached in order to improve 
biological performance. Therefore, Jiang et al.115 fabricated chitosan encapsulating PLAGA 
microsphere sintered microsphere scaffolds to impart functionality to the previously developed 
PLGA matrices and further improve their bioactivity. It was observed that the PLAGA/chitosan 
	 40	
matrices had porosities and mechanical properties similar to their PLAGA counterparts. The 
presence of chitosan on the scaffold surface retarded the proliferation of MC3T3-E1 osteoblast 
like cells on composite chitosan/PLAGA scaffolds at early time points due to very high 
roughness of composite microsphere surface, however cell proliferation on composite scaffolds 
become comparable to the PLAGA scaffold at later time points. Moreover, monitoring of 
phenotypic expression of the MC3T3-E1 cells revealed that the composite scaffold up-regulated 
the expression of osteopontin (OPN) as compared to the PLAGA scaffold, which suggested that 
the presence of chitosan facilitates the maturation of MC3T3-E1 cells. Furthermore, the elevated 
expression of bone sialoprotein (BSP) on chitosan/PLAGA scaffold at days 14 and 21 suggested 
higher mineralized matrix formation on composite scaffold. Additionally, it was demonstrated 
that heparin could be immobilized onto the PLAGA/chitosan composite scaffolds due to the 
functionality imparted by chitosan because of its reactive amino groups. Immobilized heparin at 
a low dosage showed a stimulatory effect on MC3T3-E1 cell proliferation and differentiation 
(indicated by the enhanced osteocalcin expression) whereas high heparin loading did not show 
such effects116. The chitosan/PLAGA scaffolds were further implanted in vivo in a critical-sized 
rabbit ulnar defect to evaluate their bone regeneration capacities. New bone formation at the 
defect initially occurred at the distal ends of the scaffolds and on the side of the scaffold adjacent 
to the radius irrespective of the type of the scaffold. This was because of the fact that distal ends 
of the scaffold were in contact with the bone marrow, which contains bone marrow stromal cells, 
and the side of the scaffold adjacent to the radius was in contact with the periosteum, which 
contains osteoprogenitor cells. It was observed that immobilization of heparin and recombinant 
human bone morphogenetic protein-2 on the chitosan/PLAGA scaffold surface promoted early 
bone formation as evidenced by complete bridging of the defect along the radius and 
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significantly enhanced mechanical properties when compared to the chitosan/PLAGA scaffold. 
Furthermore, histological analysis suggested that chitosan/PLAGA-based scaffolds supported 
normal bone formation via intra-membranous ossification route117. 
Almost 70% of bone mass is composed of a mineral, primarily poorly crystalline 
hydroxyapatite (HA), therefore, efforts are being made to incorporate ceramics (particularly 
calcium phosphates) into scaffolds to enhance bone regeneration. Moreover, ceramics like HA 
are highly biocompatible, osteoconductive, and osteointegrative through the cyclical process of 
calcium phosphate dissolution and remineralization therefore; their use in scaffolds is further 
warranted. Additionally, the Ca2+ and PO42- functional groups present in HA make it an excellent 
substrate for protein absorption during growth factor loading. On the other hand, crystalline 
calcium phosphates are known to have slow degradability, high melting temperatures, and brittle 
nature, which present certain difficulties when used as candidate materials for bone grafting. 
Therefore, to overcome these limitations ceramics are used in combination with a biodegradable 
polymer, thus benefitting from the structural and biodegradable properties of the polymer and 
from the bioactive and osteointegrative properties of the ceramic. Cushnie et al.46 studied the 
effects of adding in-situ synthesized amorphous HA to the PLAGA microsphere scaffolds on 
their physical characteristics. Moreover, they also investigated the in vitro degradation 
mechanism of these scaffolds. Surface area of the PLAGA scaffolds was found to be 
significantly increased with HA addition due to the presence of small micropores (< 50µm) on 
the surface of the composite microspheres. Uniaxial compression testing showed that the purely 
polymeric scaffolds were significantly stronger than the composite ones because of the increased 
porosity that resulted from HA addition. Lv et al.160 demonstrated that varying parameters, such 
as sintering temperature, sintering time, and PLAGA/nano-HA ratio, could control the physical 
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characteristics of the composite scaffolds. Furthermore, evaluation of human mesenchymal stem 
cells (hMSCs) response to the PLAGA/n-HA scaffolds that the cells showed enhanced 
proliferation, differentiation, and mineralization on the composite when compared with those on 
PLAGA scaffolds. Apart from calcium phosphates, inorganic materials like titanium dioxide 
(TiO2) and hexagonal mesoporous silica (HMS) are also incorporated into microsphere scaffolds 
for bone regenration. TiO2 powder has been shown to improve the osteoconductivity in vitro and 
in vivo. It induces apatite formation on PLGA/TiO2 composite surface in simulated body fluids 
(SBF), which is believed to be a prerequisite for bioactivity. Moreover, TiO2 nanoparticles 
effectively enhance cell attachment and proliferation by promoting protein absorption. Wang et 
al.246 fabricated TiO2 encapsulating PLGA microsphere sintered scaffold and observed that these 
scaffolds had rougher surfaces, which promoted more protein adsorption than the PLGA SMSs. 
Moreover, these scaffolds exhibited mechanical properties similar to trabecular bone and 
promoted the proliferation and maturation of the seeded osteoblasts. Additionally, Xu et al.255 
demonstrated that the incorporation of HMS into PLGA SMSs significantly improved the 
compressive properties of the PLGA scaffold and promoted apatite deposition onto these 
scaffolds that further improved their cytocompatibilty. The benefits of having a ceramic or 
mineral on a scaffold can also be reaped by applying it as a coating on the surface of the 
scaffolds. Jabbarzadeh et al.107 explored the feasibility of mineral formation on PLAGA SMSs 
via surface hydrolysis followed by incubation in simulated body fluid (SFB). In addition, they 
investigated the effect of mineralization on the level of protein adsorption on the surface of the 
coated SMSs. They observed that mineralized scaffolds displayed a rough surface with a 
relatively well-distributed apatite deposition. Mineral covered much of the microsphere surfaces 
and was comprised of nano-structured plate-like crystals. A higher protein adsorption with 
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hydrolyzed and mineralized PLAGA scaffolds was observed as compared to untreated PLAGA 
scaffolds. Moreover, the protein release behavior was not affected by the mineral coating. 
Microspheres serve as excellent delivery vehicles, therefore another strategy involving 
SMSs for bone regeneration includes fabricating raw material (such as dexamethasone, 
alendronate and Vitamin D3) encapsulating microsphere scaffolds. These raw materials are 
cheap, have high stability and also possess capabilities for driving differentiation of the seeded 
cells thereby overcoming drawbacks of high administration dosage, short half-lives and ease of 
deactivation associated with the growth factor/protein encapsulating approaches. Shi et al. 208 
encapsulated osteogenesis-inducing drugs (dexamethasone, ascorbic acid and β-
glycerophosphate) into PLGA-SMSs and studied the osteogenesis of human MSCs (hMSCs) 
seeded onto these SMSs. It was observed that hMSCs cultured on a combination scaffold 
(encapsulating dexamethasone, ascorbic acid and β-glycerophosphate) exhibited superior 
osteogenic differentiation owing to significantly high phenotypic expression of typical 
osteogenic genes like osteocalcin (OC), alkaline phosphatase (ALP) etc., and protein secretion of 
bone-relevant markers such as osteoclast and type I collagen when compared with just 
dexamethasone encapsulating scaffolds. This phenomenon could be due to the synergistic effect 
of the three encapsulated raw materials in driving the osteogenesis of hMSCs. Additionally, Das 
et al. designed a PLAGA SMS system to sustain the release of FTY720, a selective agonist for 
sphingosine 1-phosphate (S1P) receptors and study the effect of its release in treating critical size 
cranial defects in a rat model. S1P receptor signaling affects the migration of osteoblast 
precursors and osteoclast progenitor cells and sustained release of S1P or S1P receptor-targeted 
compounds has been previously shown to enhance the bone regeneration in critical-size cranial 
defects. It was observed that the copolymer ratio of 85:15 in PLAGA led to higher initial 
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cumulative release of FTY720 from the microspheres that in turn led to enhanced bone 
regeneration for up to 9 weeks. The higher cumulative release could be attributed to the tendency 
of FTY720 to localize towards the surface of the relatively hydrophobic 85:15 PLAGA during 
microsphere fabrication thereby prolonging its release47.  
Osseous healing and integration with the surrounding tissue depends in part on new blood 
vessel formation within the porous structure of a scaffold and endothelial cells (ECs) play a key 
role in this process. Therefore, Jabbarzadeh et al.106 studied human endothelial cell attachment, 
viability, growth, and phenotypic expression on sintered PLAGA microsphere scaffolds. It was 
observed that these cells proliferated on the surface of microspheres and through the pores of the 
scaffold by organizing their cytoskeleton. Moreover, these cells exhibited normal morphological 
structural and functional phenotypes. Furthermore, the potential of genetically modified adipose-
derived stromal cells (ADSCs) combined with ECs to direct the formation of a vascular network 
on PLAGA SMSs was also studied. The purpose of using modified ADSCs was to release 
angiogenic growth factor (VEGF) that would drive the proliferation of ECs. Moreover, the 
ADSCs would also secrete other bioactive factors that would have a mitogenic effect on ECs as 
well. The results demonstrated that the combination of VEGF producing ADSCs and ECs 
resulted in marked vascular growth within the PLAGA scaffolds108.  In a slightly different 
approach to direct the formation of a vascular network within a PLAGA SMS, VEGF was 
immobilized onto the surface of mineralized scaffold fabricated by sintering together PLAGA 
microspheres followed by nucleation of minerals in a SBF. It was observed that ECs attached 
and proliferated on the surface of microspheres and through the scaffold pore structures. The 
cells exhibited normal morphological, structural, and functional phenotypes with enhanced 
performance on mineralized VEGF-immobilizing scaffolds105. 
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To more closely mimic the natural architecture of bone, in which there exists a center 
cavity where the bone marrow resides, a tubular composite-sintered microsphere matrix was 
formed using HA encapsulating PLAGA microspheres. It was observed that opening the central 
axis of the scaffold did not compromise mechanical properties of the PLAGA/HA SMS. The 
tubular design might promote accelerated healing in vivo when compared with the PLAGA 
cylindrical scaffold by providing a path for host marrow cells to migrate along the center axis of 
the scaffold without nutrient and oxygen limitations 137. On the other hand, Wang et al.242 
fabricated a two-part scaffold to mimic the natural structure of bone. The scaffold consisted of a 
highly porous inner spiral part integrated with a rigid outer tubular part. The outer tubular part 
was made of PLGA sintered microparticles to provide support for the host tissue, and the inner 
spiral structured scaffolds consisted of nanofiber-coated porous thin polycaprolactone (PCL) 
sheets made by solvent casting/porogen leaching electrospinning technique to promote bone 
regeneration. The PCL insert was designed in a spiral 3D shape within thin outer walls of PLGA 
SMS to allow cells to grow completely across, and with open gaps to provide sufficient space for 
nutrient supply and waste removal. The morphological and mechanical properties of the scaffold 
were assessed and compared with the properties of three other types of scaffold: a PLGA 
cylindrical scaffold, a PLGA tubular scaffold and a PLGA tubular scaffold with the spiral insert 
but without the nanofiber coating. Moreover, attachment, proliferation and differentiation of 
human osteoblasts onto these scaffolds were also studied. The results demonstrated that the inner 
and outer parts were integrated well with each other as determined by pull-out testing that 
showed that the inner insert broke before detaching from the outer part. Moreover, it was 
demonstrated that integrated scaffolds provide more surface and space for cell attachment and 
growth compared with cylindrical and tubular scaffolds as high cell numbers were observed on 
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integrated cells determined via cell proliferation assay.  Furthermore, it was observed that fibrous 
coating enhanced the differentiation potential of the seeded cells as fibrous integrated scaffolds 
showed significantly higher ALP activity and more calcium accumulation than the porous 
integrated scaffolds alone. 
Microspheres offer several morphological and structural advantages as discussed 
previously for use in BTE. Another advantage of using microspheres is that they are robust and 
can withstand preservation processes like cryopreservation and lyophilization. The clinical 
application of a tissue engineering approach for bone regeneration involves isolation of 
autogenous cells, their in vitro expansion followed by seeding on a scaffold and then 
implantation. A time scale for this process might require weeks, during which the patient is 
incapacitated. An alternative approach that allows for the large-scale clinical use of the tissue 
engineered constructs, is to cryopreserve the constructs. Banking tissue-engineered constructs 
would allow for its immediate procurement upon an orthopedic surgeon’s request. Therefore, to 
assess the durability of the microspheres Kofron et al.138 tested the ability of human osteoblast 
like cells adhered to PLAGA microsphere matrices to withstand the stresses associated with low-
temperature tissue banking in dimethylsulfoxide (DMSO), ethylene glycol and glycerol. It was 
observed that the DMSO solution yielded the greatest percent cell survival for the cells adhered 
to PLAGA matrices. Moreover, the extracellular matrix architecture was no different between 
the pre- and post-thaw structures. Another key advantage of using microspheres in BTE is that 
they can be used, as injectable scaffolds to fill irregularly shaped tissue defects. Habraken et al.91 
developed PLGA microsphere/calcium phosphate cements to be used as injectable scaffolds. It 
was demonstrated that their properties like injectability, setting time, cohesiveness and pore 
interconnectivity could be adjusted by changing the ratio of polymer and ceramic in the 
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injectable mixture. In addition, Kang et al.124 demonstrated that suspension of osteoblast and 
apatite coated PLGA microspheres was easily injectable and led to formation of bone upon in 
vivo implantation.    
 
CARTILAGE 
Normal cartilage is an avascular tissue with an intercellular protein matrix reinforced by a three- 
dimensional network of collagen fibrils. Severe damage to cartilage tissue caused by 
developmental abnormalities, trauma, or aging-related degeneration result in extensive pain and 
if left untreated further lead to disability. Adult cartilage tissue has limited self-repair capacity 
due to the sparse distribution of highly differentiated, non-dividing chondrocytes, slow matrix 
turnover, low supply of progenitor cells and lack of vascular supply. Current treatment methods 
for cartilage damage are often not good enough to restore normal function therefore; cartilage 
tissue engineering is developing as a promising approach for cartilage repair245. One of the major 
thrusts in cartilage tissue engineering is to develop a minimally invasive cell transplantation 
system in which cells and an injectable scaffold could be injected into defect area via an 
arthroscopic procedure. In addition, injectable scaffolds can fill various sizes and shapes of 
defects more easily than preformed scaffolds. Since microspheres possess small size they can 
serve as ideal candidates for such minimally invasive procedures. Mercier et al.166 first 
documented the use of biodegradable poly(lactide-co-glycolide) (PLG) microspheres as an 
injectable scaffold for cartilage tissue engineering. Chondrocytes were delivered via injection 
either in a cylindrical mold in vitro or to the subcutaneous space of athymic mice in the presence 
and absence of PLG microspheres. They observed progressive cartilage formation in samples 
containing microspheres. The presence of microspheres increased the quantity of tissue formed, 
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the amount of glycosaminoglycan that accumulated, and the uniformity of type II collagen 
deposition. Moreover, microsphere composition influenced the growth of the tissue-engineered 
cartilage. Higher molecular weight PLG resulted in a larger mass of cartilage formed and a 
higher content of proteoglycans. Microspheres comprised PLG with methyl ester end groups 
yielded increased tissue mass and matrix accumulation, but did not display homogenous matrix 
deposition. The microencapsulation of Mg(OH)2 had negative effects on tissue mass and matrix 
accumulation suggesting that buffer release might be a contributing factor in poor tissue 
growth166, 167. 
Kang et al.121 tested whether PLGA microspheres along with chondrocytes could be used 
to regenerate hyaline cartilage in rabbit knees. Histological scores indicating the extent of the 
cartilaginous tissue repair and the absence of degenerative changes were significantly higher in 
the experimental group than in the control groups consisting of no treatment and cell-alone 
injection. Moreover, the transplanted group with microspheres showed thicker and better-formed 
cartilage compared to the control groups as determined by Alcain blue, Masson’s trichrome and 
Collagen II (IHC) staining.  
Conventional cell culture methodologies using PLGA microspheres for the 
manufacturing of engineered cartilage tissue products are hampered by the well-known behavior 
of chondrocytes or mesenchymal stem cells (MSCs) cultured on PLGA microspheres, which 
undergo a prompt loss of their cartilage-specific phenotype and become fibroblastic. Therefore, 
to make a neocartilage using PLGA microsphere matrix, specific drug is needed for inducing 
chondrogenesis on PLGA microspheres. To meet this goal, Park et al.187 fabricated 
nanostructured three-dimensional scaffolds onto which growth factor (TGF-β3) loaded 
heparin/poly(L-lysine) nanoparticles (NP) were physically attached via tapping the ionic 
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interaction between the positively charged surface of PLGA microspheres and 
poly(ethyleneimmine) (PEI). It was observed that the PLGA microsphere constructs coated with 
NP loaded TGF-β3 showed significantly higher GAG content than those coated with NP alone or 
uncoated ones. Moreover, MSCs cultivated in the NP TGF-β3 PLGA microspheres synthesized 
higher amount of total collagen than those in the PLGA microspheres without TGF-β3. 
Furthermore, after 4 weeks TGF-β3 containing PLGA microsphere constructs were filled with 
hyaline cartilage cells, lacunae, and specific expression of extracellular matrix components.  
 
OSTEOCHONDRAL INTERFACE 
Osteochondral defects are a type of articular cartilage defects that extend deep into the 
subchondral bone. If untreated, they do not heal and osteoarthritis (OA) may develop over time. 
Yet, such osteochondral defects are difficult to treat because the subchondral bone and the 
articular cartilage possess very dissimilar intrinsic healing capacities.  Structural changes in the 
subchondral bone resulting from inferior subchondral bone repair translate into altered 
biomechanical properties of the entire osteochondral unit thus, influencing the long-term 
performance of the cartilaginous repair tissue. For osteochondral repair, highly specialized 
scaffolds mimicking the hierarchical anatomical architecture of the natural osteochondral unit are 
needed155. Classically approaches to engineer osteochondral interface have largely focused on 
creating graded-structures (e.g., biphasic, triphasic) in cellular/biomaterial composition, which 
do not closely mimic the continuous transitions of native cartilage to bone, a design limitation 
that leads to stress concentrations at each interface and eventual failure of the implants213. A 
continuously graded osteochondral construct that simultaneously regenerates both cartilage and 
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bone in addition to promoting proper integration at the interface is a promising approach to 
firmly anchor a cartilage substitute to surrounding tissues.  
Dormer et al.64 fabricated protein-loaded microsphere scaffolds to achieve spatially and 
temporally controlled delivery of bioactive signals. Bone morphogenetic protein-2 (BMP-2) and 
transforming growth factor-β1 (TGF-β1) loaded PLGA microspheres were utilized with a 
gradient scaffold fabrication technology to produce microsphere scaffolds containing opposing 
gradients of these signals. Constructs were then seeded with either hBMSCs or human umbilical 
cord mesenchymal stromal cells (hUCMSCs), and osteochondral tissue regeneration was 
assessed in gradient scaffolds and compared to multiple control groups. The results demonstrated 
that the gradient scaffolds produced regionalized extracellular matrix, and outperformed the 
blank control scaffolds in cell number, glycosaminoglycan production, collagen content, alkaline 
phosphatase activity, and in some instances, gene expression of major osteogenic and 
chondrogenic markers suggesting that engineered signal gradients are beneficial for 
osteochondral tissue engineering. Moreover, Singh et al.213 demonstrated that the microsphere 
gradient technology could be employed to create scaffolds containing a continuous macroscopic 
gradient in composition that further yielded a stiffness gradient along the axis of the scaffold. 
PLGA, and composite microspheres encapsulating a higher stiffness nano-phase material (PLGA 
encapsulating CaCO3 or TiO2 nanoparticles) were used for the construction of microsphere 
scaffolds. The extent of sintering, composition of the microspheres and the relative content of the 
two microsphere types can be selectively varied to alter the stiffness of the matrix to create 
regular and inverse-gradients in mechanical properties. Furthermore, the performance of the 
novel microsphere gradient scaffolds was evaluated in regenerating osteochondral defects in the 
rabbit mandibular and femoral condyles. BMP-2 and TGF-β1 loaded microsphere scaffolds were 
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implanted in mandibular and medial femoral condyles and evaluated for osteochondral repair in 
vivo for 6 weeks. The results demonstrated that the gradient design led to more uniform neotissue 
synthesis than in unfilled defects and also to thicker cartilage layers. Moreover, it was also 
observed that incorporation of hydroxyapatite (in the bone part) along with the growth factors led 
to formation of a tissue that more closely resembled the native cartilage in terms of 
glycosoaminoglycan content and cartilage thickness. It also led to higher bone filling and better 
edge integration with surrounding bone59, 169. Thus, these microsphere scaffolds with continuous 
gradients in both tissue-specific signals and material composition may be a beneficial approach 
for treating osteochondral defects in clinical settings. 
 
MUSCLE 
Skeletal muscles are composed of bundles of highly oriented and dense muscle fibers, each a 
multinucleated cell derived from myoblasts. These muscle fibers are closely packed together in 
an extracellular three-dimensional matrix to form an organized tissue with high cell density and 
cellular orientation. After muscle injuries, myofibers become necrotic and are removed by 
macrophages. A specialized myoblast sub-population called satellite cells present below the 
basal lamina of myofibers gets activated thus initiating muscle regeneration. These cells enter the 
mitotic circle in response to specific local factors released by the macrophages. This induces 
proliferation and fusion of myoblasts to form multinucleated and elongated myotubes, which 
self-assemble to form a more organized structure, namely muscle fiber. However, the number of 
satellite cells in skeletal muscle is very low (1%–5%) and also depends on age and muscle fiber 
composition. Furthermore, satellite cells themselves can migrate to the injured area and 
proliferate forming a scar tissue that leads to loss of functionality10. Therefore, there is a critical 
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need to develop tissue-engineering strategies for reconstructing highly organized and complex 
skeletal tissue.  
Lorrez et al.233 explored the use of biodegradable porous, gas-foamed PLG microsphere 
scaffolds as a substrate to which primary human myoblasts could be attached using clinical grade 
extracellular matrix (ECM) carriers and differentiated into myofibers, which could be maintained 
under tension. An immunodeficient non-obese diabetic/severe combined immunodeficiency 
(NOD/SCID) animal model was used to assess the in vivo characteristics of the constructs. It was 
demonstrated that human myoblasts could be efficiently seeded and differentiated into post 
mitotic myofibers on gas-foamed PLG SMSs and maintained under tension when implanted 
subcutaneously. The PLG scaffolds improved human myofiber viability in vivo relative to non-
scaffold implants and therefore might be useful for future clinical applications. 
 
Summary Of Microsphere Scaffolds In Musculoskeletal Tissue Engineering 
Microsphere scaffolds have the potential to enhance the repair of musculoskeletal tissues because 
of their excellent mechanical properties. Moreover, gradient microsphere constructs providing 
opposing gradients of tissue-specific signals and mechanical properties are an attractive strategy 
to treat musculoskeletal tissue interfaces like osteochondral interface, cortical-cancellous bone 
interface, and ligament/tendon-bone interface. In this regard, in vivo comparison of these 
gradient microsphere constructs with other conventionally fabricated constructs will provide 
more insight regarding the usefulness of graded microsphere structures. 
 





Besides their unique ability to encapsulate growth factors with a known and controllable delivery 
profile, one promising feature of microspheres as scaffolds is that they provide three-dimensional 
environments that can better preserve the phenotypes of the cells. The following section will 
review some of the applications of microspheres as scaffolds in fields like skin, heart, liver, and 
nerve regeneration and also in developing in vitro models for studying cancers/tumors.  
 
SKIN REGENERATION 
The skin is the largest organ of the body and is critical to survival of an organism. It acts as a 
barrier to the environment and is also responsible for thermal regulation and hydration retention. 
In order to serve these critical functions, the skin is constantly undergoing renewal and possesses 
limited capacity for repair of wounds. Therefore, engineered skin substitutes have a critical 
medical application especially to patients with extensive burn wounds and chronic ulcers. 
However, current skin substitutes (like epidermal sheet grafts) do not restore the normal skin 
anatomy, lacking the normal appendages of skin including hair follicles, sebaceous glands, and 
sweat glands as well as the normal mechanical properties of the skin252.  
Kim et al.135 demonstrated the feasibility of using PLGA microspheres as both cell 
culture substrate and transplantation vehicle for skin cells (keratinocytes and dermal fibroblasts) 
to regenerate full thickness skin defects on the back of athymic mice. Histological and 
immunohistochemical analysis showed dermal regeneration with positive staining for vimentin, a 
marker of dermal fibroblast, and differentiated epithelium that stained positively for cytokeratin, 
a marker of epidermis, three weeks after the implantation. Furthermore, Huang et al.100 showed 
that bone marrow derived MSCs (BM-MSCs) delivered via an instructive (growth factor loaded) 
microsphere scaffold can have significant effects on enhancement of healing quality and sweat 
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gland repair during skin regeneration process. It was observed that after only three weeks, BM-
MSC microsphere scaffold with encapsulated epidermal growth factor exhibited accelerated 
healing with increased re-epithelialization rates and less skin contraction. Additionally, 
histological and immunofluorescence staining analysis revealed appearance of sweat glands-like 
structures in regenerated tissue.  
The use of microspheres to treat skin wounds is advantageous over currently available 
skin grafts because the microsphere method avoids the enzymatic steps to harvest grafts by 
culturing cells directly on the transplantation vehicles (microspheres) thereby, also reducing the 
fabrication time. Secondly, this method can reduce the inflammatory reactions caused after 
implantation using microspheres made from biocompatible and biodegradable materials. Lastly, 




Some of the challenges in cardiac tissue engineering include that engineered myocardium must 
contain a dense population of properly aligned and electrically connected cardiomyocytes. 
Moreover, these cells are highly metabolically active, form a well-coupled electromechanical 
syncytium therefore; they must be in intimate contact with the vascular system. Furthermore, the 
scaffold materials must be extremely resistant to foreign body reaction because fibrous 
encapsulation might electrically isolate the engineered tissue and cause arrhythmia. Lastly, most 
of the current methods for producing porous scaffolds utilize processing conditions that are not 
compatible with cell survival. To overcome these challenges, a different approach was recently 
developed with the formation of cell scaffolds by cross-linking hydrogel microparticles in the 
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presence of cardiomyocytes. Smith et al.217 assembled poly(ethylene glycol) (PEG) microspheres 
around HL-1 cardiomyocytes to produce highly porous scaffolds. PEG microspheres were phase 
separated in dextran solutions causing them to rapidly de-swell and crosslink together, 
eliminating the need for serum protein-based crosslinking that could result in an antigenic 
response. This also led to a dramatic increase in the stiffness of the scaffolds and greatly 
improved the handling characteristics. HL-1 cardiomyocytes exhibited high cell viability 
following scaffold formation as evident from the 9-fold expansion in cell number over a two-
week period. The cardiac functional markers, sarcomeric α-actinin and connexin 43, were 
expressed at 13 and 24 days after scaffold formation. HL-1 cells were spontaneously 
depolarizing 38 days after scaffold formation, which was visualized by confocal microscopy 
using a calcium-sensitive dye. Electrical stimulation resulted in synchronization of activation 
peaks throughout the scaffolds. These findings demonstrate that the fabricated PEG microsphere 
scaffolds can support the long-term three-dimensional culture of cells, suggesting applications in 
cardiovascular tissue engineering.  
 
LIVER REGENERATION 
The liver, the largest organ in the body, has a complex architecture and performs a myriad of 
functions. Even though the liver is highly regenerative, drugs and toxins or viral infections can 
cause extensive damage to hepatocytes, reducing function and regeneration. In the engineering of 
liver tissues, the creation of a proper biomimetic environment for hepatocytes growth and 
functionality is an important factor. The use of microspheres in liver tissue engineering is 
gaining attention because of the versatility that microspheres offer in guiding cell growth. This 
versatility includes not just the ease of scaffold assembly into various shapes suitable for 
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different tissue applications, but also offers easy and controllable surface modification for 
enhanced cell–material interaction. Zhu et al.261 demonstrated this versatility by covalently 
conjugating PHBV microspheres with three proteins collagen I, laminin, and fibronectin using 1-
ethyl-3-(3-dime- thylaminopropyl) carbodiimide and N-hydroxysuccinimide cross linkers. The 
results indicated that combination of the three ECM proteins on microsphere surfaces has a 
significant effect on the proliferation of Hep3B cells, thus better mimicking the in vivo 
environment for liver tissue engineering. The ability of PHBV microsphere scaffolds to 
encapsulate and then release hepatocyte growth factor (HGF) was also demonstrated. It was 
observed that the three-dimensional microsphere scaffolds with the direct delivery of HGF to the 
primary hepatocytes were proven to be able to better maintain their viability and phenotype than 
its delivery via the cell culture medium263. 
In liver tissue, hepatocytes not only interact with adjacent hepatocytes but also with non-
parenchymal cells. Thus, cell–cell interactions and hormone stimulation play the central role in 
the regulation of cellular behaviors such as migration, differentiation, and proliferation. To 
maintain the hepatocytes function in vitro, open porous microspheres seem ideal, as they would 
enhance the transports of oxygen and nutrients, provide protection from exerted shear stress, 
provide heterotypic cell–cell contact within and between microspheres thereby building a 
functional tissue construct. Furthermore, these microspheres have the potentials for being 
injected in vivo into cavities, even of irregular shape and size, in a minimally invasive manner. 
Chou et al.41 prepared porous PLGA microsphere scaffolds for constructing injectable three-
dimensional hepatocyte spheroids. The porous sites of PLGA microspheres provided space for 
hepatocyte distribution within the microspheres. The feasibility of co-culturing these spheroids 
with other cell types was demonstrated by culturing them with human umbilical vein endothelial 
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cell, BMSCs, or NIH/3T3 cells. It was observed that hepatocellular-specific functions were 
sustained up to 2 weeks with co-culture demonstrating the potential of creating hepatic tissue 
using these microspheres.  
 
NERVE REGENERATION 
Nerve regeneration is a complex biological phenomenon. In the peripheral nervous system, 
nerves can regenerate on their own if injuries are small. Larger injuries must be surgically treated, 
typically with nerve grafts harvested from elsewhere in the body that further leads to donor site 
morbidity. Allografts provide an alternative option but with the increasing number of patients the 
availability of such grafts is limited. Moreover, there is also a risk of immune response 
associated with these grafts. Tissue-engineered strategies provide an attractive alternative but 
traditional scaffolds, which are tubular with and without inner lumen-like architecture, support 
regeneration along the walls of the scaffolds or the lumen only and do not possess enough 
surface area to house a large number of cells needed for complete and faster regeneration. 
Valmikinathan et al.239 developed a novel spiral-shaped nanofibrous microsphere scaffold for 
peripheral nerve regeneration. These spiral scaffolds had optimal mechanical properties and also 
sufficient porosity to promote cellular ingrowth. They were also modified to present a 
nanofibrous surface to enhance cell attachment, migration and proliferation on the surface of the 
scaffolds. The in vitro tests conducted using Schwann cells showed that the nanofibrous spiral 
scaffolds promoted higher cell attachment and proliferation when compared to contemporary 
tubular scaffolds or nanofiber-based tubular scaffolds. Also, the nanofiber coating on the 
surfaces enhanced the surface area, mimicing the extracellular matrix and providing 




In vitro cancer models have been applied in pre-screening anticancer drugs where a two-
dimensional (2-D) monolayer culture model serves as the standard to determine drug effects on 
growth inhibition and apoptosis. However, in vivo and clinical cancers are three-dimensional (3-
D) and present differences from the 2-D model in terms of cell surface receptor expression, 
proliferation, extracellular matrix synthesis, cell density and metabolic function. These 
differences are one of the major reasons for poor co-relationship between in vitro and in vivo 
measurements120.  
One of the major thrusts in the field of cancer therapy is to develop better in vitro models 
that would mimic in vivo tumors, which will yield more practical assessment of drug efficacy 
prior to testing in animal models. For this reason, culture of cancer cells on a polymeric scaffold 
has become more attractive and is expected to provide improved in vitro/in vivo co-relationship 
for therapeutic evaluation. Because of their ability to provide large surface area for cell 
attachment and growth, porous microsphere scaffolds make 3-D suspension cultures feasible in a 
stirred suspension bioreactor. Moreover, microsphere scaffolds fabricated from biodegradable 
and non-cytotoxic materials, can also be used as a cancer cell transplantation vehicle for tumor 
construction in small animals, eliminating trypsinization step of cultured cells that causes 
perturbation of cell–cell interactions and serious damage on cell surface proteins120. Lastly, 
microsphere scaffolds can also serve the need to cryopreserve the tumor cells by shielding them 
from stresses associated with the freeze-thaw process.  
Sahoo et al.199 designed and evaluated biodegradable porous PLGA/PLA microparticles 
as a scaffold for growing breast cancer cells.  PLA microparticles containing poly(vinyl alcohol) 
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(PVA) in the matrix structure (PLA-PVA) and treated with serum prior to cell seeding 
demonstrated better cell adhesion and cell growth than other formulations of microparticles. 
Cells were seen to grow into clumps, engulfing microparticles completely with time, and 
forming a 3-D tissue-like structure. The mechanism of better cell growth on PLA-PVA 
microparticles appears to be due to the PVA associated with the internal matrix structure of 
microparticles. To study the applicability of these porous microspheres in pre-screening anti-
cancer drugs, Horning et al. evaluated the anti-proliferative activity of three anti-cancer drugs 
(doxorubicin, paclitaxel and tamoxifen), which are currently used in the treatment of breast 
cancer. The drug diffusion and cellular uptake studies revealed discrepancy in the drug efficacy 
in 2-D monolayer vs 3-D model. The overall results demonstrated significantly lower drug 
activities in 3-D model vs in 2-D monolayer96. Furthermore, Kang et al.120 demonstrated that cell 
viability and metabolic activity of cancer cells did not significantly change during one freeze-
thaw cycle when cultured on microsphere scaffolds. 
 
Summary Of Microsphere Scaffolds In Other Tissue Engineering Applications 
Microsphere based tissue engineering strategies to regenerate musculoskeletal tissue have 
primarily been focused on regenerating bone and cartilage however; lately they have been 
gaining attention to regenerate other tissue types as well. Due to their small size, microspheres 
allow the seeded cells to establish intimate contacts with their neighbors. These cell-cell contacts 
have great implication in regenerating tissues like heart, liver and peripheral nerves where cell-
cell interaction plays an important role in carrying out the tissue function (electromechanical 
syncytium in cardiomyocytes), in regulating cellular behavior (hepatocyte migration and 
proliferation), and in guiding cell growth (to establish cell directionality in peripheral nerves). 
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Microspheres have also been applied to develop tissue models for studying tumors/cancers either 
in vitro or in vivo and screen anti-cancer agents as they allow the cells to be transferred easily 
without the need of trypsinization and also because of their stress-shielding abilities during 
cryopreservation. Thus, in this regard, more studies need to be conducted to realize the full 
potential of microsphere scaffolds in regenerating different tissues and developing cell and tissue 
models for studying diseases.  
 
DISCUSSION 
In the last decade, microsphere scaffolds have come into the spotlight because of their ability to 
combine controlled release functionalities for regulating tissue development and the skill to 
promote cell growth, so that unique superior structures could be fabricated for better tissue 
regeneration. The microspheres allow control over various aspects of scaffold parameters 
because of the versatility offered in terms of choice of material and methods for microsphere 
fabrication and sintering. In addition, microspheres can be used as carriers for a plethora of 
bioactive molecules thus holding potential for being used in gradient-based technologies to 
regenerate heterogeneous tissues and tissue interfaces. Lastly, due to their small size and 
injectability microspheres are being used to treat irregular shaped defects either alone or via 
shape-specific scaffolds fabricated through rapid prototyping technologies. 
The synthetic biodegradable polyesters such as poly(lactide)s, poly(glycolide)s, and 
poly(lactide-co-glycolide)s have been widely used for fabricating microspheres (Tables 2.1 and 
2.2) because of their biocompatibility,  physical/mechanical properties, and controlled 
degradation profiles4, 11, 19, 25, 26, 29, 30, 41, 42, 44, 46, 47, 51, 59, 60, 62, 64, 66, 73, 86, 90, 91, 99, 105-109, 112, 114-117, 121-
125, 135, 137, 138, 140, 149-151, 160, 166-169, 171, 178, 183, 187, 190, 200, 208, 213, 215, 216, 228, 233, 239, 242, 246, 255, 257, 260. 
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While these polymers have yielded very positive results in tissue engineering application, there 
are some disadvantages associated with their use. First, these polyesters have the possibility of 
causing an aseptic inflammatory response due to their acidic byproducts. Moreover, these 
byproducts negatively affect the bioactivity of the encapsulated molecules. Lastly, the drop in pH, 
caused by the acidic byproducts, may further increase polymer degradation, leading to significant 
drop in the mechanical properties of the overall scaffold. Other synthetic biopolymers such as 
poly(propylene fumarate) (PPF) have the ability to be broken down into non-toxic waste 
products however, they lack the ability to induce cell differentiation. Often, these polymers have 
to be modified with natural macromolecules (peptides/proteins) to improve their bioactivity67. 
Natural polymers such as chitosan, gelatin, cellulose, etc. have also been investigated as 
microsphere fabrication materials (Table 2.2) because they are nontoxic, promote cell adhesion 
and migration, enhance wound healing, and are biodegradable at rates dependent on controllable 
factors such as molecular weight and crystallinity14, 39, 69, 70, 73, 90, 100, 115-117, 140, 179, 230, 247, 261-263. 
However, these polymers lack sufficient strength to be used in load bearing applications such as 
bone and cartilage. Thus, there is a need for a material that could combine the mechanical 
properties of the synthetic materials with cell affinity of the natural materials. For example, 
polyphosphazenes (Table 2.2) have recently been used for fabricating microsphere scaffolds for 
bone regeneration 29, 30, 184, 186. Polyphosphazenes are a unique class of polymers that offer 
synthetic flexibility and a high degree of freedom in modulating their physical and chemical 
properties. They are organic-inorganic hybrid polymers with alternating phosphorus and nitrogen 
atoms in the backbone with every phosphorus atom bearing two organic side groups. These side 
groups can be substituted to form amino acid ester polyphosphazenes that have cell-affinity 
moieties. Moreover, the side group substitution also allows for tailoring the polymers’ physico-
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chemical properties such as glass transition temperature and degradation rate. Furthermore, these 
materials are capable of degrading into neutral and buffering degradation products. However, 
most of the currently used amino acid ester substituted polyphosphazenes are soft elastomeric 
polymers and may not be suitable for load bearing applications. Moreover, synthesis of 
polyphosphazenes is a complex and time intensive process that could further limit their use. 
Hence, search for an ideal material for microsphere fabrication is still on that would culminate in 
a material that combines the robustness of polyesters, functionality of natural polymers and 
flexibility of hybrid polyphosphazenes. 
Not only there are a variety of matrix materials available for fabricating microspheres but 
there also exist numerous methods for their fabrication as well. These methods control their size 
and morphology and also influence the release behavior of the encapsulated molecule. 
Furthermore, sintering process parameters affect scaffold porosities and mechanical properties.  
For microspheres to provide clinically relevant tissue-engineered grafts for replacing current 
surgical standards, it is imperative that these fabrication and sintering technologies are easily 
scalable and able to generate reproducible microsphere scaffolds in substantial quantities. 
A major advantage of microsphere scaffolds is that they possess inherent capabilities to 
provide controlled release of encapsulated molecules whereas in scaffolds fabricated via 
conventional methods the bioactive molecule is physically mixed into the scaffold matrix that 
leads to a burst release. Moreover, for providing controlled released traditional scaffolds 
themselves use microspheres with encapsulated factors. The versatility of microspheres to 
provide controlled release from tissue-engineered scaffolds has been exemplified in numerous 
studies15, 20, 31, 33, 48, 52, 78, 95, 104, 109, 111, 119, 129-131, 133, 143-148, 153, 159, 165, 182, 194, 195, 197, 198, 219, 220, 236, 241, 
243, 244, 248, 259, 264, 265. However, during encapsulation a protein or growth factor is subjected to 
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harsh environments, which could result in either complete or partial loss of its bioactivity. To 
compensate for the loss of bioactivity, higher doses of protein are encapsulated that can further 
cause cytotoxicity in the regenerating tissue. Several stabilizing agents (like carbohydrates and 
carrier proteins) are used to prevent denaturation of the encapsulated protein however; success 
with these agents has been fairly limited.  Recently, Mohan et al.171 demonstrated that 
extracellular matrix (ECM) components (like chondroitin sulfate) could be encapsulated either 
singly or in conjunction with growth factor to direct cell differentiation in tissue-engineered 
constructs. These ECM materials are cheaper than growth factors and have the potential to act as 
(i) signaling molecules to elicit favorable cell response, and (ii) raw materials that can be 
bioresorbed, and thus integrated into the regenerating tissue. This alternative strategy to 
encapsulate ECM components can have profound implications in terms of lower cost and faster 
regulatory approval for more rapid translation of regenerative medicine products to the clinic. 
Continuous gradient scaffolds have shown great promise in regenerating complex tissue 
and tissue interfaces because continuous gradient designs represent a seamless interfacial 
transition that better approximates the gradual, rather than sharp, interface between native tissues. 
Microsphere scaffolds can continuously provide both physical and chemical signal gradients 
simultaneously, thereby making them ideal candidates to engineer heterogeneous tissues and 
tissue interfaces. These scaffolds provide chemical and signal gradients through spatially and 
temporally controlled delivery of exogenous bioactive factors.  The cells sense physical signal 
gradients in these scaffolds by detecting variations in microsphere size, pore size, material 
stiffness and surface physicochemical characteristics. These signal gradients in turn affect cell 
behaviors such as adhesion, spreading, motility, and survival, thereby causing them to 
differentiate into different cell types at different regions of the scaffold. These microsphere 
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scaffolds have been studied to regenerate osteochondral interface in the knee and the 
temporomandibular joints59, 64, 169, 171, 213. However, their potential in regenerating other 
biological primary (such as between soft tissue and bone, muscle, and tendon), or subsidiary 
interfaces (among articular cartilage layers, mineralized, and non-mineralized layers of 
fibrocartilage, tunicae of the vasculature, and dermal layering) is yet to be explored. 
There is a growing impetus in the tissue engineering community to create injectable 
systems for in situ scaffold formation, thus avoiding complicated surgical procedures. Although 
injectable scaffolds have been around from mid 1990’s, still they suffer from limitations like 
poor mechanical properties and inadequate porosities. Lately, microspheres have started to gain 
attention as injectable and/or moldable matrices that can be delivered via minimally invasive 
surgeries because of their spherical nature and ability to pass through small needles42, 73, 91, 94, 99, 
118, 121, 122, 124, 125, 149, 150, 166, 167, 187, 210, 257. Moreover, they do not suffer from limitations, such as 
insufficient porosity and poor mechanical properties, associated with conventional injectable 
scaffolds. However, injectable microspheres made from synthetic polymers can leak from the 
defect site causing undesirable results in the surrounding tissue. This problem can be overcome 
by using natural polymers like gelatin that can be crosslinked via a chemical or UV light.  
Since tissue-engineering aims to produce patient-specific biological substitutes to 
circumvent limitations of existing clinical treatments, it becomes necessary for the scaffolds not 
only to mimic the function of the native extracellular matrix but also its structure. The 
conventional scaffold fabrication techniques are highly process dependent rather than design 
dependent therefore, they are unable to fabricate scaffolds with complex geometries and 
architecture. On the other hand, rapid prototyping (RP) technologies offer complete user control 
in terms of structural features and are able to meet specific mechanical, mass-transport, and 
	 65	
external shape requirements for producing a scaffold. However, there are several challenges 
associated with the use of these RP technologies such as limited range of materials, bioactivity of 
the fabricated scaffold, as well as the issue of cell seeding. Recently, it was demonstrated that 
microspheres can be used as building blocks to fabricate scaffolds via SLS thereby opening a 
whole new area of materials that can be processed in RP technologies69, 260. Moreover, with the 
ability of microspheres to provide controlled release of bioactive factors and act as cell carriers 
the issues of bioactivity and cell seeding can be resolved as well.  
In conclusion, the potential of microspheres as drug delivery vehicles has been explored 
for several decades, whereas their use as tissue engineering scaffolds has been only advocated 
over the last decade. The use of microsphere scaffolds has primarily been limited to bone and 
cartilage repair but their potential to regenerate other tissue types is yet to be realized. In this 
review, a variety of methods for microsphere fabrication and sintering were discussed and how 
these methods affect the microsphere and overall scaffold properties were also assessed.  
Hopefully, the assessment will help in designing microsphere scaffolds that will closely mimic 
the extracellular matrix of the target tissue. Furthermore, the versatility of the microsphere 
scaffolds was also discussed with respect to fabrication materials, encapsulated factors, and 
abilities to provide physicochemical gradients and shape-specific grafts. It is expected that the 
discussion of the versatility of microsphere scaffolds will stimulate the interest of researchers 
across the tissue-engineering field towards microsphere scaffolds thereby making them a front-
runner among other scaffolding approaches in the race to create clinically relevant grafts for 
regenerative medicine. 
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CHAPTER 3: MICROSPHERE-BASED SCAFFOLDS CARRYING OPPOSING 
GRADIENTS OF CHONDROITIN SULFATE AND TRICALCIUM PHOSPHATE‡ 
ABSTRACT 
Extracellular matrix (ECM) components such as chondroitin sulfate (CS) and tricalcium 
phosphate (TCP) serve as raw materials and thus spatial patterning of these raw materials may be 
leveraged to mimic the smooth transition of physical, chemical and mechanical properties at the 
bone-cartilage interface. We hypothesized that encapsulation of opposing gradients of these raw 
materials in high molecular weight poly(D,L-lactic-co-glycolic acid) (PLGA) microsphere-based 
scaffolds would enhance differentiation of rat bone marrow stromal cells (rBMSCs). The raw 
material encapsulation altered the microstructure of the microspheres and also influenced the 
cellular morphology that depended on the type of material encapsulated. Moreover, the 
mechanical properties of the raw material encapsulating microsphere-based scaffolds initially 
relied on the composition of the scaffolds and later on were primarily governed by the 
degradation of the polymer phase and newly synthesized extracellular matrix by the seeded cells. 
Furthermore, raw materials had a mitogenic effect on the seeded cells and led to increased 
glycosaminoglycan (GAG), collagen, and calcium content. Interestingly, the initial effects of raw 
material encapsulation on a per-cell basis might have been overshadowed by medium-regulated 
environment that appeared to favor osteogenesis. However, it is to be noted that in vivo, 
differentiation of the cells would be governed by the surrounding native environment. Thus, the 
results of this study demonstrated the potential of the raw materials in facilitating neo-tissue 
synthesis in microsphere-based scaffolds and perhaps in combination with bioactive signals, 
                                                
‡Published as Gupta V, Mohan N, Berkland CJ, Detamore MS, Microsphere-Based Scaffolds Carrying Opposing 
Gradients Of Chondroitin Sulfate And Tricalcium Phosphate, Frontiers in Bioengineering and Biotechnology, 3: p. 
1-15, 2015. (PMC4486839) 
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these raw materials may be able to achieve intricate cell differentiation profiles required for 
regenerating the osteochondral interface. 
 
INTRODUCTION 
A scaffold with opposing gradients of physical and chemical signals at the osteochondral 
interface may trigger simultaneous bone and cartilage regeneration by having a cooperative 
effect on tissue regeneration. Our previous studies have shown that 3D microsphere-based 
gradient scaffolds have the potential to guide the chondro- and osteogenic differentiation of cells 
in different regions of the scaffolds. Moreover, the gradients in signals have the ability to control 
patterning of cell phenotype and to secrete tissue-specific extracellular matrix (ECM) 
components to promote osteochondral interface regeneration58, 63, 65, 169. 
Chondroitin sulfate (CS), a glycosaminoglycan (GAG) and a key ECM component of 
cartilage, when incorporated into 3D scaffolds resulted in increased DNA, GAG and collagen 
accumulation by the cultured cells134, 238. Moreover, CS also enhanced their chondrogenic gene 
expression34. Likewise, bioactive ceramic beta-tricalcium phosphate (β-TCP) is widely used in 
bone tissue engineering because of its excellent oseteoconductivity, cellular adhesion, 
mechanical properties and faster degradation rate than other crystalline calcium phosphates. 
Scaffolds incorporating β-TCP have shown better potential for osteogenic differentiation than the 
scaffolds without it152, 229, 234. We have previously demonstrated that encapsulation of raw 
materials such as CS and bioactive glass (BG, possesses the capability to directly bind to bone) 
in low molecular weight (around 40-45 kDa) poly(D,L-lactic-co-glycolic acid) (PLGA) 
microsphere-based scaffolds created a favorable environment for cells to create a tissue-specific 
ECM. Additionally, evident regional variation in newly synthesized ECM indicated that the raw 
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materials could potentially be used to replace growth factors, thus holding tremendous clinical 
significance by providing a more streamlined path for regulatory approval and greater financial 
incentive for translation to the clinic170. 
 The low molecular weight PLGA microsphere-based scaffolds are well suited for in vitro 
studies as signal release and cellular response to the encapsulated signals can be conveniently 
studied in these scaffolds because of rapid degradation of microspheres2, 61, 63, 170, 215, 235. 
Moreover, these low molecular weight scaffolds can also be used to study tissue regeneration in 
small animal model in vivo studies where skeletal changes occur at a faster rate compared to 
humans65, 169, 188. In order for a scaffold to be clinically effective and commercially successful, it 
is imperative that its biodegradation rate matches with the tissue regeneration rate in animal 
models that closely approximate the human regeneration rate. To begin exploring the clinical 
implications of our raw material microsphere gradient scaffolds, we need to translate our 
successes with scaffolds in vitro and in vivo with small animal models to scaffolds that can be 
employed in preclinical animal models. The foremost step in that direction will be to study 
cellular response toward encapsulated factors released from a scaffold system that can be 
employed in translational animal models (such as sheep, dogs, etc.). Therefore, the objective of 
this study was to investigate the in vitro response of raw material encapsulating microsphere-
based scaffolds fabricated with high molecular weight PLGA as a first step to establish the 
clinical efficacy of these scaffolds. PLGA with an intrinsic viscosity (i.v.) of ~ 0.7 (MW 106-112 
kDa) was chosen for this study due to its relevance in large animal studies77, and to correspond to 
an ongoing sheep study from our group. The polymer formulation used in the study represents a 
more translational product, inspired by a Coulter Foundation-funded project and input from Food 
and Drug Administration (FDA) regulatory consultant and business advisors. From this study, 
	 69	
we hope to gain an insight into parameters that can have profound implications during in vivo 
experiments.  
In this study, we investigated whether the encapsulated raw materials (CS and TCP) in 
high molecular weight PLGA scaffolds can provide building blocks and facilitate differentiation 
of the seeded cells simultaneously in the direction of bone- and cartilage-like cells. 3D 
microsphere-based scaffolds were fabricated using high molecular weight PLGA microspheres 
encapsulating CS (for cartilage regeneration) and TCP (for bone regeneration) as raw materials. 
Additionally, scaffolds containing gradient of the raw materials were also fabricated via a 
gradient technology as previously reported215. The response of rat bone marrow-derived stromal 
cells (rBMSCs) to the raw materials was evaluated when cultured in a medium consisting of 
exogenous factors. We hypothesized that encapsulation of raw materials; CS and TCP, in high 
molecular weight PLGA microsphere-based scaffolds would enhance the differentiation of 
rBMSCs toward chondrogenic and osteogenic lineages, respectively. Moreover, we anticipate 
rBMSCs in gradient scaffolds to differentiate simultaneously along an osteochondral route as 
previously seen in low molecular weight scaffolds encapsulating CS and BG170. 
 
MATERIALS AND METHODS 
MATERIALS 
Poly(D,L-lactic-co-glycolic acid) (PLGA) (50:50, lauryl ester end group, MW = 106 kDa) with 
an i.v. of 0.65 dL/g (“PLGA50:50”), and PLGA (75:25, lauryl ester end group, MW = 112 kDa)  
with an i.v. of 0.69 dL/g (“PLGA75:25”), were obtained from Lakeshore Biomaterials 
(Birmingham, AL). Murine IGF-I was obtained from Peprotech, Inc. (Rocky Hill, NJ). 
Chondroitin-4-sulfate (lyophilized powder of CS A sodium salt from bovine trachea) and TCP 
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powder  (< 200 nm particle) were obtained from Sigma (St. Louis, MO). All other reagents and 
organic solvents utilized were of cell culture or ACS grade. 
 
FABRICATION OF MICROSPHERES 
Three different types of microspheres were fabricated for the study: - (i) PLGA75:25 
microspheres (PLGA), (ii) CS-NaHCO3 encapsulated PLGA50:50 microspheres (CS), and (iii) 
TCP-encapsulated PLGA75:25 microspheres (TCP). The rationale for choosing PLGA with two 
different compositions was to correspond to an on going in vivo sheep study from our group. The 
relatively faster degrading polymer (PLGA50:50) was selected for its ability to release the raw 
materials quickly in the cartilage region to facilitate chondrogenesis whereas the slower 
degrading polymer (PLGA75:25) in the bone region was selected to lend more structural stability 
to the regenerating tissue. The CS-NaHCO3 encapsulated microspheres were fabricated by 
adding 2% w/v CS and 2% w/v NaHCO3 to 16% w/v PLGA50:50 dissolved in dichloromethane 
(DCM) and the TCP encapsulated microspheres were fabricated by adding 4% w/v TCP to 16% 
w/v PLGA75:25 dissolved in DCM. Using the PLGA-CS/TCP emulsions, microspheres were 
fabricated via our previously reported technology18, 58, 61, 63, 65, 169, 170, 215. Briefly, using acoustic 
excitation produced by an ultrasonic transducer (Branson Ultrasonics, Danbury, CT), regular jet 
instabilities were created in the polymer stream, thereby creating uniform polymer droplets. An 
annular carrier non-solvent stream of 0.5% w/v poly (vinyl alcohol) (PVA, 88% hydrolyzed, 25 
kDa, Polysciences, Inc., Warrington, PA) in deionized water (DI H2O) surrounding the polymer 
droplets was flowed using a coaxial nozzle that carried the emanated polymer droplets into a 
beaker containing the non-solvent solution at 0.5% w/v in DI H2O to prevent aggregation of the 
droplets. The polymer droplets were stirred for 3-4 h to allow for solvent to evaporate and then 
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filtered and rinsed with DI H2O to remove residual PVA and stored at -20°C. The particles were 
lyophilized for 48 h before further use. 
 
SCAFFOLD FABRICATION 
Gradient scaffolds (“GRADIENT” group) were prepared using our previously established 
technology63, 169, 170, 215. In brief, lyophilized microspheres (50–100 mg) of two different types, 
CS and TCP, were dispersed in DI H2O and loaded into two separate syringes. The suspensions 
were then pumped at opposing flow rates using programmable syringe pumps (PHD 22/2000; 
Harvard Apparatus, Inc., Holliston, MA) into a cylindrical plastic mold (diameter ~ 4 mm) 
having a filter at the bottom until a height of about 6 mm was reached. The scaffolds were 3.8-
4.0 mm in diameter and around 6 mm in height. The profile for these gradient constructs was 
linear, where the top one-fourth of the total height comprised of CS microspheres (1.5 mm), then 
the next one-fourth (1.5 mm) was a linear transition from CS to TCP microspheres, and the 
remaining half (3 mm) contained only TCP microspheres. The stacked microspheres were then 
sintered with ethanol-acetone (95:5 v/v) for 55 min. The scaffolds were further lyophilized for 48 
h and sterilized with ethylene oxide for 12 h prior to cell seeding experiments. The control 
PLGA and other homogenous scaffolds, abbreviated as CS and TCP, were fabricated by packing 
the corresponding microspheres into the same molds, followed by sintering for 55 min, except 
for PLGA scaffolds (sintered for 45 min). The homogeneous scaffolds had dimensions similar to 
GRADIENT scaffolds (diameter 3.8-4.0 mm and height 6 mm). A total of four different groups 
were tested in the study and were named according to the composition of microspheres as: 
PLGA, CS, TCP, and GRADIENT.  
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CELL SEEDING OF SCAFFOLDS 
rBMSCs were obtained from the femurs of 10 young male Sprague–Dawley rats (176–200 g, 
SASCO) following a University of Kansas approved IACUC protocol (175–08) and cultured in 
medium consisting of α−MEM supplemented with 10% FBS (MSC-Qualified, cat #10437-028) 
and 1% penicillin–streptomycin (P/S) (all from Invitrogen Life Technologies, Carlsbad, CA). 
When the cells were 80% to 90% confluent, they were trypsinized and re-plated at 7,000 
cells/cm2. Seeding was performed when cells reached P4. Scaffolds were sterilized using 
ethylene oxide for 12 hours, allowed to ventilate overnight after sterilization, and placed in a 24-
well plate. Cells (P4) were resuspended in culture medium at a concentration of approximately 
10 million/mL. 80 µL of this cell suspension (~750K cells) was placed directly onto the top of 
the scaffold, which infiltrated the scaffold via capillary action61. Cells were allowed to attach for 
1 h after which 2 mL of culture medium was added. After 24 h, the culture medium was replaced 
by 2 mL of differentiation medium consisting of α−MEM, 1% P/S, 10% FBS, 4 mM β-
glycerophosphate (β-GP), 100 nM dexamethasone (DEX) (MP Biomedicals, Santa Ana, CA), 25 
mM HEPES buffer (Fisher Scientific, Fairlawn, NJ), and 100 ng/mL murine IGF-I (Peprotech 
Inc., Rocky Hill, NJ). Every 48 h for 6 weeks, two-thirds of the differentiation medium was 
replaced with fresh medium. 
 
SCANNING ELECTRON MICROSCOPY (SEM) 
Scaffolds in culture were fixed in glutaraldehyde followed by dehydration in ethanol. Afterward, 
the scaffolds were lyophilized for 48 h prior to imaging. The PLGA, CS, TCP and GRADIENT 
acellular (week 0) and cellular (week 1.5) microsphere-based scaffolds were imaged using a 
LEO 1550 field emission scanning electron microscope at an accelerating voltage of 10kV. 
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MECHANICAL TESTING 
Unconfined compression tests of the acellular (week 0) and cellular (week 6) microsphere-based 
scaffolds (n = 4-5) were conducted using a uniaxial testing apparatus (Instron Model 5848, 
Canton, MA) with a 50 N load cell. A custom-made stainless steel bath and compression-plate 
assembly were mounted in the apparatus211. Cylindrical scaffold samples were compressed to 
80% strain at a strain rate of 1%/s under phosphate-buffered saline [PBS—0.138 M sodium 
chloride, 0.0027 M potassium chloride] at 37°C). Among all possible testing modalities, 
compression at a 1%/sec strain rate provides the most valuable information in terms of achieving 
high strain levels to view the entire stress-strain profile, which cyclic testing and stress 
relaxation/creep testing do not provide, and moreover a reproducible elastic modulus can be 
obtained without preconditioning as we have done in the past55. Compressive moduli of elasticity 
were calculated from the initial linear regions, ~5% strain, of the stress-strain curves as described 
previously61, 63, 170, 215.  
 
POROSITY MEASUREMENT 
We have previously demonstrated a close match between theoretical porosities and porosities 
measured by porosimetry and microCT114, 215. Therefore, a fluid saturation method was used in 
this study to calculate the porosities of the scaffolds: - 
V!  =  4m÷ πd!h, 
W!"#$%  =  W! −W!, 
V!  =  W!"#$% ÷ ρ!"#$%, 
Porosity φ (%)  =  (V! ÷ V!)×100 
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where VB, m, d, h, WW, WD, VP are the bulk volume, mass, diameter, height, wet weight, dry 
weight, and pore volume of the scaffolds, respectively. WWater and ρWater are the weight and 
density of water. Briefly, wet and dry weights of scaffolds were recorded after fabrication and 
porosities were determined by the above-described method. 
 
BIOCHEMICAL ANALYSES 
Engineered constructs (n = 5) were analyzed for matrix production at 0, 3, and 6 weeks. The 
samples were digested in two different types of digestion solution: - (i) Papain solution for DNA, 
GAG and hydroxyproline (HYP) content analyses, and (ii) Triton-X solution for calcium content 
and ALP activity analyses. The papain digestion solution consisted of 125 mg/mL papain (from 
papaya latex), 5 mM N-acetyl cysteine, 5 mM ethylenediaminetetraacetic acid, and 100 mM 
potassium phosphate buffer (20 mM monobasic potassium phosphate, 79 mM dibasic potassium 
phosphate) (all reagents from Sigma Aldrich) in DI H2O. Engineered constructs were removed 
from culture in a sterile manner, placed in microcentrifuge tubes, homogenized with the papain 
solution (1 mL), and allowed to digest overnight in a 60°C water bath. The digested scaffolds 
were then centrifuged at 10,000 rpm for 5 minutes to pellet fragments of polymer and other 
impurities and stored at -20°C. Later, the supernatant was used to determine DNA, 
glycosaminoglycan (GAG), and hydroxyproline (HYP) contents using the Picogreen (Molecular 
Probes, Eugene, OR), dimethylmethylene blue (DMMB) (Biocolor, Newtownabbey, Northern 
Ireland), and HYP (cat #MAK008, Sigma Aldrich, St. Louis, MO) assays, respectively. For 
calcium and ALP analyses, constructs were digested in 0.05% Triton X-100 and the supernatants 
were placed in the -20°C before the analyses. Calcium content was assessed using a 
QuantiChromTM Calcium Assay Kit (DICA-500; QuantiChrom, Hayward, CA). Alkaline 
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phosphatase (ALP) activity was estimated by determining liberated p-nitrophenol (p-NITRO) 
rate (concentration/µg DNA per minute) as described elsewhere28. In the cases of GAG and 
calcium content, the values of acellular controls for CS and TCP groups (listed in Tables 3.1 and 
3.2), respectively, were subtracted from the corresponding values of the cellular scaffolds at each 
time point in an effort to distinguish the bioactivity provided by the CS and TCP from the 
amounts retained in the scaffolds.  
 
GENE EXPRESSION ANALYSES 
Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed for gene 
expression analyses in microsphere-based constructs (n = 3-5) at weeks 0, 1.5, 3, and 6. Certain 
groups at certain time points (indicated in results section) had insufficient sample size (n < 3) 
because some of the samples were lost during processing. In preparation for RT-qPCR, samples 
were first homogenized in 1 mL of Trizol reagent (Invitrogen), and the RNA was isolated 
according to the manufacturer’s guidelines. Isolated RNA was cleaned using an RNeasy spin 
column method (Qiagen, Valencia, CA) and converted to complementary DNA using a TaqMan 
High Capacity kit (Applied Biosystems, Foster City, CA) in an Eppendorf Realplex Mastercycler. 
TaqMan Gene expression assays from Applied Biosystems for appropriate genes (Table 3.3) 
were run in the Eppendorf system. A 2-ΔΔCt method was used to evaluate the relative level of 
expression for each target gene. For quantification, the PLGA constructs at week 0 were 




SPSS 21.0 (IBM, Armonk, NY) was used for constructing standard box plots for outlier 
elimination. For statistical inference in Sections Mechanical Testing and Porosity Measurements, 
a single factor analysis of variance (ANOVA) was performed with SPSS, followed by a Tukey’s 
honestly significant difference post hoc test when significance was detected below the p = 0.05 
value. In Sections Biochemical Analysis and Gene Expression Analysis, the statistical inference 
was performed using a two-factor ANOVA followed by a Tukey’s honestly significant 
difference post hoc test when significance was detected below the p = 0.05 value. The model 
included the two factors (scaffold type and time) and the possible interactions between them. All 
quantitative results (numerical values and representative diagrams) are expressed as the average 





Figures 3.1 and 3.2 represent the scanning electron micrographs of all four types of scaffolds. 
Figure 3.1 demonstrates that the fabricated microspheres were uniform in size (also refer Figure 
3.10) and also illustrates the overall porous nature of microsphere-based scaffolds with 
interconnected pores. Additionally, it highlights the differences in microsphere morphology 
among the various scaffold groups. The microspheres in PLGA-only scaffolds (Figure 3.1A) 
were smooth with surface film layers being formed as a result of plasticization of PLGA with 
ethanol-acetone215. The microspheres in CS scaffolds (Figures 3.1B & 3.1D) had minute pores 
on their surface while the microspheres in TCP scaffolds had a rougher appearance (Figures 3.1C 
& 3.1E) than microspheres in the PLGA-only group. The GRADIENT scaffold image (Figure 
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3.1F) shows fusion between porous (CS) and rough (TCP) microspheres at the transition region 
of the scaffold. Apart from the differences in microsphere structure, variations were also 
observed in the cellular morphology of the cell-seeded constructs (Figure 3.2). At Day 10 (week 
1.5), very few cells were observed in the PLGA-only scaffolds residing in pores between the 
adjacent microspheres, and these cells possessed a rounded morphology (Figure 3.2A). In 
contrast, a far greater number of cells could be seen in the other three groups with differences 
appearing in the cellular morphologies. Cells covered the surface of the microspheres almost 
completely in the CS scaffolds and appeared to be flat with cell-cell connections being evident at 
the sintering junctions between the adjacent microspheres (Figure 3.2B). Cells in the TCP 
scaffolds had a round appearance, and were clustered around the microsphere sintering junctions 
(Figure 3.2C). Both cell types with round (in clusters) and flat morphologies were present in the 
GRADIENT group (Figure 3.2D). However, no apparent morphological differences were 
observed in cells from distinct regions of the GRADIENT scaffold. 
 
MECHANICAL TESTING 
TCP acellular scaffolds had an average elastic modulus of 194 ± 16 kPa at week 0 that was 4- (p 
< 0.05), 4.8- (p < 0.05), and 2.8-fold (p < 0.05) higher than the moduli of PLGA, CS, and 
GRADIENT scaffolds, respectively (Figure 3.3A). Additionally, among the cell-seeded scaffolds, 
TCP constructs at week 6 had an average modulus of 0.84 ± 0.55 MPa that was 208.8-fold (p < 
0.05) higher than the modulus of the CS group (Figure 3.3B). Surprisingly, it was observed that 
the PLGA constructs at week 6 had an average modulus of 11.4 ± 6.6 MPa (not shown in the 
figure) that was orders of magnitude higher than the moduli of the other three groups at that time. 
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No significant differences were observed between the elastic moduli of CS and GRADIENT 
groups at week 6. 
 
POROSITY MEASUREMENT 
The average porosity of CS group was 49.6 ± 4.4 % that was 2.4-fold (p < 0.05) higher than the 
porosity of the PLGA group (Table 3.4). Moreover, the porosities of the scaffolds in the CS 
group were also statistically significantly higher than the porosities of their counterparts in the 





The DNA content results (Figure 3.4) revealed no significant differences in the amount of DNA 
present in the four distinct types of scaffolds at weeks 0 and 3. At week 6, the DNA content in 
CS scaffolds was 31.7- fold (p < 0.05) higher than the DNA content in the PLGA group. The 
TCP and GRADIENT groups also outperformed the PLGA control at week 6, with 15- (p < 
0.05) and 18-fold (p < 0.05) higher DNA contents, respectively. Moreover, the DNA content in 
the CS group at week 6 was statistically significantly higher than the DNA contents in the TCP 
and GRADIENT groups at that time. Additionally, the CS, TCP and GRADIENT groups were 
observed to have statistically significantly higher DNA content at week 6 than their 
corresponding values at weeks 0 and 3 however, no significant differences in the DNA content 




A trend similar to DNA content was observed in the GAG content (Figure 3.5A), where no 
significant differences appeared among groups at weeks 0 and 3. At week 6, the net GAG 
content of the CS scaffolds was 5.5-fold (p < 0.05) higher than the GAG content of the PLGA 
group. Moreover, the GAG content in the CS group at week 6 was also statistically significantly 
higher than the GAG contents in the TCP and GRADIENT groups. No significant differences in 
the GAG content were observed among the other three groups week 6, meaning that the CS 
group was the only group to statistically significantly outperform the PLGA control at that time. 
The GAG content in the CS scaffolds (22.2 ± 7.5 µg) at week 6 was found to be statistically 
significantly higher than its corresponding values at weeks 0 and 3. The TCP and the 
GRADIENT groups had significantly higher GAG content at week 6 than their respective values 
at week 0. Furthermore, the PLGA and TCP groups at week 3 had significantly higher GAG 
content when it was normalized to the DNA content than the normalized GAG content of the CS 
and GRADIENT groups at that time (Figure 3.5B). However, at week 6 only the TCP group 
statistically significantly differed from the PLGA group in the normalized GAG content. It must 
be noted that the values of GAG content obtained from the biochemical analysis represent both 
the GAGs present in the ECM secreted by the cells and the chondroitin sulfate released by the 
scaffold and then entrapped within the ECM. The values do not represent the CS left entrapped 





At week 0, only the GRADIENT group outperformed the PLGA group in HYP content with 2.6-
fold (p < 0.05) higher HYP content (Figure 3.6A). Moreover, the HYP content in the 
GRADIENT group at week 0 was statistically significantly higher than the HYP contents in the 
CS and TCP groups. Week 3 HYP content results showed that the CS and GRADIENT groups 
had 1.9- (p < 0.05) and 2.9-fold higher HYP content than the PLGA group, respectively. Also, 
the GRADIENT group at week 3 had statistically significantly higher HYP content than the CS 
and TCP groups. At week 6, both the CS and the GRADIENT groups outperformed the PLGA 
control, with HYP contents that were 2.2- (p < 0.05) and 2.1-fold (p < 0.05) higher, respectively. 
Additionally, the CS and GRADIENT groups had statistically significant higher HYP contents 
than the TCP group at week 6.  The CS and GRADIENT groups were the only groups that 
showed statistically significant increases in HYP content over time. The HYP content in the CS 
group at week 6 was significantly higher than its corresponding values at weeks 0 and 3 whereas 
the HYP content in the GRADIENT group at week 3 was significantly higher than its HYP 
content at week 0. In the normalized HYP (per DNA) content, the PLGA, CS, and the 
GRADIENT groups were statistically significantly higher than the CS group at week 3 (Figure. 
3.6B) with no significant differences occurring in the normalized HYP content among the PLGA, 
CS and GRADIENT groups. The PLGA and TCP groups at week 3 had statistically significantly 
higher normalized HYP content than their values at week 0 and 6, respectively. No significant 





The calcium content analysis revealed no significant differences between the PLGA and CS 
groups at week 0 (Figure 3.7A). The calcium contents of TCP and GRADIENT scaffolds at 
week 0 are not reported because of insufficient sample size (n < 3), as some of the samples were 
lost during processing. At week 3, the calcium content in the PLGA group was statistically 
significantly greater than the calcium contents in the CS, TCP, and GRADIENT groups. Also, 
the calcium contents in the CS and TCP groups at week 3 were statistically significantly higher 
than the calcium content in the GRADIENT group. At week 6, the calcium contents in the CS 
and GRADIENT groups were 3.4- (p < 0.05) and 2.3-fold (p < 0.05) greater than the calcium 
content of the PLGA group. Moreover, the CS group calcium content at week 6 was observed to 
be statistically significantly higher than the calcium contents of the TCP and GRADIENT groups 
and the GRADIENT group was found to be significantly higher than the TCP group in calcium 
content at week 6. No significant differences were observed in the calcium contents of the PLGA 
and TCP groups at that time, meaning that only the CS and GRADIENT groups outperformed 
the PLGA control in calcium content at week 6. The calcium content of the PLGA group 
increased statistically significantly at week 3 from its week 0 value, followed by a decrease at 
week 6 that was not statistically significant. The CS group had significantly higher calcium 
content at week 6 than at weeks 0 and 3. In addition, the GRADIENT group had significantly 
more calcium at week 6 than at week 3. No significant differences in calcium content of the TCP 
group were observed over time. The normalized calcium content (Figure 3.7B) of PLGA 
scaffolds at week 3 was statistically significantly higher than the normalized calcium contents in 
the CS, TCP and GRADIENT groups. Additionally, the normalized calcium content in the TCP 
group at week 3 was statistically significantly higher than the normalized calcium contents of the 
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CS and GRADIENT groups. Furthermore, at week 6 the PLGA group’s normalized calcium 
content was significantly higher than the normalized calcium content in the CS, TCP and 
GRADIENT groups. The normalized calcium contents in the PLGA group at weeks 3 and 6 were 
statistically significantly higher than its corresponding value at week 0. However; the normalized 
calcium contents in the PLGA and TCP groups at week 6 were statistically significantly lower 
than their corresponding values at week 3. Again, it is to be emphasized that the values of 
calcium content are intended to represent the calcium present in the ECM secreted by the cells, 
and the calcium released from the microspheres and retained by the construct, and not the 
calcium still entrapped within the polymeric matrix. 
 
ALP ACTIVITY 
At week 0, the ALP activities in the TCP and GRADIENT groups were 2.2- (p < 0.05) and 2.5-
fold (p < 0.05) higher than the ALP activity in the PLGA group (Figure 3.8). Moreover, the ALP 
activities in the TCP and GRADIENT groups at week 0 were statistically significantly higher 
than the ALP activity in the CS group. No significant differences were observed in the ALP 
activities of PLGA and CS groups at week 0, meaning that only the TCP and GRADIENT 
groups outperformed the PLGA control in ALP activity at that time point. No significant 
differences in ALP activity were observed over time in the PLGA and CS groups. However, it 
was observed that the ALP activities of the TCP and GRADIENT groups at week 0 were 




SOX9 and COL2A1 
Relative SOX9 expression (Figure 3.9A) showed no significant differences among groups at 
week 0 and also no significant differences among the CS, TCP and GRADIENT groups at week 
1.5. The SOX9 expression for PLGA group is not reported at week 1.5 due to insufficient sample 
size (n < 3 as some of the samples were lost during processing). The SOX9 expression for the 
PLGA group at week 3 was statistically significantly higher than the SOX9 expression of the CS, 
TCP and GRADIENT groups. No significant differences among groups were observed in the 
SOX9 expression at week 6. The PLGA group was found to have statistically significantly 
higher SOX9 expression at week 3 than at weeks 0 and 6. No significant differences over time 
were observed in SOX9 expression within any of the other three groups. 
The COL2A1 (collagen II) expression (Figure 3.9B) in the PLGA group followed a trend 
similar to SOX9 expression. No significant differences were observed in COL2A1 expression 
among the PLGA, CS, and GRADIENT groups at week 0 (the TCP group collagen II expression 
at week 0 is not reported due to insufficient sample size). The COL2A1 expression of the PLGA 
group at week 1.5 was statistically significantly higher than the COL2A1 expression of the CS 
and TCP groups. Additionally, the PLGA group had statistically significantly higher COL2A1 
expression than the CS, TCP, and the GRADIENT groups at week 3. The CS group at week 3 
had significantly higher COL2A1 expression than the TCP and GRADIENT groups. No 
significant differences in COL2A1 expression between the other two groups were observed at 
week 3. The CS group at week 6 outperformed the PLGA group in COL2A1 expression with 
2.7-fold (p < 0.05) higher expression. Moreover, the CS group was statistically significantly 
higher in COL2A1 expression than the TCP and GRADIENT groups. No significant differences 
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were observed in COL2A1 expression among the other three groups at that time, meaning that 
only the CS group outperformed the PLGA control group in COL2A1 expression at week 6. The 
COL2A1 expression in the PLGA and CS groups peaked at week 3 with statistically significant 
higher expression at week 3 than their respective values at earlier time points of weeks 0 and 1.5 
however, the expression values in these groups decreased significantly at week 6 compared to 
their week 3 COL2A1 expression values. No significant differences over time were observed 
within the other two groups.  
 
ACAN AND COL1A1 
No significant differences among groups were observed in the ACAN (aggrecan) expression at 
week 0 (Figure 3.9C). At week 1.5, the ACAN expression in the GRADIENT group was 11.8-
fold (p < 0.05) higher than the PLGA group. Moreover, the ACAN expression in the 
GRADIENT group at week 1.5 was statistically significantly higher than the CS and TCP groups. 
No significant differences among other three groups were observed in the ACAN expression at 
that time, meaning that only the GRADIENT group outperformed the PLGA control group in 
ACAN expression at week 1.5. The ACAN expression of the CS group at week 3 was 10.5- fold 
(p < 0.05) higher than the PLGA group. In addition, the ACAN expression in the CS group at 
week 1.5 was significantly higher than the expression levels in the TCP and GRADIENT groups. 
Only the CS group outperformed the PLGA group in ACAN expression at week 3 as no 
significant differences were observed in ACAN expression among the other three groups. At 
week 6, the TCP group alone outperformed the PLGA group in ACAN expression with a 3.3-
fold (p < 0.05) higher expression. Moreover, the TCP group also had statistically significantly 
higher expression than the CS and GRADIENT groups at week 6. No significant differences 
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were observed in ACAN expression over time in the PLGA group. The ACAN expression in the 
CS group at week 3 was statistically significantly higher than the ACAN expression at the other 
three time points in the group. The TCP group had statistically significantly higher ACAN 
expression at week 6 than at weeks 0, 1.5, and 3. Lastly, the GRADIENT group had statistically 
significantly higher ACAN expression at week 1.5 than ACAN expression at the other three 
weeks.  
The COL1A1 (collagen I) expression (Figure 3.9D) of the GRADIENT at week 1.5 was 
97-fold (p < 0.05) higher than the COL1A1 expression of the PLGA group, which was one of the 
only instances where a test group outperformed the PLGA control. In addition, the COL1A1 
expression of the GRADIENT group was statistically significantly higher than the COL1A1 
expression levels of the CS and TCP groups. No significant differences were observed in 
COL1A1 expression among groups at weeks 0, 3, and 6. Additionally, the week 1.5 COL1A1 
expression of the GRADIENT group was statistically significantly higher than its COL1A1 
expression at any other time point. No significant differences were observed over time in any 
other group in the COL1A1 expression. 
 
RUNX2 AND BGLAP 
RUNX2 expression (Figure 3.9E) showed no significant differences among groups at week 0. 
However, at week 1.5 the PLGA and GRADIENT groups had statistically significantly higher 
RUNX2 expression than the expression levels of the CS and TCP groups, but were not 
significantly different from each other. At week 3, the PLGA group had statistically significantly 
higher RUNX2 expression than the other three groups. Moreover, the CS group at week 3 had 
significantly higher RUNX2 expression than the TCP group. Week 6 expression levels indicated 
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that the TCP group had significantly higher RUNX2 expression than the CS and GRADIENT 
groups. The PLGA RUNX2 expression at week 3 was found to be statistically significantly 
higher than its corresponding values at week 0 and week 6, but was not significantly different 
from its week 1.5 value. The GRADIENT group RUNX2 expression at week 1.5 was statistically 
significantly higher than at its values at weeks 0 and 6, but did not differ significantly from its 
value at week 3. No significant differences over time were observed in the RUNX2 expression 
levels of the CS and TCP groups. 
BGLAP expression (Figure 3.9F) showed no significant differences among groups at 
week 0 and no significant differences among the CS, TCP, and GRADIENT groups at week 1.5 
(PLGA value at week 1.5 is not reported because of insufficient sample size. At week 3, the CS 
group had 10.4-fold (p < 0.05) higher BGLAP expression than the PLGA group. Moreover, the 
CS group had statistically significantly higher BGLAP expression than the TCP and GRADIENT 
groups. At week 6, the PLGA group had statistically significantly higher BGLAP expression 
than the GRADIENT group. In addition, the CS group expression level was significantly higher 
than the expression levels of the TCP and GRADIENT groups. The CS group BGLAP 
expression at week 3 was statistically significantly higher than its values at weeks 0, 1.5 and 6, 
respectively. In addition, the CS group BGLAP expression at week 6 was statistically 
significantly higher than its values at weeks 0 and 1.5, but was significantly lower than its week 




SPP1 AND IBSP 
The SPP1 (osteopontin) expression (Figure 3.9G) showed no significant differences among 
groups at week 0. At week 1.5, the GRADIENT scaffolds had 248-fold (p < 0.05) higher SPP1 
expression than the PLGA group, another example of gene expression in a test group 
outperforming the PLGA control. Moreover, the SPP1 expression in the GRADIENT group was 
statistically significantly higher than the CS and TCP groups. No significant differences among 
the CS, TCP and GRADIENT groups were observed in the SPP1 expression levels at week 3 
(the PLGA group expression at week 3 is not reported due to insufficient sample size). Again, no 
significant differences among groups were observed at week 6. The CS group expression at week 
3 was statistically significantly higher than at week 0. The GRADIENT group expression at 
week 1.5 was significantly higher than at weeks 0, 3, and 6. No significant differences over time 
were observed within any of the remaining two groups.  
IBSP expression (Figure 3.9H) showed no significant differences among the CS, TCP 
and GRADIENT groups at week 1.5 (the values for CS, TCP, and GRADIENT groups at week 
0; and the PLGA group at week 1.5 are not reported because of insufficient sample size). At 
week 3, the IBSP expression of the CS group was 1.8-fold (p < 0.05) higher than the PLGA 
group. In addition, the CS group IBSP expression at week 3 was statistically significantly higher 
than the TCP and GRADIENT groups. The PLGA group at week 3 also had significantly higher 
expression than the TCP and GRADIENT groups. No significant differences among groups were 
observed at week 6. The CS group IBSP expression at week 3 was statistically significantly 
higher than at weeks 1.5 and 6. No significant differences were observed over time within any of 
the other groups.  
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DISCUSSION 
The current study for the first time demonstrated the feasibility of raw material encapsulation in 
high molecular weight PLGA microsphere-based scaffolds that could potentially be used in large 
animal models or human patients. This work builds on our previous efforts that spoke of the 
advantages of raw material encapsulation (in conjunction with growth factors) toward creating a 
new tissue-specific ECM in low molecular weight PLGA scaffolds170. Furthermore, employing 
opposing gradients of CS and TCP to provide bioactive cues and building blocks for 
simultaneous chondrogenic and osteogenic differentiation of cells is a promising approach for 
osteochondral interfacial tissue engineering. Additionally, to the best of our knowledge, we are 
the first group to encapsulate TCP in microsphere-based scaffolds for the bone part of our 
scaffolds. Most of the other groups utilizing microsphere-based scaffolds have relied on other 
calcium phosphates and minerals for engineering the bone tissue46, 161, 228, 255. 
The SEM images, depicting the overall porous nature of microsphere-based scaffolds 
with interconnections among the pores, were in agreement with our previous findings with these 
scaffolds fabricated with low molecular weight PLGA215. Moreover, raw material encapsulation 
did not affect the spherical nature of the microspheres; however, it was found to have altered the 
microstructure of the microspheres. Specifically, the CS microspheres had a porous surface that 
could be attributed to the solvent removal process during the microsphere fabrication step, as we 
have also observed previously170. The presence of sub-micron pores on the CS microspheres 
contributed toward higher average porosity in these scaffolds compared to the other three groups. 
The TCP encapsulating microspheres, on the other hand, did not possess pores on their surfaces, 
but had a rough surface instead. The surface roughness of these microspheres, specifically the 
presence of ridge-like features, may have resulted from the partitioning of TCP particles on the 
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surface of the microspheres. These surface characteristics of raw material encapsulating 
microspheres may have great implications in cell attachment or anchorage and also in diffusion 
of nutrients and wastes in and out of the scaffolds189, 254. Furthermore, raw material encapsulation 
impacted the cellular morphology of the seeded rBMSCs. Flat cells with significant cell 
spreading were observed in the CS and GRADIENT groups while cluster forming round cells 
could be seen in the TCP and GRAIDENT groups. Though the GRADIENT group contained 
both flat and round cells, no differences in cell morphologies were observed in cells from distinct 
regions of the scaffold. The different cell morphologies on microsphere-based scaffolds might 
suggest that cells responded favorably to the encapsulated raw materials, at least initially, which 
may have influenced their differentiation along discrete pathways. This initial cellular response 
to encapsulated raw materials could have pivotal significance in regenerating interfacial tissues 
that require differentiation of cells from a single source along multiple pathways. 
Mechanical testing results demonstrated the compressive moduli of microsphere-based 
scaffolds to be in the range of articular cartilage (0.1-0.9 MPa) and within an order of magnitude 
of the moduli for cancellous bone (0.01-2 GPa)128, 164, 251. Moreover, the elastic modulus of TCP 
scaffolds at week 0 was found to be at least 3 times as large as any other group, thereby 
conforming to the observations of Lv et al.,161 demonstrating that calcium phosphates enhance 
the mechanical properties of polymeric scaffolds. However, at week 6 the cell seeded TCP 
constructs had significantly higher modulus than the CS group alone. All the other groups, 
except for the CS group, had an increase in their elastic moduli from week 0. Differences among 
groups in degradation rates of the scaffolds, cell proliferation within the scaffolds, and ECM 
deposition could have all contributed to the increase in moduli. PLGA microspheres are known 
to degrade via bulk erosion where the rate-limiting step is the diffusion of water molecules into 
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the microsphere core. CS microspheres because of their porous nature may have allowed faster 
diffusion of the water molecules into their core, thereby initiating the polymer degradation more 
quickly than in the other three groups. Higher glycolic acid content in PLGA (PLGA50:50) of 
CS microspheres may have further accelerated polymer degradation in the CS group2. 
Additionally, swelling (Table 3.5) caused by penetration of water inside of the microspheres may 
have also played a part in the drop in elastic modulus of CS scaffolds170. On the other hand, 
swelling was absent (PLGA and TCP groups) or less pronounced (GRADIENT group) in the 
other three groups compared to the CS group, which may have prevented the drop in elastic 
moduli of scaffolds from the PLGA, TCP and GRADIENT groups at week 6. Moreover, 
polymer composition (PLGA75:25) and microsphere morphology (absence of minute pores on 
surface) may have allowed the PLGA, TCP and GRADIENT scaffolds to further retain their 
mechanical properties. Surprisingly, the PLGA scaffolds had a tremendous increase in modulus 
from week 0 to week 6, translating to an elastic modulus orders of magnitude higher than the 
moduli of the other three groups at week 6. We previously observed a similar trend in elastic 
moduli in raw material encapsulating low molecular weight PLGA scaffolds where deviations 
from the overall scaffold structure at week 6 led to a significant increase in elastic modulus170. 
Additionally, the elastic moduli of high molecular weight PLGA acellular scaffolds at week 6 
(unpublished data) also hinted toward a similar phenomenon. Therefore, it is speculated that 
cellular contributions, in conjunction with polymer degradation led to microscopic changes in the 
scaffold morphology (closure of pores) that caused the elastic moduli of PLGA constructs to 
jump at week 6. However, further investigation is needed to better understand the degradation in 
these high molecular weight PLGA scaffolds and the mechanism of increase in their compressive 
moduli with time. Altogether, results from the mechanical testing provided information that 
	 91	
would be valuable in designing microsphere-based scaffolds for future in vitro and in vivo 
studies in rabbits, sheep, etc. 
The biochemical content results were found to be consistent with the SEM observations. 
A small number of cells were observed on the PLGA scaffolds at Day 10, which agreed with the 
DNA content analysis that revealed low quantities of DNA on these scaffolds throughout the 6-
week culture period. In contrast, the DNA contents of all the raw material encapsulating groups 
increased over time with significant differences appearing at week 6. Our DNA results on 
microsphere-based scaffolds suggest that raw material encapsulation encouraged rBMSC 
proliferation on these scaffolds, thus agreeing with the findings of some other groups showing 
that the raw materials such as CS and β-TCP could cast a positive influence on the proliferative 
capacity of rBMSCs134, 229, 234, 238. GAG data showed that the CS group had at least a three-fold 
higher GAG content than the rest of the groups at week 6. Since the GAG content of acellular 
constructs (Table 3.1) was subtracted at each time point, it is to be stressed that the data 
primarily represented GAG secreted by the cells and also released CS entrapped within the 
newly synthesized ECM. A trend similar to GAG content was seen in the HYP content of CS 
scaffolds suggesting that the encapsulated CS played a significant role in enhancing the cellular 
GAG and collagen secretion, thus having a modulatory effect on the seeded rBMSCs. However, 
observance of lower normalized GAG and HYP content in the CS group than the PLGA group 
suggest that the bioactive effects seen due to CS encapsulation may have been primarily due to 
the improvement in cellularity without sacrificing biosynthesis on a per cell basis. Calcium 
content analysis revealed some unanticipated results. The CS group had a significantly higher net 
calcium content than the other groups at week 6 and the PLGA group was higher in calcium per 
DNA content compared to rest of the groups at that time. The counter-intuitive phenomenon of 
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high calcium (or calcium per DNA) contents in the CS and PLGA groups could be attributed to 
culture medium components such as DEX, β-GP, and IGF-I. DEX is a glucocorticoid, which is 
used extensively in vitro as an osteogenic factor. β-GP is the common source for MSCs to form 
CaP deposits in vitro76, 207. IGF-I is an anabolic signal that does not necessarily influence the 
proliferation and differentiation of MSCs toward osteoblasts on its own, but it is an important 
molecule directing the differentiation of already osteogenically committed cells93. Thus, the 
presence of these components likely influenced the commitment of rBMSCs on the microsphere-
based scaffolds toward osteogenesis. Furthermore, the ALP activities of the TCP and 
GRADIENT groups at week 0 were higher than their activities at week 6. The elevated ALP 
activities in these constructs at earlier time points may have been due to the medium components. 
However, failure to observe a similar effect in the other two groups hint that TCP encapsulation 
might have influenced their behavior initially as seen with the SEM micrographs as well. Lastly, 
higher normalized HYP and calcium contents in the TCP encapsulating scaffold groups than the 
CS group at later time points suggest that TCP encapsulation may have improved rBMSC 
performance by promoting their differentiation in addition to enhancing their proliferation (as 
seen with DNA content results).  
Gene expression results were in agreement with the other results of the study. Relatively 
higher expressions of SOX9, COL2A1, and RUNX2 by the cells in the PLGA group at week 3 
followed by higher mineral content at week 6 (as indicated by the biochemical data) suggest that 
the dexamethasone in culture the medium may have caused the rBMSCs in the PLGA scaffolds 
to go down the osteogenic pathway via a cartilage-like intermediate. Higher expression levels of 
chondrogenic markers (collagen II and aggrecan) in conjunction with up regulation of osteogenic 
markers (BGLAP and IBSP) by the cells in the CS group at week 3 than compared to the initial 
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time points suggest a similar phenomenon as observed in the PLGA group. Lower expression of 
BGLAP and IBSP in the TCP group than the CS group suggests that TCP presence inhibited 
expression of osteogenic markers by creating a substrate environment that was already high in 
mineral content, a phenomenon previously observed with hydroxyapatite encapsulating low 
molecular weight PLGA microsphere-based scaffolds61. The cells in the GRADIENT group 
showed relatively higher expression of ACAN and SPP1 (along with higher expression of 
RUNX2 by the cells in the group than at week 0) than the cells in the PLGA control group at 
week 1.5. The higher expression of some chondrogenic and osteogenic markers in the 
GRADIENT group at earlier time points may be due to faster maturation of rBMSCs toward 
cartilage- and bone-like cells in this group however, more evidence is needed to reinforce this 
speculation.  
Overall, the results of the current study indicate that raw material encapsulation into 
microsphere-based scaffolds influenced the behavior of the seeded rBMSCs. Differences in the 
cell morphologies and greater cell numbers in the raw material groups leading to enhanced 
matrix synthesis in these groups demonstrates that the raw materials provide a head start in the 
(re)generation of tissues. It is of interest to infer the amount of matrix synthesized by cells in the 
scaffolds beyond the exogenously included amounts. Therefore, the biochemical content (CS and 
calcium) for the acellular constructs was subtracted from the content of the cell seeded constructs 
assuming that the acellular scaffolds degrade and release encapsulated molecules at the same rate 
as their cellular counterparts. However, we acknowledge that this assumption is weak as cells 
synthesizing new matrix, and perhaps altering the surrounding pH, etc., will influence the 
polymer degradation rate, but with the higher molecular weight PLGA, it should be a reasonable 
approximation that allows us to better evaluate differences among groups due to cellular 
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contribution. In addition, static seeding approach employed in this study has limitations 
associated with it due to the manual- and operator-dependent nature of the process. However, we 
followed a uniform manual seeding procedure and we think that the differences observed in the 
DNA content at week 0 (24 hours post seeding) among various scaffold type might have resulted 
more from the differences in cell attachment arising due to differences in scaffold composition 
than arising from variations in cell seeding. Moreover, we did not specifically explore the dosing 
effect of CS and TCP, but our group has demonstrated in the past that the concentration of the 
raw materials can have a significant effect on the differentiation of the cells61. Additionally, 
higher cell number, greater biochemical content and relatively higher expression of some 
osteogenic and chondrogenic markers in the GRADIENT group accentuated the advantages of 
using gradient-based strategies for engineering the osteochondral interface. However, we 
recognize that these scaffolds not being amenable to histology due to the stiffness of the polymer 
constructs, given the high molecular weight and slow degradation of the PLGA was a limitation 
of the study that would have further elaborated the differences among groups based on their 
regional material composition, but we have substantiated previously both in vitro and in vivo that 
regionalized tissue formation occurs in raw material gradient microsphere-based engineered 
constructs169, 170. Furthermore, the initial effects of raw material encapsulation on a per-cell basis 
might have been obscured by the culture medium components that appeared to favor 
osteogenesis. However, it is to be noted that in vitro advancements observed initially with raw 
material encapsulation could translate in vivo to a more favorable interaction with infiltrating 
MSCs, and perhaps facilitate differentiation in a native environment rather than in a medium-
governed environment. Lastly, an important consideration in designing scaffolds for clinical use 
is determining the mechanical integrity. We have shown in our prior work that microsphere-
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based scaffolds possess adequate mechanical properties for the regeneration of osteochondral 
tissues and the encapsulation of raw materials may impact those properties61, 63, 170. Our 
mechanical testing results in the current study also agreed with our previous findings; 
additionally, the results also suggested that the mechanical properties of microsphere-based 
scaffolds can be impacted by scaffold degradation and cellular matrix synthesized by the seeded 
cells. Additional cyclic testing in the future may yield interesting information about degree of 
hysteresis and narrower strain ranges about a fixed strain point (e.g., 5%) with a frequency sweep 
could yield interesting tan delta profiles as well, which we will consider for future studies.  
Altogether, the overall findings emphasize the need to further refine the technology, 
perhaps by adjusting raw material concentration or by altering PLGA degradation rate. The 
degradation of the polymer will play a key role in tissue regeneration in vivo, where premature 
failure in scaffold mechanical properties can have a deleterious effect on the regenerating tissue 
and extended degradation in contrast could become an obstacle to tissue regeneration. Therefore, 
it is important to identify a polymer with a biodegradation rate comparable to the neo-tissue 
formation rate. Additionally, identifying raw material concentrations that are most efficacious in 
promoting osteogenesis and chondrogenesis would yield valuable information, which could then 
be leveraged for tailoring scaffold degradation in future sheep or any other large animal model 
studies. Nevertheless, the current study highlights several benefits of raw material microsphere 
gradient scaffold technology. The raw material encapsulating microsphere-based scaffolds 
attempt to regenerate both cartilage and bone simultaneously, thus stressing on the importance of 
growing cartilage and bone within the physical proximity of each other; many signaling 
pathways and endogenous proteins responsible for progenitor cell commitment to the osteoblast 
or chondrocyte lineages have a high degree of interrelatedness88. The raw materials apart from 
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being conductive to tissue (re)generation can also provide inductive signals to the surrounding 
cells guiding their differentiation. In addition, the raw materials provide clinical significance to 
microsphere gradient scaffolds, as these scaffolds may be tactically placed for swifter and less 
costly regulatory approval.  
 
CONCLUSIONS 
The present study assessed the in vitro response of microsphere-based scaffolds with clinical 
relevance fabricated using a raw material approach. Overall, the results demonstrated that the 
primary improvements observed with the raw materials−CS and TCP−were more due to greater 
initial interaction with cells and greater cellularity with comparable performance on a per-cell 
basis rather than on specifically driving differentiation. Moreover, the medium-governed 
environment that seemed to favor osteogenesis concealed the initial in vitro advancements 
observed with raw material encapsulation. Additionally, there was also evidence of faster 
maturation of rBMSCs in the raw material GRADIENT constructs that can be leveraged further 
to engineer the complex osteochondral interface. Therefore, a strategy combining the “building 
block” side of the raw material philosophy (as we have done here) with the “signaling” side, for 
example by including hydroxyapatite with the TCP, or maybe TGF-β with CS, or by altering the 
dose of CS (without TGF-β), in a scaffold with a biodegradation rate comparable to the neo-
tissue formation rate, we may be able to achieve the differentiation profiles we seek in vitro. 
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CHAPTER 4: MICROSPHERE-BASED SCAFFOLDS ENCAPSULATING TRICALCIUM 
PHOSPHATE AND HYDROXYAPATITE§ 
ABSTRACT 
Bioceramic mixtures of tricalcium phosphate (TCP) and hydroxyapatite (HAp) are widely used 
for bone regeneration because of their excellent cytocompatibility, osteoconduction, and 
osteoinduction. Therefore, we hypothesized that incorporation of a mixture of TCP and HAp in 
microsphere-based scaffolds would enhance osteogenesis of rat bone marrow stromal cells 
(rBMSCs) compared to a positive control of scaffolds with encapsulated bone-morphogenic 
protein-2 (BMP-2). Poly(D,L-lactic-co-glycolic acid) (PLGA) microsphere-based scaffolds 
encapsulating TCP and HAp mixtures in two different ratios (7:3 and 1:1) were fabricated with 
the same net ceramic content (30 wt%) to evaluate how incorporation of these ceramic mixtures 
would affect the osteogenesis in rBMSCs. Encapsulation of TCP/HAp mixtures impacted 
microsphere morphologies and the compressive moduli of the scaffolds. Additionally, TCP/HAp 
mixtures enhanced the end-point secretion of extracellular matrix (ECM) components relevant to 
bone tissue compared to the “blank” (PLGA-only) microsphere-based scaffolds as evidenced by 
the biochemical, gene expression, histology, and immunohistochemical characterization. 
Moreover, the TCP/HAp mixture groups even surpassed the BMP-2 positive control group in 
some instances in terms of matrix synthesis and gene expression. Lastly, gene expression data 
suggested that the rBMSCs responded differently to different TCP/HAp ratios presented to them. 
Altogether, it can be concluded that TCP/HAp mixtures stimulated the differentiation of 
rBMSCs toward an osteoblastic phenotype, and therefore may be beneficial in gradient 
microsphere-based scaffolds for osteochondral regeneration.  
                                                
§To be submitted as Gupta V, Lyne D, Barragan M, Berkland C, Detamore M, Microsphere-Based Scaffolds 
Encapsulating Tricalcium Phosphate and Hydroxyapatite, Biomaterials Science, 2015. 
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INTRODUCTION 
Several regenerative medicine strategies for osteochondral repair have relied on the use of 
bioceramics such as tricalcium phosphate (TCP) and hydroxyapatite (HAp) for regenerating the 
bone region of the tissue56, 113, 155, 193, 205, 209. TCP and HAp are both chemically similar to the 
inorganic component of bone and are osteoconductive because of their capability to bond with 
bone. TCP lacks osteoinductivity, while HAp is widely accepted to be osteoinductive84, 157. On 
the other hand, HAp degrades over the course of several years, whereas TCP may be resorbed 
into the new bone tissue75, 223. Numerous studies have shown that mixtures of TCP and HAp 
without the addition of any growth factors or cells can treat large bone defects, which supports 
their great clinical potential22, 74, 258. 
Microsphere-based scaffolds are promising substrates for musculoskeletal regeneration 
because of their structural attributes like rigidity in shape, ability to provide a porous network, 
and uniform mechanical properties101. Moreover, they offer a wide range of alternatives in terms 
of materials for microsphere matrices, and methods for microsphere fabrication and sintering18, 21, 
25, 29, 32, 184. Our group has demonstrated that microsphere-based scaffolds can provide opposing 
signal gradients via spatio-temporal release of growth factors to facilitate regeneration of 
complex tissues such as the osteochondral interface58, 63, 65, 169, 214, 215. Furthermore, we have 
shown that opposing gradients of materials such as TCP and chondroitin sulfate can provide raw 
materials (i.e., bioactive signals and building blocks) to simultaneously guide the regional osteo- 
and chondrogenic differentiation of cells89, 173. Delivering raw materials in lieu of growth factors 
holds tremendous financial incentive for translation to the clinic by providing a more streamlined 
path for regulatory approval as well as saving on the cost of including the growth factor in the 
product. With regard to osteochondral regeneration, the ceramic mixtures can be combined with 
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chondrogenic raw materials in a gradient scaffold to regenerate the bone region of the tissue. To 
first evaluate the osteogenic response, the systematic approach is to assess the performance of 
homogenous microsphere-based scaffolds encapsulating bioceramic mixtures before employing 
them in a continuously graded design. Therefore, the objective of the current study was to 
investigate the in vitro response of homogenous microsphere-based scaffolds encapsulating TCP 
and HAp mixtures.  
In the current study, we investigated whether encapsulation of a bioceramic mixture 
(TCP and HAp) in PLGA microsphere-based homogenous scaffolds would promote osteogenesis 
in rat bone marrow stromal cells (rBMSCs). Homogenous microsphere-based scaffolds were 
fabricated using PLGA microspheres encapsulating TCP and HAp mixtures in two of the most 
widely studied w/w ratios of 7:3 and 1:1 (TCP:HAp) with the same net ceramic content of 30 
wt%36, 71, 103. The response of rBMSCs to the bioceramic mixtures was evaluated when cultured 
in a medium consisting of exogenous factors. Cell response to an osteogenic growth factor, bone 
morphogenetic protein (BMP)-2, encapsulated in microspheres has been studied in detail in our 
earlier work63, 169. Microsphere-based scaffolds with encapsulated BMP-2 served as the positive 
control, and “blank” microsphere-based scaffolds (i.e., no BMP-2, TCP or HAp) served as the 
negative control. We hypothesized that the bioceramic mixture encapsulating groups would 
outperform the BMP-2 group (positive control) in gene expression and extracellular matrix 
(ECM) synthesis relevant to bone tissue.  
 
	 100	
MATERIALS AND METHODS 
MATERIALS 
Poly(D,L-lactide-co-glycolide) (PLGA) (50:50 lactic acid:glycolic acid ratio, ester end group) 
with an intrinsic viscosity (i.v.) of 0.37 dL/g, was obtained from Evonik Industries (Essen, 
Germany). Human BMP-2 and Murine insulin-like growth factor (IGF)-I were obtained from 
PeproTech, Inc. (Rocky Hill, NJ). HAp and TCP powders  (< 200 nm particle) were obtained 
from Sigma Aldrich (St. Louis, MO). All other reagents and organic solvents utilized were of 
cell culture or ACS grade. 
 
PREPARATION OF MICROSPHERES 
Four different types of microspheres were fabricated for the study: - (i) PLGA microspheres 
(BLANK), (ii) BMP-2 encapsulated PLGA microspheres (BMP), (iii) 7:3 w/w TCP:HAp-
encapsulated in PLGA microspheres (abbreviated as TH73 or TCP/HAp 7:3), and (iv) 1:1 w/w 
TCP:HAp-encapsulated in PLGA microspheres (abbreviated TH11 or TCP/HAp 1:1). For 
fabricating BMP-2 encapsulated microspheres, BMP-2 was first reconstituted in 10 mg/ml 
bovine serum albumin (BSA) in phosphate buffered saline (PBS) (both from Sigma, St. Louis, 
MO). The reconstituted protein solution was mixed with 20% w/v PLGA dissolved in 
dichloromethane (DCM) at a loading of 60 ng BMP-2 per 1.0 mg of PLGA. The final mixture 
was then sonicated over ice (50% amplitude, 20 s). The TCP/HAp 7:3 and TCP/HAp 1:1 
encapsulated microspheres were fabricated by adding 4.2% and 3% w/v TCP and 1.8% and 3% 
w/v HAp, respectively to 14% w/v PLGA dissolved in DCM. The net ceramic content 
encapsulated in TCP/HAp 7:3 and TCP/HAp 1:1 groups was 30 wt%. Using the PLGA-protein 
and PLGA-TCP/HAp emulsions, microspheres with mean diameters ranging from 172-186 µm 
	 101	
(Supplementary Figure 1), were fabricated via our previously reported technology58, 61, 63, 65, 89, 114, 
169, 172, 173, 214, 215, 224. Briefly, using acoustic excitation produced by an ultrasonic transducer 
(Branson Ultrasonics, Danbury, CT), regular jet instabilities were created in the polymer stream, 
thereby creating uniform polymer droplets. An annular carrier non-solvent stream of 0.5% w/v 
poly (vinyl alcohol) (PVA, 88% hydrolyzed, 25 kDa, Polysciences, Inc., Warrington, PA) in 
deionized water (DI H2O) carried the emanated polymer droplets (i.e., microspheres) into a 
beaker containing the non-solvent solution at 0.5% w/v in DI H2O. The microspheres were 
stirred for 2-3 h to allow the solvent to evaporate, and then these microspheres were filtered, 
rinsed and stored at -20°C. The microspheres were then lyophilized for 48 h before further use. 
 
SCAFFOLD FABRICATION 
Scaffolds were prepared from the microspheres using our previously established technology61, 63, 
89, 172, 215, 224. In brief, lyophilized microspheres (50-70 mg) were dispersed in DI H2O and loaded 
into a syringe. The dispersion was then pumped using a programmable syringe pump (PHD 
22/2000; Harvard Apparatus, Inc., Holliston, MA) into a cylindrical plastic mold (diameter ~ 4 
mm) having a filter at the bottom until a height of about 2 mm was reached. The scaffolds were 
3.8-4.0 mm in diameter and around 2 mm in height. The packed microspheres were then sintered 
with ethanol-acetone (95:5 v/v) for 55 min. The scaffolds were further lyophilized for 48 h and 
sterilized with ethylene oxide for 12 h prior to cell seeding experiments. A total of four different 
groups were tested in the study and were named according to the composition of microspheres 
as: BLANK, BMP, TH73 or TCP/HAp 7:3, and TH11 or TCP/HAp 1:1.  
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CELL SEEDING OF SCAFFOLDS 
rBMSCs were obtained from the femurs of eight young male Sprague–Dawley rats (176–200 g, 
SASCO) following a University of Kansas approved IACUC protocol (175–08) and cultured in 
medium consisting of αMEM supplemented with 10% FBS (MSC-Qualified, cat #10437-028) 
and 1% penicillin–streptomycin (P/S) (both from Thermofisher Scientific, Waltham, MA). When 
the cells were 80% to 90% confluent, they were trypsinized and re-plated at 7,500 cells/cm2. 
Seeding was performed when cells reached P4. Scaffolds were sterilized using ethylene oxide for 
12 h, allowed to ventilate overnight after sterilization, and placed in a 48-well plate. Cells (P4) 
were resuspended in culture medium at a concentration of approximately 50 million/mL. 25 µL 
of this cell suspension (~1.25M cells) was placed directly onto the top of the scaffold, which 
infiltrated the scaffold via capillary action 61, 89. Cells were allowed to attach for 1 h, after which 
1 mL of culture medium was added. After 24 h, the culture medium was replaced by 1 mL of 
differentiation medium consisting of αMEM, 1% P/S, 10% FBS, 4 mM β-glycerophosphate (β-
GP), 100 nM dexamethasone (DEX) (MP Biomedicals, Santa Ana, CA), 1% insulin-transferrin-
selenium 100X (ITS) (Thermofisher Scientific, Waltham, MA), 1% non-essential amino acids 
(NEAA) (Thermofisher Scientific, Waltham, MA), 15 mM HEPES buffer (Thermofisher 
Scientific, Waltham, MA), and 100 ng/mL murine IGF-I. Every 48 h for 6 weeks, three-fourths 
of the differentiation medium was replaced with fresh medium. 
 
SCANNING ELECTRON MICROSCOPY (SEM) AND ENERGY DISPERSION 
SPECTROSCOPY (EDS) 
Microspheres and acellular scaffolds were imaged via a Versa 3D Dual Beam (FEI, Hillsboro, 
OR) scanning electron microscope (SEM) with a detector for energy dispersive spectroscopy 
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(EDS). The BMP and TH11 microspheres were cryo-fractured using a sharp blade and the 
dispersion of BMP-2, TCP and HAp within the microspheres was further analyzed using EDS at 
an accelerating voltage of 10 kV. Pixel maps for atomic calcium, nitrogen and phosphorus were 
generated using Aztec analysis software (Oxford Instruments, Abingdon, United Kingdom). The 
PLGA (BLANK) microspheres were also imaged as a negative control to confirm the absence of 
calcium, nitrogen and phosphorous in the EDS maps.  
 
MECHANICAL TESTING 
Unconfined compression tests of acellular (i.e., week 0) microsphere-based scaffolds (n = 6) 
were conducted using a uniaxial testing apparatus (Instron Model 5848, Canton, MA) with a 50 
N load cell. A custom-made stainless steel bath and a compression-plate assembly were mounted 
in the apparatus212. Cylindrical scaffold samples were compressed to 40% strain at a strain rate of 
10%/min under phosphate-buffered saline [PBS—0.138 M sodium chloride, 0.0027 M potassium 
chloride] at 37°C. Among all possible testing modalities, compression at a 10%/min strain rate 
provides the most valuable information in terms of achieving high strain levels to view the entire 
stress-strain profile, which cyclic testing and stress relaxation/creep testing do not provide, and 
moreover a reproducible elastic modulus can be obtained without preconditioning as we have 
done in the past55. Compressive moduli of elasticity were calculated from the initial linear 




We have previously demonstrated a close match between theoretical porosities and porosities 
measured by porosimetry and microCT114, 215. Therefore, a fluid saturation method as described 
previously89 was used in this study to calculate the porosities of the scaffolds: 
V!  =  4m÷ πd!h, 
W!"#$%  =  W! −W!, 
V!  =  W!"#$% ÷ ρ!"#$%, 
Porosity φ % =  V! ÷ V! ×100% 
 
where VB, m, d, h, WW, WD, VP are the bulk volume, mass, diameter, height, wet weight, dry 
weight, and pore volume of the scaffolds, respectively. WWater and ρWater are the weight and 
density of water. Briefly, wet and dry weights of scaffolds were recorded after fabrication and 
porosities were determined by the above-described method. 
 
BIOCHEMICAL ANALYSES 
Engineered constructs were analyzed for matrix production at 0 (i.e., 24 h post seeding), 3, and 6 
weeks. The samples were digested in two different types of digestion solution (n = 6 for each): 
(i) Papain solution for DNA and hydroxyproline (HYP) content analyses, and (ii) Triton-X 
solution for calcium content and ALP activity analyses. The papain digestion solution consisted 
of 125 mg/mL papain (from papaya latex), 5 mM N-acetyl cysteine, 5 mM 
ethylenediaminetetraacetic acid, and 100 mM potassium phosphate buffer (20 mM monobasic 
potassium phosphate, 79 mM dibasic potassium phosphate) (all reagents from Sigma Aldrich) in 
DI H2O. Engineered constructs were removed from culture in a sterile manner, placed in 
microcentrifuge tubes, homogenized with the papain solution (1 mL), and allowed to digest 
overnight in a 60°C water bath. The digested scaffolds were then centrifuged at 10,000 rpm for 5 
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minutes to pellet fragments of polymer and other impurities and stored at -20°C. Later, the 
supernatant was used to determine DNA and hydroxyproline (HYP) contents using the 
PicoGreen (Molecular Probes, Eugene, OR) and HYP (cat #MAK008, Sigma Aldrich, St. Louis, 
MO) assays, respectively. For calcium and ALP analyses, constructs were digested in 0.05% 
Triton X-100 (Sigma Aldrich, St. Louis, MO) and the supernatants were stored at -20°C before 
the analyses. Calcium content and alkaline phosphatase (ALP) activity were assessed using the 
QuantiChromTM Calcium Assay (DICA-500; QuantiChrom, Hayward, CA) and Alkaline 
Phosphatase Activity Colorimetric Assay (K412-500, Biovision, Milpitas, CA) kits, respectively. 
The calcium contents of the acellular controls for TCP/HAp 7:3 and TCP/HAp 1:1 groups were 
also measured at each time point in an effort to distinguish the bioactivity provided by TCP and 
HAp from the calcium amounts retained in the scaffolds. The calcium contents for the TCP/HAp 
7:3 and TCP/HAp 1:1 groups (both cellular and acellular) at week 0 are not reported because of 
incomplete extraction of calcium from these scaffolds. 
 
GENE EXPRESSION ANALYSES 
Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed for gene 
expression analyses in microsphere-based constructs (n = 6) at weeks 0, 1.5, 3, and 6. Certain 
groups at certain time points (indicated in Results section) had no Ct values, indicating that the 
fluorescence intensities in these samples did not cross the threshold fluorescence. These samples 
were marked as zero for RNA expression. RNA was isolated and purified using QIAshredders 
and an RNeasy Kit (Qiagen, Valencia, CA) according to the manufacturer’s guidelines. Isolated 
RNA was converted to complementary DNA using a TaqMan High Capacity kit (Applied 
Biosystems, Foster City, CA) in an Eppendorf RealPlex Mastercycler. TaqMan Gene expression 
	 106	
assays from Applied Biosystems for appropriate genes (Table 4.1) were run in the Eppendorf 
system. A 2-ΔΔCt method was used to evaluate the relative level of expression for each target gene. 
For quantification, the BLANK constructs at week 0 were designated as the calibrator group and 
GAPDH expression as the endogenous control.  
 
HISTOLOGY AND IMMUNOHISTOCHEMISTRY (IHC) 
At 6 weeks, microsphere-based constructs (n = 3) were soaked in 30% w/v sucrose 
(Thermofisher Scientific, Waltham, MA) solution in PBS for 24 h. Afterward, the constructs 
were equilibrated in optimal cutting temperature embedding medium (OCT, Tissue-Tek, 
Torrance, CA) overnight at 37°C and then frozen at -20°C. 10 µm thick sections were cut using a 
cryostat (Micron HM-550 OMP, Vista, CA) and stained using Hematoxylin (cell nuclei) and 
Eosin (cytoplasm); Masson’s trichrome for collagen, cell nuclei, and cytoplasm; Alizarin red for 
calcium phosphates; von Kossa for mineralization; and Sudan Black for residual polymer. 
Acellular constructs (n = 2) at week 6 from the TCP/HAp 7:3 and TCP/HAp 1:1 groups were 
also stained using Alizarin red and von Kossa. The sections from cellular constructs were stained 
for the presence of collagen type I using immunohistochemistry (IHC). Mouse monoclonal anti-
collagen type I (1:200 dilution; Thermofisher Scientific, Waltham, MA) primary antibody was 
used for the immunostaining. Following the primary antibody, biotinylated secondary antibody 
was used followed with the ABC complex (Vector Laboratories, Burlingame, CA). The 
antibodies were visualized with the diaminobenzidine (DAB) substrate per the manufacturer’s 
(Vector Laboratories, Burlingame, CA) protocol. Negative controls were also run with the 




GraphPad Prism 6 statistical software (GraphPad Software, Inc., La Jolla, CA) was used to 
compare experimental groups using a one-factor ANOVA (sections 2.6 and 2.7) or a two-factor 
ANOVA (sections 2.8 and 2.9) followed by a Tukey’s post hoc test, where p < 0.05 was 
considered significant. Additionally, standard box plots were constructed to eliminate outliers. 
All quantitative results are reported as average ± standard deviation within text or as average + 
standard deviation within figures. 
 
RESULTS 
SEM AND EDS 
Figure 4.2 represents the scanning electron micrographs of all four types of microspheres. The 
microspheres in the BLANK (i.e., PLGA only) group had a smooth surface, while the 
microspheres in the BMP, TH73 (TCP/HAp 7:3), and TH11 (TCP/HAp 1:1) groups had minute 
pores on their surfaces. The BLANK and the BMP microspheres had a spherical morphology, 
whereas the TH73 and TH11 microspheres had a deflated soccer ball-like appearance with 
obvious indentations on the surfaces of the microspheres. Figure 4.3 depicts the distribution of 
atomic calcium (Ca), nitrogen (N) and phosphorous (P) in the interior of BLANK, BMP, and 
TH11 microspheres. As expected, the three elements were essentially absent from the BLANK 
microspheres. Nitrogen was uniformly distributed inside the BMP microspheres as demonstrated 
by the spectral maps. The EDS maps also depicted the presence of phosphorus and calcium in 
the BMP microspheres. Calcium and phosphorous were uniformly distributed inside the TH11 
microspheres, while nitrogen was absent from the TCP/HAp 1:1 group. Figure 4.4 represents the 
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SEM images of all of the scaffold groups used for the study. All scaffolds were porous in nature 
with interconnected pores.  
 
MECHANICAL TESTING 
BLANK scaffolds had an average compressive modulus of 330 ± 120 kPa that was 80% (p < 
0.05) and 40-fold (p < 0.05) higher than the moduli of TCP/HAp 7:3 and TCP/HAp 1:1 scaffolds, 
respectively (Figure 4.5). The average moduli of the BMP and TCP/HAp 7:3 groups were 35-
fold (p < 0.05) and 22-fold (p < 0.05) higher than the modulus of the TCP/HAp 1:1 group, 
respectively. No significant differences in compressive modulus were observed between the 
BMP and TCP/HAp 7:3 groups, or between the BMP and BLANK groups.  
 
POROSITY MEASUREMENT 
The average porosity of the TCP/HAp 1:1 group was 47.7 ± 5.0%, which was 1.9-fold (p < 0.05), 
1.5-fold (p < 0.05), and 1.3-fold (p < 0.05) higher than the porosities of the BLANK, BMP, and 
TCP/HAp 7:3 groups, respectively (Figure 4.6). The porosity of the TCP/HAp 7:3 group was 
1.5-fold (p < 0.05) higher than the porosity of the BLANK group. No significant differences in 




At week 0, the BLANK group had 8.3-fold (p < 0.05) and 3.1-fold (p < 0.05) higher DNA 
content than the TCP/HAp 7:3 and TCP/HAp 1:1 groups, respectively (Figure 4.7). The DNA 
content of the BMP group at week 0 was 7.2-fold (p < 0.05) and 2.7-fold (p < 0.05) higher than 
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the DNA contents of the TCP/HAp 7:3 and TCP/HAp 1:1 groups, respectively. No significant 
differences in DNA content were observed between the TCP/HAp 7:3 and TCP/HAp 1:1 groups 
at week 0. Additionally, no significant differences were observed in DNA content among the 
groups at weeks 3 or 6. The DNA contents in the BLANK and BMP groups at week 0 were 
statistically significantly higher than their corresponding values at later time points, while no 
significant changes in DNA content were observed in the TCP/HAp 7:3 and TCP/HAp 1:1 
groups over time. The BLANK group at week 0 had 22-fold (p < 0.05) and 8.6-fold (p < 0.05) 
higher amounts of DNA than its values at weeks 3 and 6, respectively. The BMP group at week 0 
had 29-fold (p < 0.05) and 6-fold (p < 0.05) higher DNA content than its corresponding values at 
weeks 3 and 6, respectively. 
 
HYDROXYPROLINE (HYP) CONTENT 
At week 0, the BLANK group had 11-fold (p < 0.05) higher net HYP content than the BMP 
group (Figure 4.8A). No significant differences in net HYP content were observed among any 
other groups at week 0. Additionally, no significant differences in net HYP content were 
observed among the groups at week 3. Week 6 net HYP content results showed that only the 
TCP/HAp 7:3 group outperformed the BLANK control, with HYP content that was 2.7-fold (p < 
0.05) higher. No significant differences in net HYP content were observed among any other 
groups at week 6. Only the BMP and TCP/HAp 7:3 groups showed significant changes in net 
HYP content over time. The BMP group at week 6 had 13-fold (p < 0.05) higher net HYP than 
its corresponding value at week 0. The net HYP contents of the TCP/HAp 7:3 group at weeks 3 
and 6 were 9.6-fold (p < 0.05) and 15-fold (p < 0.05) higher than its HYP content at week 0, 
respectively. In the normalized HYP (per DNA) content, no significant differences were 
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observed among the groups at weeks 0 and 3 (Figure 4.8B). At week 6, both the TCP/HAp 7:3 
and TCP/HAp 1:1 groups outperformed the BLANK control in normalized HYP content with 
values that were 14-fold (p < 0.05) and 6.9-fold (p < 0.05) higher, respectively. Moreover, the 
normalized HYP contents in the TCP/HAp 7:3 and TCP/HAp 1:1 groups at week 6 were 15-fold 
(p < 0.05) and 7.9-fold (p < 0.05) higher than the HYP content in the BMP group, respectively. 
Additionally, the normalized HYP content in the TCP/HAp 7:3 group at week 6 was 2-fold (p < 
0.05) higher than the HYP content in the TCP/HAp 1:1 group. Only the TCP/HAp 7:3 and 
TCP/HAp 1:1 groups showed significant changes in normalized HYP content over time. The 
TCP/HAp 7:3 group at week 6 had 35-fold (p < 0.05) and 3.4-fold (p < 0.05) higher normalized 
HYP content than its matching values at weeks 0 and 3, respectively. The TCP/HAp 1:1 group at 
week 6 had 6.7-fold (p < 0.05) higher normalized HYP content than its value at week 0. 
 
ALP ACTIVITY 
No significant differences were observed in the ALP activities among the groups at weeks 0 and 
3 (Figure 4.9). However, at week 6, the TCP/HAp 7:3 and TCP/HAp 1:1 groups outperformed 
the BLANK control in ALP activity, with activities that were 40-fold (p < 0.05) and 20-fold (p < 
0.05) higher, respectively. Additionally, the TCP/HAp 7:3 and TCP/HAp 1:1 groups at week 6 
surpassed the BMP group in ALP activity, with activities that were 40-fold (p < 0.05) and 20-
fold (p < 0.05) higher, respectively. Also, the ALP activity of the TCP/HAp 7:3 group at week 6 
was 2-fold (p < 0.05) higher than the ALP activity of the TCP/HAp 1:1 group. Only the 
TCP/HAp 7:3 showed significant changes in ALP activity over time, with its week 6 activity 




The calcium contents for the cellular BLANK and BMP constructs at week 0 were 32.7 ± 5.3 µg 
and 54 ± 19 µg, respectively. The calcium contents for the TCP/HAp 7:3 and TCP/HAp 1:1 
groups (both cellular and acellular) at week 0 are not reported because of inadequate extraction 
of calcium from these scaffolds at that time point. Week 3 calcium content results showed no 
significant differences among groups at that time point (Figure 4.10). At week 6, the calcium 
content of the BMP group was 1.7-fold (p < 0.05) higher than the calcium content of the 
TCP/HAp 1:1 group. The calcium content of the TCP/HAp 7:3 group at week 6 was 3.3-fold (p 
< 0.05) higher than the calcium content of the TCP/HAp 7:3 [Acellular] group. No significant 
differences were observed in calcium content among the other groups at week 6. The BLANK 
group at week 3 had 21-fold (p < 0.05) and 1.7-fold (p < 0.05) higher calcium content than its 
corresponding values at weeks 0 and 6, respectively. Additionally, the calcium content of the 
BLANK group at week 6 was 12-fold (p < 0.05) higher than its calcium content at week 0. The 
BMP group at weeks 3 and 6 had 12-fold (p < 0.05) and 10-fold (p < 0.05) higher calcium 
contents than its matching value at week 0, respectively. The calcium content of the TCP/HAp 
1:1 group at week 3 was 1.7-fold (p < 0.05) higher than its corresponding value at week 6. The 
TCP/HAp 7:3 [Acellular] and TCP/HAp 1:1 [Acellular] groups at week 3 had 3.9-fold (p < 0.05) 
and 3.2-fold (p < 0.05) higher amounts of calcium than their matching values at week 6, 





RUNX2 AND COL1A1 
Both the BLANK and the BMP groups at week 0 had 3-fold (p < 0.05) higher relative RUNX2 
expression than the expression of the TCP/HAp 7:3 group (Figure 4.11A). No significant 
differences were observed in the RUNX2 expression at week 0 among the BLANK, BMP and 
TCP/HAp 1:1 groups. At week 1.5, the RUNX2 expression for the TCP/HAP 7:3 group was 2.1-
fold (p < 0.05) and 3.8-fold (p < 0.05) higher than the expression values for the BMP and 
TCP/HAp 1:1 groups, respectively. No significant differences in RUNX2 expression were 
observed among the groups at weeks 3 and 6. The TCP/HAp 7:3 and TCP/HAp 1:1 groups were 
the only groups that showed statistically significant changes in RUNX2 expression over time. 
The TCP/HAp 7:3 group at week 0 had 7.3-fold (p < 0.05) higher expression than at week 6. At 
week 1.5, the TCP/HAp 7:3 group had 4.2-fold (p < 0.05) and 31-fold (p < 0.05) higher RUNX2 
expression than its matching values at weeks 0 and 6, respectively. Moreover, the TCP/HAp 7:3 
group at week 3 had 18-fold (p < 0.05) higher RUNX2 expression than its expression at week 6. 
The TCP/HAP 1:1 group at week 3 had 3.7-fold (p < 0.05), 4.3-fold (p < 0.05), and 2.8-fold (p < 
0.05) higher RUNX 2 expression than its expression values at weeks 0, 1.5, and 6, respectively. 
The COL1A1 (collagen I) expression values (Figure 4.11B) of the BLANK, BMP, and 
TCP/HAp 1:1 groups at week 0 were 2-fold (p < 0.05), 2-fold (p < 0.05), and 1.7-fold (p < 0.05) 
higher than the expression value of the TCP/HAp 7:3 group, respectively. No significant 
differences were observed in COL1A1 expression among the BLANK, BMP, and TCP/HAp 1:1 
groups at week 0. Additionally, no significant differences were observed in COL1A1 expression 
among the groups at weeks 1.5 and 3. At week 6, the TCP/HAP 1:1 group outperformed the 
BLANK and BMP controls in COL1A1 expression with 7.5-fold (p < 0.05) and 15-fold (p < 
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0.05) higher expression, respectively. In addition, the TCP/HAp 1:1 group at week 6 had 60-fold 
(p < 0.05) higher COL1A1 expression than the TCP/HAp 7:3 group at that time point. All of the 
groups showed statistically significant changes in COL1A1 expression over time. The BLANK 
group at week 0 had 5.4-fold (p < 0.05), 9.8-fold (p < 0.05), and 12-fold (p < 0.05) higher 
COL1A1 expression than its corresponding values at weeks 1.5, 3, and 6, respectively. The BMP 
group at week 0 had 7.4-fold (p < 0.05), 11-fold (p < 0.05), and 24-fold (p < 0.05) higher 
COL1A1 expression than its matching values at weeks 1.5, 3, and 6, respectively. The COL1A1 
expression values of the TCP/HAp 7:3 group at weeks 0 and 1.5 were 48-fold (p < 0.05) and 34-
fold (p < 0.05) higher than its week 6 value, respectively. The TCP/HAp 1:1 group at week 0 had 
3.8-fold (p < 0.05) and 2.1-fold (p < 0.05) higher COL1A1 expression than its corresponding 
expression at weeks 1.5 and 3, respectively. Additionally, the TCP/HAp 1:1 group at week 6 had 
2.7-fold (p < 0.05) higher COL1A1 expression than its matching value at week 1.5.  
 
BGLAP AND IBSP 
The BGLAP expression values for the BLANK group at weeks 1.5, 3, and 6; BMP group at 
weeks 1.5 and 3; TCP/HAp 7:3 group at week 3; and TCP/HAp 1:1 group at weeks 1.5 and 3, 
were marked as zero because the fluorescence intensities in these samples did not cross the 
threshold fluorescence. BGLAP expression (Figure 4.11C) showed no significant differences 
among groups at week 0. At week 1.5, the relative BGLAP expression of the TCP/HAp 7:3 
group was statistically significantly (p < 0.05) higher than the expression of the BLANK, BMP, 
and TCP/HAp 1:1 groups. No significant differences were observed in BGLAP expression 
among the groups at week 3. Week 6 BGLAP expression showed that the BMP group expression 
was statistically significantly (p < 0.05) higher than the expression of the BLANK group. In 
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addition, the BMP group BGLAP expression at week 6 was 74-fold (p < 0.05) higher than the 
expression of the TCP/HAp 7:3 group. No significant differences in BGLAP expression were 
observed at week 6 between the BMP and TCP/HAp 1:1 groups. Only the BMP and TCP/HAp 
7:3 groups showed statistically significant changes in BGLAP expression over time. The BMP 
group at week 6 had statistically significantly (p < 0.05) higher BGLAP expression than its 
expression values at weeks 1.5 and 3. The TCP/HAp 7:3 group at week 1.5 had 14-fold (p < 
0.05) and 113-fold (p < 0.05) higher BGLAP expression than its corresponding values at weeks 0 
and 6. Moreover, the TCP/HAp 7:3 group at weeks 1.5 and 6 had statistically significantly (p < 
0.05) higher BGLAP expression than its value at week 3.  
The IBSP expression values for the BLANK group at weeks 1.5 and 3; BMP group at 
weeks 3 and 6; TCP/HAp 7:3 group at weeks 1.5, 3, and 6; and TCP/HAp 1:1 group at weeks 1.5 
and 3, were marked as zero because the fluorescence intensities in these samples did not cross 
the threshold fluorescence. No significant differences were observed in IBSP expression among 
the groups at weeks 0, 1.5 and 3 (Figure 4.11D). The TCP/HAp 1:1 group at week 6 
outperformed the BLANK control with 98-fold (p < 0.05) higher IBSP expression. Moreover, 
the IBSP expression for the TCP/HAp 1:1 group at week 6 was statistically significantly (p < 
0.05) higher than the expression of the BMP and TCP/HAp 7:3 groups. Only the TCP/HAp 1:1 
group showed statistical significant changes in IBSP expression over time. The TCP/HAp 1:1 
group at week 6 had 193-fold (p < 0.05) higher IBSP expression than its corresponding 
expression at week 0. Additionally, the TCP/HAp 1:1 group at week 6 had statistically 
significantly (p < 0.05) higher expression than its matching values at weeks 1.5 and 3.  
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HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
Figure 4.12 represents the histological staining for the BLANK, BMP, TH73 (TCP/HAp 7:3), 
and TH11 (TCP/HAp 1:1) groups at week 6. From H&E staining, it was clear that the BLANK 
and BMP groups were primarily tissue without any evidence of spherical microsphere shapes as 
observed in the TH73 and TH11 groups. Additionally, H&E images indicated toward higher cell 
numbers in the BLANK and BMP groups compared to the TCP/HAp groups. Masson’s 
trichrome staining images showed no apparent differences in staining intensities between the 
BLANK and BMP groups or between the TCP/HAp 7:3 and TCP/HAp 1:1 groups. The 
TCP/HAp groups had higher numbers of blue stained specks for collagen (indicated by arrows in 
than those observed in the BLANK and BMP groups. Alizarin red and von Kossa staining for 
calcium and calcium deposits was observed in all of the groups. The TCP/HAp 7:3 group stained 
more intensely for calcium and calcium deposits than the TCP/HAp 1:1 group, while no 
differences in staining intensities were observed between the BLANK and BMP groups. 
Additionally, the TCP/HAp groups had higher staining intensities for both the Alizarin Red and 
von Kossa than the staining intensities in the BLANK and BMP groups. The higher staining 
intensities for Alizarin red and von Kossa in the TCP/HAp scaffolds could be attributed to 
inherent calcium present in these scaffolds, which was confirmed by the histological images of 
the acellular TCP/HAp scaffolds (Figure 4.13). All of the groups stained positively for Sudan 
Black, and microsphere architecture was evident in the TCP/HAp groups, whereas no 
discernable microsphere shapes were noted in the BLANK and BMP groups. The observance of 
intact microsphere structure with Sudan Black staining suggest that TCP and HAp encapsulation 
might have altered polymer degradation, which was also indicated by the macroscopic 
observations where the culture medium in the acellular BLANK and BMP scaffolds became 
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acidic more rapidly than the medium in their TCP/HAp counterparts (Figure 4.14). 
Immunohistochemical (IHC) staining of week 6 microsphere-based scaffolds was positive for 
collagen I (Figure 4.15). Collagen I staining was more intense in the TCP/HAp 1:1 group than 
the staining in the BLANK and TCP/HAp 7:3 groups. Moreover, the BMP group had more 
intense staining for collagen I than the staining in the BLANK group.  
 
DISCUSSION 
The current study was the first to examine the effects of encapsulating TCP and HAp mixtures 
for stimulating osteogenesis in microsphere-based scaffolds. This work builds on our previous 
efforts establishing that incorporation of inorganic materials such as TCP, HAp, and bioactive 
glass (BG) alone in microsphere-based scaffolds provides both bioactive cues and building 
blocks for osteogenic differentiation of cells61, 89, 169, 172, 173. Additionally, it has been shown by 
others that combining TCP and HAp for bone regeneration is a promising strategy given that a 
combination of these materials provides both osteoinductive and osteoconductive cues to the 
surrounding cells71, 85, 98, 103, 132, 141, 201, 203. Furthermore, we have previously demonstrated that 
higher concentrations (10 and 20 wt%) of TCP and HAp in microsphere-based scaffolds were 
more favorable for synthesis of ECM components relevant to bone tissue, thus providing the 
motivation for encapsulating even higher concentrations of TCP and HAp than our previous 
reported studies61, 89. Hence, the present study investigated the response of rBMSCs to TCP/HAp 
mixtures, encapsulated at a concentration of 30 wt%, during osteogenic differentiation on 
microsphere-based scaffolds.  
The SEM images depicted that all four types of microspheres were uniform in size, with 
average microsphere diameter ranging between 172-186 µm  (Figure 4.1). The BMP, TH73 
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(TCP/HAP 7:3), and TH11 (TCP/HAp 1:1) microspheres possessed micron and sub-micron 
pores on their surface, which could be attributed to the solvent removal process during 
microsphere fabrication214. Additionally, it was observed that the TH73 and TH11 microspheres 
had a deflated soccer ball-like shape. The deflated shape and the presence of pores on the surface 
of the microspheres may have contributed toward higher average porosities in the TCP/HAp 7:3 
and TCP/HAp 1:1 scaffolds compared to the BLANK group. The deflated shapes might have 
resulted from the incongruent solvent exchange across the microsphere surface as a direct 
consequence of changes in emulsion viscosity due to addition of TCP/HAp mixtures into the 
polymer phase. We observed a similar phenomenon with PLGA microspheres containing 
bioactive glass (BG), where these microspheres were spherical in shape at the time of fabrication 
but lost their shape during the droplet hardening step172. Similar to our observations, Bao et al.12 
noted that the encapsulation of biphasic calcium phosphates (BCP) at a concentration of 30% or 
higher in poly(ε-caprolactone) microspheres fabricated using the emulsion solvent-evaporation 
method, also resulted in irregularly-shaped microspheres. It was suggested that the viscosity of 
the dispersion mixture of polymer and BCP increased with BCP concentrations higher than 30%, 
thereby affecting the dispersibility of the microemulsion in the continuous phase and also the 
efflux velocity of solvent during the solvent exchange that further led to non-uniform shaped 
microspheres with sunken structures. Although we noticed differences in microsphere 
morphologies among the groups, the scaffolds in all the groups were found to be porous in nature 
with interconnections among the pores, which agreed with our previous findings89, 215. 
Furthermore, the elemental distribution of calcium and phosphorus as observed via EDS 
confirmed the uniform distribution of calcium phosphates inside the TCP/HAp microspheres 
with no evidence of agglomeration at any site. The BMP microspheres depicted the presence of 
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phosphorus that could be attributed to the PBS buffer used for reconstitution of the protein. The 
presence of calcium in BMP microspheres could be regarded as artifacts of the automatic peak 
identification software used for the EDS analysis177. 
Uniaxial compression testing results showed that the compressive moduli of microsphere-
based scaffolds were within an order of magnitude of the moduli for cancellous bone128, 250. The 
compressive modulus of BLANK scaffolds was found to be at least 2 times as large as the 
moduli of the TCP/HAP 7:3 and TCP/HAp 1:1 groups, while the porosities of the TCP/HAp 
groups were at least 1.5 times larger than the porosity of the BLANK scaffolds. The compressive 
modulus results agreed with our previous findings that the presence and subsequent modification 
of microspheres by calcium phosphates led to lower moduli of TCP/HAp scaffolds compared to 
the BLANK controls61, 214. Additionally, the modulus of TCP/HAp 1:1 scaffolds was 
significantly lower than the moduli of the BMP and TCP/HAp 7:3 groups. The lower modulus in 
the TCP/HAp 1:1 group may be attributed to its higher porosity as it has been shown that the 
compressive modulus is inversely related to the porosity of scaffolds175, 222.  
The biochemical content results revealed some interesting trends. It was observed that the 
TCP/HAp scaffolds at week 0 (24 h post seeding) had significantly lower DNA contents than the 
BLANK and BMP controls. Kucharska et al.139 observed a similar trend in initial cell numbers 
when they cultured MG-63 osteoblast-like cells on chitosan-TCP microsphere based scaffolds. 
The cell numbers on the chitosan-TCP scaffolds were significantly lower than the controls 48 h 
post seeding; however, the elevated ALP activity of the cells at that time point suggested that the 
cells on the chitosan-TCP were being directed toward osteogenic differentiation as early as 2 
days after seeding. Our ALP data at week 0 hint toward a similar phenomenon where rBMSCs 
were being directed toward osteogenic differentiation; however, no significant differences were 
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observed in the ALP activities among groups at week 0. Although the DNA content was lower in 
the TCP/HAp groups initially, no significant differences were observed in DNA content among 
the study groups at later time points. The HYP and ALP results suggest that the incorporation of 
TCP and HAp in microsphere-based scaffolds enhanced synthesis of bone-relevant ECM 
components over time. The TCP/HAp groups at 6 weeks had roughly 8 times the amount of 
collagen per cell (HYP/DNA) as the BLANK and BMP controls, a trend we previously observed 
with HAp-only microsphere-based scaffolds with comparable HYP amounts compared to the 
HAp-only scaffolds61. In addition, the ALP activities in the TCP/HAp groups at week 6 were 
approximately 20 times higher than the activities in the BLANK and BMP groups at that time 
point. The total calcium content analysis suggests that the calcium detected in the TCP/HAp 
groups predominantly represented the inherent calcium remaining in these scaffolds. However, it 
was observed that the calcium content in the TCP/HAp 7:3 group at week 6 was about 1.4 times 
higher than the calcium content of its acellular equivalent. Additionally, the TCP/HAp 7:3 
calcium content at week 6 was comparable to its week 3 value, indicating that the cells might 
have retarded microsphere degradation, perhaps by covering the microspheres with collagen, etc. 
Higher secretion of calcium by the cells or incorporation of inherent calcium into the newly 
synthesized might have also contributed to the observed differences in calcium content between 
the acellular and cellular scaffolds in the TCP/HAp 7:3 group. 
Gene expression data highlighted some key differences in the differentiation of rBMSCs 
on TCP/HAp scaffolds compared to those on the BLANK and BMP scaffolds. The TCP/HAp 
groups compared to the BLANK and BMP controls had lower expression values for RUNX2, 
COL1A1, and IBSP expression early on and had higher expression values at later time points. 
These differences in the expression of TCP/HAP groups and controls indicated that the presence 
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of TCP/HAp may have inhibited expression of osteogenic markers initially61, 89. On the other 
hand, elevated expression of osteogenic genes in the TCP/HAp groups at later time points 
signifies that the incorporation of ceramic mixture propelled the differentiation of the seeded 
cells toward osteogenic lineage. Furthermore, differences in gene expression were observed 
between the TCP/HAp encapsulating groups with both the groups showing fluctuating 
expressions for RUNX2, COL1A1, and BGLAP over time. These oscillating expression patterns 
in the TCP/HAp groups may suggest that the rBMSCs responded differently to different 
TCP/HAp ratios in microsphere-based scaffolds6, 71, 85, 103, 141.  
Histological images of the engineered constructs at week 6 suggested higher cell numbers 
in the BLANK and BMP groups compared to the TCP/HAp groups. However, failure to observe 
any statistically significant differences in DNA content at week 6 among groups suggest that 
observed differences in cell number (if any) might have been due to differences in initial cell 
attachment. Masson’s trichrome images pointed toward higher collagen synthesis in the 
TCP/HAp groups, thus agreeing with the biochemical results of the study that demonstrated 
higher collagen synthesis (on per cell basis) in TCP/HAp constructs at 6 weeks. Additionally, 
collagen I IHC images depicted that the TCP/HAp 1:1 scaffolds at week 6 stained more intensely 
for collagen I than the TCP/HAp 7:3 scaffolds, further concurring with the gene expression data 
where COL1A1 expression in TCP/HAp 1:1 scaffolds at week 6 was significantly higher than 
the TCP/HAp 1:1 group at that time point. Alizarin red and von Kossa stains demonstrated that 
all scaffold groups possessed a mineral matrix of calcium and calcium phosphates at week 6, 
with the TCP/HAp encapsulating groups exhibiting the most-intense staining. Additionally, the 
staining intensities for Alizarin red and von Kossa stains were higher in the TCP/HAp 7:3 group 
at week 6 than the intensities in the TCP/HAp 1:1 group at that time point. Furthermore, it was 
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observed that the mineral staining intensities in the TCP/HAp 7:3 group at week 6 were higher 
than their acellular counterparts (Figure 4.13). The TCP/HAp constructs are expected to stain 
positive for mineralization because of inherent mineral present in these scaffolds. The higher 
mineral staining intensities in the TCP/HAp 7:3 at week 6 suggest that the cells in the TCP/HAp 
7:3 group either made more calcium or utilized inherent calcium as a raw material in the ECM, 
thereby agreeing with the calcium content results. Sudan Black staining indicated presence of 
residual polymer in all of the groups after 6 weeks of culture, although residual spherical shapes 
of the microspheres were evident only in the TCP/HAp groups. Additionally, the TCP/HAp 
scaffolds had a lower degree of swelling throughout the 6-week culture period than the BLANK 
and BMP scaffolds. The observance of intact microsphere structure with Sudan Black staining 
and less severity of the macroscopic changes in the TCP/HAp groups suggest that TCP and HAp 
encapsulation might have retarded polymer degradation due to their intrinsic buffering capacity1.  
Overall, the results of the current study demonstrated that TCP/HAp encapsulation into 
microsphere-based scaffolds altered microsphere morphology, impacted the mechanical 
properties of the scaffolds (i.e., reduced moduli) and influenced the differentiation of the seeded 
rBMSCs toward an osteogenic lineage. Higher end point ECM synthesis and enhanced 
expression of osteogenic markers in TCP/HAp groups relative to the BMP-2 group suggest that 
the TCP/HAp encapsulation fast-tracked the osteogenic commitment of cells on these scaffolds. 
Additionally, biochemical and gene expression evidence was presented for the TCP/HAp groups 
outperforming the BLANK and BMP controls. Furthermore, differences in gene expression 
profiles between the TCP/HAp groups hint that the cells responded differently to two different 
ratios of TCP and HAp presented to them. Lastly, we did not specifically explore degradation of 
the TCP/HAp scaffolds; however, our histological and macroscopic findings indicate that the 
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presence of TCP/HAp altered polymer degradation in microsphere-based scaffolds181, 256. 
Altogether, it can be concluded that TCP/HAp mixtures when incorporated into microsphere-
based gradient scaffolds may be able to enhance the performance of the bone-like region of the 
engineered construct by providing raw materials for the regenerating tissue.   
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CHAPTER 5: MICROSPHERE-BASED SCAFFOLDS ENCAPSULATING 
CHONDROITIN SULFATE OR DECELLULARIZED CARTILAGE** 
ABSTRACT 
Extracellular matrix (ECM) materials such as decellularized cartilage (DCC) and chondroitin 
sulfate (CS) may be attractive chondrogenic materials for cartilage regeneration. The goal of the 
current study was to investigate the effects of encapsulation of DCC and CS in homogeneous 
microsphere-based scaffolds, and to test the hypothesis that encapsulation of these ECM 
materials would induce chondrogenesis of rat bone marrow stromal cells (rBMSCs). Four 
different types of homogeneous scaffolds were fabricated from microspheres of poly(D,L-lactic-
co-glycolic acid) (PLGA): Blank (PLGA only; negative control), transforming growth factor 
(TGF)-β3 encapsulated (positive control), DCC encapsulated, and CS encapsulated. These 
scaffolds were then seeded with rBMSCs and cultured for 6 weeks. The DCC and CS 
encapsulation altered the morphological features of the microspheres, resulting in higher 
porosities in these groups. Moreover, the mechanical properties of the scaffolds were impacted 
due to differences in the degree of sintering, with the CS group exhibiting the highest 
compressive modulus. Biochemical evidence suggested a mitogenic effect of DCC and CS 
encapsulation on rBMSCs with the matrix synthesis boosted primarily by the inherently present 
ECM components. An important finding was that the cell seeded CS and DCC groups at week 6 
had up to an order of magnitude higher GAG contents than their acellular counterparts. Gene 
expression results indicated a suppressive effect of DCC and CS encapsulation on rBMSC 
chondrogenesis with differences in gene expression patterns existing between the DCC and CS 
groups. Overall, DCC and CS were easily included in microsphere-based scaffolds; however, 
                                                
**To be submitted as Gupta V, Tenny K, Barragan M, Berkland C, Detamore M, Microsphere-Based Scaffolds 
Encapsulating Chondroitin Sulfate and Decellularized Cartilage, Journal of Biomedical Materials Research Part A, 
2015. 
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there is a requirement to further refine their concentrations to achieve the differentiation profiles 
we seek in vitro.  
 
INTRODUCTION 
Scaffold-based regenerative strategies for osteochondral tissue that take into consideration 
physiological and hierarchical variations in properties of native bone and cartilage have been 
increasingly gaining attention56, 155, 205, 209. Several of these strategies employ extracellular matrix 
(ECM)-based materials because of their ability to regulate behavior such as migration, 
proliferation and differentiation of resident or transplanted cells17, 37. For cartilage regeneration, 
cartilage matrix has been used as a chondroinductive material because of its potential to retain 
bioactive molecules to which the regenerating tissue is naturally predisposed to respond17, 38, 83, 
227. Moreover, materials like chondroitin sulfate (CS), the major sulfated glycosaminoglycan 
(GAG) found in the ECM of native cartilage, are used for cartilage regeneration because of their 
ability to create a favorable microenvironment for cells102, 163, 202.  
Microsphere-based scaffolds possess an immense potential for musculoskeletal 
regeneration because of their characteristics like rigidity in shape, ability to provide a porous 
network, and uniform mechanical properties101. Additionally, they offer a variety of alternatives 
in terms of materials for microsphere matrices, and methods for microsphere fabrication and 
sintering18, 21, 25, 29, 32, 184. We have previously demonstrated that three-dimensional (3D) 
microsphere-based gradient scaffolds containing gradients of growth factors are capable of 
directing cell phenotype by influencing them to secrete tissue-specific ECM components to 
promote osteochondral regeneration58, 63, 65, 169. In addition, we have shown that microsphere-
based scaffolds containing gradients of CS and tricalcium phosphate can provide “raw materials” 
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for synthesis of new ECM components, and in combination with growth factors (or alone) can 
furnish the surrounding progenitor cells with bioactive signals for their differentiation along the 
chondro- and osteogenic lineages in different regions of the scaffolds89, 172, 173. Furthermore, we 
recently evaluated the response of decellularized cartilage (DCC) encapsulation in homogeneous 
microsphere-based scaffolds. The DCC encapsulation at a concentration of 10 wt% evoked a 
biosynthetic response from the seeded rat bone marrow stromal cells (rBMSCs) with comparable 
gene expression to cells seeded on transforming growth factor-β3 (TGF-β3) encapsulated 
scaffolds227. To establish the benefits of our raw material gradient microsphere-based scaffolds, 
it is imperative to identify raw materials that are most efficacious in promoting osteogenesis and 
chondrogenesis. For determining the leading chondrogenic materials, the most rational step 
would be to evaluate the performance of homogeneous microsphere-based scaffolds 
incorporating chondrogenic materials in propelling chondrogenesis. Therefore, the objective of 
this study was to investigate the effects of encapsulating a higher concentration of ECM 
materials (DCC and CS), compared to what we have previously used, on influencing rBMSC 
chondrogenesis in homogeneous microsphere-based scaffolds. The results would have 
implications for identifying raw material concentrations that can then be combined with 
osteogenic raw materials for use in microsphere-based gradient scaffolds toward osteochondral 
repair. 
In the present study, we investigated whether encapsulated raw materials (DCC and CS) 
at a higher concentration in poly(D,L-lactic-co-glycolic acid) (PLGA) microsphere-based 
scaffolds would provide building blocks and drive the differentiation of the seeded cells toward a 
chondrogenic lineage. Homogeneous microsphere-based scaffolds were fabricated encapsulating 
DCC and CS (at a concentration of 30 wt%) as chondrogenic raw materials.  The response of 
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seeded rBMSCs to the raw materials was evaluated when cultured for 6 weeks in a medium 
consisting of dissolved factors. We hypothesized that encapsulation of raw materials, DCC or CS, 
in homogeneous microsphere-based scaffolds would induce chondrogenesis in rBMSCs. 
 
MATERIALS AND METHODS 
MATERIALS 
All reagents for the decellularization process were purchased from Sigma–Aldrich (St. Louis, 
MO) unless otherwise noted. Poly(D,L-lactic-co-glycolic acid) (PLGA) (50:50 lactic acid: 
glycolic acid ratio, ester end group) with an intrinsic viscosity (i.v.) of 0.37 dl/g, was obtained 
from Evonik Industries (Essen, Germany). Human TGF-β3 and Murine insulin-like growth factor 
(IGF)-I were obtained from PeproTech, Inc. (Rocky Hill, NJ). Chondroitin sulfate A sodium salt 
(from bovine trachea) was obtained from Sigma (St. Louis, MO). All other reagents and organic 
solvents utilized were of cell culture or ACS grade. Two porcine knees obtained from a 
Berkshire hog (castrated male that was approximately 7-8 months old and weighed 120 kg) were 
purchased from a local abattoir (Bichelmeyer Meats, Kansas City, KS). 
 
TISSUE RETRIEVAL AND DECELLULARIZATION 
Articular cartilage was harvested from hip and knee joint surfaces using scalpels and 
immediately rinsed in phosphate buffered saline (PBS). PBS was then drained from the cartilage 
and the tissue was stored at -20 °C. After freezing overnight, the cartilage was thawed and 
coarsely cryoground with dry ice pellets using a cryogenic tissue grinder (BioSpec Products, 
Bartlesville, OK). The dry ice was allowed to sublime overnight in the freezer. Decellularization 
of the cartilage was performed using our previously described protocol225, 227. Coarse-ground 
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cartilage particles were packed into dialysis tubing (3500 MWCO) and stored in hypertonic salt 
solution (HSS) overnight at room temperature with gentle agitation (70 rpm). The packets were 
then subjected to 220 rpm agitation with two reciprocating washes, encompassing triton X-100 
(0.01% v/v) followed with HSS, to permeabilize intact cellular membranes. The tissue was then 
treated overnight with benzonase (0.0625 KU ml-1) at 37 ºC and later treated with sodium-
lauroylsarcosine (NLS, 1% v/v) overnight to further lyse cells and denature cellular proteins. 
After NLS exposure, the tissue was washed with ethanol (40% v/v) at 50 rpm and subjected to 
organic exchange resins to extract the organic solvents at 65 rpm. Afterward, the tissue was 
washed in saline-mannitol solution at 50 rpm followed by two hours of rinsing with DI water at 
220 rpm. The tissue was then removed from the packets and was frozen and lyophilized. The 
decellularized cartilage (DCC) particles were further cryoground into a fine powder with a 
freezer-mill (SPEX SamplePrep, Metuchen, NJ) and then lyophilized. The DCC powder was 
filtered using a 45 µm mesh (ThermoFisher Scientific, Waltham, MA) to remove large particles 
and then frozen until use. 
 
PREPARATION OF MICROSPHERES 
Four different types of microspheres were fabricated for the study: (i) PLGA microspheres 
(BLANK), (ii) TGF-β3 encapsulated in PLGA microspheres (TGF), (iii) DCC encapsulated in 
PLGA microspheres (DCC), and (iv) Chondroitin sulfate encapsulated in PLGA microspheres 
(CS). For fabricating TGF-β3 encapsulated microspheres, TGF-β3 was first reconstituted in 10 
mM citric acid. The reconstituted protein solution was mixed with 20% w/v PLGA dissolved in 
dichloromethane (DCM) at a loading of 30 ng TGF-β3 per 1.0 mg of PLGA. The final mixture 
was then sonicated over ice (50% amplitude, 20 s). The DCC and CS encapsulated microspheres 
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were fabricated by adding 6% w/v DCC or 6% w/v CS to 14% w/v PLGA dissolved in DCM, 
respectively. Using the PLGA-protein and PLGA-DCC/CS emulsions, microspheres were 
fabricated via our previously reported technology58, 61, 63, 65, 89, 114, 169, 172, 173, 214, 215, 227. In brief, 
using acoustic excitation produced by an ultrasonic transducer (Branson Ultrasonics, Danbury, 
CT), regular jet instabilities were created in the polymer stream, thereby creating uniform 
polymer droplets. An annular carrier non-solvent stream of 0.5% w/v poly (vinyl alcohol) (PVA, 
88% hydrolyzed, 25 kDa, Polysciences, Inc., Warrington, PA) in deionized water (DI H2O) 
carried the droplets (i.e., nicrospheres) into a beaker containing the non-solvent solution at 0.5% 
w/v in DI H2O (cold PVA solution in case of DCC microspheres). The microspheres were stirred 
for 1 h to allow for solvent to evaporate and then filtered, rinsed and stored at -20°C. The 
microspheres were then lyophilized for 48 h before further use. 
 
SCAFFOLD FABRICATION 
Scaffolds were prepared using our previously established technology58, 61, 63, 65, 89, 169, 172, 173, 214, 215, 
227. Briefly, lyophilized microspheres (30-50 mg) were dispersed in DI H2O and loaded into a 
syringe. The dispersion was then pumped using a programmable syringe pump (PHD 22/2000; 
Harvard Apparatus, Inc., Holliston, MA) into a cylindrical plastic mold (diameter ~ 4 mm) 
having a filter at the bottom until a height of about 2 mm was reached. The scaffolds were 3.8-
4.0 mm in diameter and around 2 mm in height. The packed microspheres were then sintered 
with ethanol-acetone (95:5 v/v) for 55 min. The scaffolds were lyophilized for 48 h and sterilized 
with ethylene oxide for 12 h prior to cell seeding experiments. A total of four different groups 
were tested in the study and were named according to the composition of microspheres as: 
BLANK, TGF, DCC, and CS.  
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CELL SEEDING OF SCAFFOLDS 
rBMSCs were obtained from the femurs of eight young male Sprague–Dawley rats (176–200 g, 
SASCO) following a University of Kansas approved IACUC protocol (175–08) and cultured in 
medium consisting of αMEM supplemented with 10% FBS (MSC-Qualified, cat #10437-028) 
and 1% penicillin–streptomycin (P/S) (all from Thermofisher Scientific, Waltham, MA). When 
the cells were 80% to 90% confluent, they were trypsinized and re-plated at 7,500 cells/cm2. 
Seeding was performed when cells reached P4. Scaffolds were sterilized using ethylene oxide for 
12 h, allowed to ventilate overnight after sterilization, and placed in a 48-well plate. Cells (P4) 
were resuspended in culture medium at a concentration of approximately 50 million/mL. 25 µL 
of this cell suspension (~1.25M cells) was placed directly onto the top of the scaffold, which 
infiltrated the scaffold via capillary action.61, 89 Cells were allowed to attach for 1 h, after which 1 
mL of culture medium was added. After 24 h, the culture medium was replaced by 1 mL of 
differentiation medium consisting of αMEM, 1% P/S, 10% FBS, 50 µg/mL ascorbic acid (Sigma, 
St. Louis, MO), 40 µg/mL L-proline (Sigma, St. Louis, MO), 100 µM sodium pyruvate 
(Thermofisher Scientific, Waltham, MA), 100 nM dexamethasone (DEX) (MP Biomedicals, 
Santa Ana, CA), 1% insulin-transferrin-selenium 100X (ITS) (Thermofisher Scientific, Waltham, 
MA), 1% non-essential amino acids (NEAA) (Thermofisher Scientific, Waltham, MA), 15 mM 
HEPES buffer (Thermofisher Scientific, Waltham, MA), and 100 ng/mL murine IGF-I. Every 48 
h for 6 weeks, three-fourths of the differentiation medium was replaced with fresh medium. 
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SCANNING ELECTRON MICROSCOPY (SEM) AND ENERGY DISPERSION 
SPECTROSCOPY (EDS) 
Microspheres and acellular scaffolds were imaged via a Versa 3D Dual Beam (FEI, Hillsboro, 
OR) scanning electron microscope (SEM) with a detector for energy dispersive spectroscopy 
(EDS). The microspheres were cryo-fractured using a sharp blade, and the dispersion of TGF-β3, 
DCC and CS within the microspheres was further analyzed using EDS at an accelerating voltage 
of 10 kV. Pixel maps for atomic nitrogen and sulfur were generated using Aztec analysis 
software (Oxford Instruments, Abingdon, United Kingdom). The PLGA (BLANK) microspheres 
were also imaged to confirm the absence of nitrogen and sulfur in the EDS maps (Figure 5.1).  
 
MECHANICAL TESTING 
Unconfined compression tests of acellular (i.e., week 0) microsphere-based scaffolds (n = 6) 
were conducted using a uniaxial testing apparatus (Instron Model 5848, Canton, MA) with a 50 
N load cell. A custom-made stainless steel bath and a compression-plate assembly were mounted 
in the apparatus212. Cylindrical scaffold samples were compressed to 40% strain at a strain rate of 
10%/min in phosphate-buffered saline [PBS—0.138 M sodium chloride, 0.0027 M potassium 
chloride] at 37°C. Compressive moduli of elasticity were calculated from the initial linear 
regions of the stress-strain curves (i.e., at ~5% strain) as described previously61, 89, 172, 214, 215, 227. 
 
POROSITY MEASUREMENT 
A fluid saturation method as described previously89 was used in this study to calculate the 
porosities of the scaffolds: 
V!  =  4m÷ πd!h, 
W!"#$%  =  W! −W!, 
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V!  =  W!"#$% ÷ ρ!"#$%, 
Porosity φ % =  V! ÷ V! ×100% 
 
where VB, m, d, h, WW, WD, VP are the bulk volume, mass, diameter, height, wet weight, dry 
weight, and pore volume of the scaffolds, respectively. WWater and ρWater are the weight and 
density of water. Briefly, wet and dry weights of scaffolds were recorded after fabrication and 
porosities were determined by the above-described equations. 
 
BIOCHEMICAL ANALYSES 
Engineered constructs (n = 6) were analyzed for matrix production at 0 (i.e., 24 h post seeding), 
3, and 6 weeks. The samples were digested in papain solution consisting of 125 mg/mL papain 
(from papaya latex), 5 mM N-acetyl cysteine, 5 mM ethylenediaminetetraacetic acid, and 100 
mM potassium phosphate buffer (20 mM monobasic potassium phosphate, 79 mM dibasic 
potassium phosphate) (all reagents from Sigma Aldrich) in DI H2O. Engineered constructs were 
removed from culture in a sterile manner, placed in microcentrifuge tubes, homogenized with the 
papain solution (1 mL), and allowed to digest overnight in a 60°C water bath. The digested 
scaffolds were then centrifuged at 10,000 rpm for 5 minutes to pellet fragments of polymer and 
other impurities and stored at -20°C. Later, the supernatant was used to determine DNA, GAG, 
and hydroxyproline (HYP) contents using the PicoGreen (Molecular Probes, Eugene, OR), 
dimethylmethylene blue (DMMB) (Biocolor, Newtownabbey, Northern Ireland), and HYP (cat 
#MAK008, Sigma Aldrich, St. Louis, MO) assays, respectively. The acellular controls from the 
DCC group were also analyzed for their inherent DNA, HYP and GAG content while the CS 
group acellular scaffolds were evaluated for their GAG content only at weeks 0, 3, and 6. The 
DNA content values of the acellular DCC scaffolds were subtracted from the corresponding 
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values of their cellular counterparts at each time point in an effort to distinguish cell proliferation 
on the cellular DCC scaffolds from the residual DNA present in these scaffolds. 
 
GENE EXPRESSION ANALYSES 
Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed for gene 
expression analyses in microsphere-based constructs (n = 6) at weeks 0, 1.5, 3, and 6. Certain 
groups at certain time points (indicated in Results section) had no Ct values, indicating that the 
fluorescence intensities in these samples did not cross the threshold fluorescence. These samples 
were marked as zero for RNA expression. RNA was isolated and purified using QIAshredders 
and an RNeasy Kit (Qiagen, Valencia, CA) according to the manufacturer’s guidelines. Isolated 
RNA was converted to complementary DNA using a TaqMan High Capacity kit (Applied 
Biosystems, Foster City, CA) in an Eppendorf RealPlex Mastercycler. TaqMan Gene expression 
assays from Applied Biosystems for appropriate genes (Table 5.1) were run in the Eppendorf 
system. A 2-ΔΔCt method was used to evaluate the relative level of expression for each target gene. 
For quantification, the BLANK constructs at week 0 were designated as the calibrator group and 
GAPDH expression as the endogenous control.  
 
HISTOLOGY AND IMMUNOHISTOCHEMISTRY (IHC) 
At 6 weeks, microsphere-based constructs (n = 3) were soaked in 30% w/v sucrose 
(Thermofisher Scientific, Waltham, MA) solution in PBS for 24 h. Afterward, the constructs 
were equilibrated in optimal cutting temperature embedding medium (OCT, Tissue-Tek, 
Torrance, CA) overnight at 37°C and then frozen at -20°C. 10 µm thick sections were cut using a 
cryostat (Micron HM-550 OMP, Vista, CA) and stained using Hematoxylin (cell nuclei) and 
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Eosin (cytoplasm); Masson’s trichrome for collagen, cell nuclei, and cytoplasm; Safranin O for 
GAGs; and Sudan Black for residual polymer. Acellular constructs (n = 2) at week 6 from the 
DCC and CS groups were also stained using Safranin O. The sections from cellular constructs 
were stained for the presence of collagen type I, collagen type II and aggrecan using 
immunohistochemistry (IHC). Mouse monoclonal primary antibodies (all from Thermofisher 
Scientific, Waltham, MA) against collagen type I (1:200 dilution), collagen type II (1:200 
dilution), and aggrecan (1:50 dilution) were used for the immunostaining. Following the primary 
antibody, biotinylated secondary antibody was used followed with the ABC complex (Vector 
Laboratories, Burlingame, CA). The antibodies were visualized with the diaminobenzidine 
(DAB) substrate per the manufacturer’s (Vector Laboratories) protocol. Negative controls were 
also run with the primary antibody omitted. Histological and IHC staining images from the CS 
constructs could not be obtained as the sections washed off the slides during the procedures of 
staining, washing, dehydration, and clearing.  
 
STATISTICAL ANALYSES 
GraphPad Prism 6 statistical software (GraphPad Software, Inc., La Jolla, CA) was used to 
compare experimental groups using a one-factor ANOVA (sections 2.7 and 2.8) or a two-factor 
ANOVA (sections 2.9 and 2.10) followed by a Tukey’s post hoc test, where p < 0.05 was 
considered significant. Additionally, standard box plots were constructed to eliminate outliers. 





Following decellularization and cryo-grinding, the DNA, GAG, and HYP contents were reduced 
by 44% (p < 0.05), 23% (p < 0.05), and 23% (p < 0.05), respectively.  
 
SEM AND EDS 
Figure 5.2 represents the scanning electron micrographs of microspheres and scaffolds from the 
four different groups. All four types of microspheres had a spherical morphology with the 
BLANK, TGF, and CS microspheres depicting a smooth surface while the DCC microspheres 
possessed a rough surface. The microspheres in the TGF, DCC, and CS groups had micron and 
sub-micron sized pores present throughout the surface while no pores were observed on the 
surface of the BLANK microspheres. The images of the scaffolds demonstrated the overall 
porous nature of microsphere-based scaffolds with similar degrees of microsphere sintering 
(extent of interconnections) among the BLANK, TGF and DCC groups; however, the 
microspheres in the CS scaffolds appeared to be fused more with each other than what was 
observed in the other three groups. Figure 5.3 illustrates the distribution of atomic nitrogen (N) 
and sulfur (S) in the interior of TGF, DCC and CS microspheres. Nitrogen was distributed 
uniformly within the TGF, DCC, and CS microspheres. Sulfur was observed to be present inside 
the TGF, DCC and CS microspheres. The spectral maps for the BLANK microspheres showed 
that the nitrogen and sulfur were essentially absent from these microspheres (Supplementary 




The average compressive moduli for BLANK, TGF, DCC, and CS scaffolds were 102 ± 56 kPa, 
38 ± 20 kPa, 16.5 ± 3.7 kPa, and 166 ± 71 kPa, respectively (Figure 5.4). The compressive 
modulus for the CS group was 4.4-fold (p < 0.05) and 10-fold (p < 0.05) higher than the moduli 
of the TGF and DCC groups, respectively. No significant differences were observed in 
compressive modulus among the BLANK, TGF and DCC groups.   
 
POROSITY MEASUREMENT 
The average porosity of the CS group was 1.7-fold (p < 0.05), 1.8-fold (p < 0.05), and 1.1-fold (p 
< 0.05) higher than the average porosities of the BLANK, TGF, and DCC groups, respectively 
(Figure 5.5). The porosity of the DCC group was 1.5-fold (p < 0.05) and 1.6-fold (p < 0.05) 
higher than the porosities of the BLANK and TGF groups, respectively. No significant 




At week 0, the DCC and CS groups outperformed the BLANK group in DNA content with 2.7-
fold (p < 0.05) and 5.3-fold (p < 0.05) higher DNA contents, respectively (Figure 5.6). 
Additionally, the DCC and CS groups at week 0 had 1.8-fold (p < 0.05) and 3.6-fold (p < 0.05) 
higher DNA contents than the DNA content in the TGF group, respectively. Moreover, the CS 
group at week 0 had 2-fold (p < 0.05) higher DNA content than the DCC group. No significant 
differences in DNA content were observed between the BLANK and TGF groups at week 0. At 
week 3, the CS group had 88-fold (p < 0.05), 82-fold (p < 0.05), and 15-fold (p < 0.05) more 
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DNA than the BLANK, TGF, and DCC groups, respectively. Similarly, the CS group at week 6 
had 3.6-fold (p < 0.05), 3.3-fold (p < 0.05), and 2.6-fold (p < 0.05) more DNA than the BLANK, 
TGF, and DCC groups, respectively. No significant differences in DNA content were observed 
among the BLANK, TGF, and DCC groups at weeks 3 or 6. All of the groups showed 
statistically significant decreases in DNA contents with time. The BLANK group at week 0 had 
35-fold (p < 0.05) more DNA than its matching value at week 3. The TGF group at week 0 had 
48-fold (p < 0.05) and 2.5-fold (p < 0.05) more DNA than its corresponding values at weeks 3 
and 6, respectively. The DCC group at week 0 had 15-fold (p < 0.05) and 3.5-fold (p < 0.05) 
higher DNA content than at weeks 3 and 6, respectively. Week 0 DNA content in the CS group 
was 2.1-fold (p < 0.05) and 2.7-fold (p < 0.05) higher than its matching values at weeks 3 and 6, 
respectively. It must be noted that the values of DNA content obtained in the DCC group 
represent the amount of DNA present as a result of cell proliferation in these scaffolds. The 
values do not represent the residual amount of DNA present in these scaffolds, as the leftover 
DNA from the acellular DCC controls was subtracted at each time point.  
 
GAG CONTENT 
The GAG content in the CS group at week 0 was 81-fold (p < 0.05), 60-fold (p < 0.05) and 6.2-
fold (p < 0.05) higher than the GAG contents in the BLANK, TGF, and DCC groups, 
respectively (Figure 5.7A). Similarly, the GAG content in the CS group at week 3 was 80-fold (p 
< 0.05), 60-fold (p < 0.05) and 19-fold (p < 0.05) higher than the GAG contents in the BLANK, 
TGF, and DCC groups, respectively. No significant differences in GAG content were observed 
among the BLANK, TGF, and DCC groups at weeks 0 and 3. At week 6, the GAG content in the 
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CS group was 4.2-fold (p < 0.05) and 2.6-fold (p < 0.05) higher than the GAG contents in the 
BLANK and TGF groups, respectively.  
Most notably, the CS and DCC groups at week 6 had up to an order of magnitude higher 
GAG contents than their acellular counterparts. Specifically, the CS group GAG content at week 
6 was 7.5-fold (p < 0.05) higher than the GAG content of the CS [Acellular] group. Likewise, the 
DCC group at week 6 had 10-fold (p < 0.05) higher GAG content than the DCC [Acellular] 
group. No significant differences in GAG content were observed between the BLANK and TGF 
groups at week 6. Only the CS and DCC groups showed statistically significant changes in GAG 
content over time. The GAG contents in the CS and CS [Acellular] groups at week 0 were 2.3-
fold (p < 0.05) and 15-fold (p < 0.05) higher than their corresponding values at weeks 6, 
respectively. Additionally, week 3 GAG amounts in the CS and CS [Acellular] groups were 2.2-
fold (p < 0.05) and 12-fold (p < 0.05) higher than their matching values at week 6, respectively. 
On the other hand, the DCC group had 6.9-fold (p < 0.05) more GAG at week 6 than at week 3. 
No significant differences in GAG content were observed in the BLANK, TGF, and DCC 
[Acellular] groups over time. 
 
HYDROXYPROLINE (HYP) CONTENT 
The HYP content results revealed that the DCC group at week 0 had 185-fold (p < 0.05), 244-
fold (p < 0.05), and 71-fold (p < 0.05) higher HYP content than the BLANK, TGF, and CS 
groups, respectively (Figure 5.7B). In addition, the DCC group at week 0 outperformed the DCC 
[Acellular] with a HYP content that was 1.2-fold (p < 0.05) higher. Week 3 HYP content results 
showed that the HYP content in the DCC group was 189-fold (p < 0.05), 458-fold (p < 0.05), and 
52-fold (p < 0.05) higher than in the BLANK, TGF, and CS groups, respectively. Likewise, the 
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HYP content in the DCC group at week 6 was 83-fold (p < 0.05), 99-fold (p < 0.05), and 62-fold 
(p < 0.05) higher than in the BLANK, TGF, and CS groups, respectively. No significant 
differences in HYP content were observed among the BLANK, TGF, and CS groups at weeks 0, 
3, or 6. Only the DCC and DCC [Acellular] groups showed statistically significant differences in 
HYP over time. The DCC group at week 0 had 1.6-fold (p < 0.05) 1.7-fold (p < 0.05) higher 
HYP content than at weeks 3 and 6, respectively. The HYP content in the DCC [Acellular] group 
at week 0 was 1.4-fold (p < 0.05) and 1.7-fold (p < 0.05) higher than its matching values at 
weeks 3 and 6, respectively.  
 
GENE EXPRESSION 
SOX9 AND COL2A1 
The BLANK group at week 0 had 31-fold (p < 0.05) and 1.1-fold (p < 0.05) higher SOX9 
expression than the DCC and CS groups, respectively (Figure 5.8A). The TGF group SOX9 
expression at week 0 was 1.4-fold (p < 0.05), 44-fold (p < 0.05), and 1.6-fold (p < 0.05) higher 
than the SOX9 expression of the BLANK, DCC, and CS groups, respectively. The CS group at 
week 0 also had 27-fold (p < 0.05) higher SOX9 expression than the DCC group. No significant 
differences in SOX9 expression were observed among the groups at weeks 1.5, 3, or 6. The 
SOX9 expression for all of the groups at week 1.5 and beyond was essentially negligible, with 
the BLANK, TGF, and CS groups showing statistically significant decrease in expression from 
their corresponding week 0 values.  
The COL2A1 expression values for the BLANK group at weeks 1.5, 3, and 6; TGF group 
at weeks 3 and 6; DCC group at weeks 1.5, 3, and 6; and CS group at weeks 1.5, 3, and 6, were 
marked as zero because the fluorescence intensities in these samples did not cross the threshold 
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fluorescence. The TGF group at week 0 had 11-fold (p < 0.05) and 2.4-fold (p < 0.05) higher 
COL2A1 expression than the DCC and CS groups, respectively (Figure 5.8B). The BLANK and 
the CS groups at week 0 had 10-fold (p < 0.05) and 4.9-fold (p < 0.05) higher COL2A1 
expression than the DCC group, respectively. No significant differences in COL2A1 expression 
were observed among the groups at weeks 1.5, 3, or 6. The BLANK, TGF, and CS groups 
showed statistically significant changes in COL2A1 expression values over time while no 
significant differences in COL2A1 expression were observed in the DCC group over time. The 
week 0 COL2A1 expression values for the BLANK, TGF, and CS groups were statistically 
significantly higher than their corresponding values at weeks 1.5, 3, and 6. 
 
ACAN AND COL1A1 
The TGF group at week 0 had 1.5-fold (p < 0.05), 20-fold (p < 0.05), and 1.5-fold (p < 0.05) 
higher ACAN expression than the expression levels of the BLANK, DCC, and CS groups, 
respectively (Figure 5.8C). Both the BLANK and the CS group at week 0 had 13-fold (p < 0.05) 
higher ACAN expression than the DCC group at that time point. No significant differences in 
ACAN expression were observed among the groups at weeks 1.5, 3 or 6. All the groups at week 
1.5 and beyond had negligible ACAN expression, with the BLANK, TGF, and CS groups 
exhibiting statistically significant decrease in expression from their corresponding week 0 values. 
The BLANK, TGF, and CS groups at week 0 had 4.6-fold (p < 0.05), 7.7-fold (p < 0.05), 
and 3.5-fold (p < 0.05) higher COL1A1 expression than the DCC group, respectively (Figure 
5.8D). The TGF group at week 0 had 1.7-fold (p < 0.05) and 2.2-fold (p < 0.05) higher COL1A1 
expression than the BLANK and CS groups, respectively. At week 1.5, the DCC group 
outperformed the BLANK, TGF, and CS groups in COL1A1 expression with expression value 
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that was 8.6-fold (p < 0.05), 3.6-fold (p < 0.05), and 4.3-fold (p < 0.05) higher, respectively. No 
significant differences in COL1A1 expression were observed among the groups at weeks 3 or 6. 
All of the groups showed statistically significant changes in COL1A1 expression over time. The 
BLANK group at week 0 had 12-fold (p < 0.05), 300-fold (p < 0.05), and 60-fold (p < 0.05) 
higher COL1A1 expression than its expression at weeks 1.5, 3, and 6, respectively. The TGF and 
the CS groups showed a similar pattern to the BLANK group in COL1A1 expression. The TGF 
group COL1A1 expression at week 0 was 8.3-fold (p < 0.05), 333-fold (p < 0.05), and 100-fold 
(p < 0.05) higher than at weeks 1.5, 3, and 6, respectively. The CS group at week 0 had 4.5-fold 
(p < 0.05), 5-fold (p < 0.05), 7.5-fold (p < 0.05) higher COL1A1 expression than at weeks 1.5, 3, 
and 6, respectively. The COL1A1 expression in the DCC group peaked at week 1.5 with an 
expression value that was 3.3-fold (p < 0.05) and 5.4-fold (p < 0.05) higher than at weeks 0 and 6, 
respectively. 
 
RUNX2, COL10A1, AND IBSP 
The BLANK, TGF, and CS groups at week 0 had 13-fold (p < 0.05), 15-fold (p < 0.05), and 13-
fold (p < 0.05) higher RUNX2 expression than the DCC group, respectively (Figure 5.8E). No 
significant differences were observed in RUNX2 expression among the BLANK, TGF, and CS 
groups at week 0. Additionally, no significant differences were observed in RUNX2 expression 
among all the groups at weeks 1.5, 3, or 6. The RUNX2 expression for all of the groups at week 
1.5 and beyond was negligible, with the BLANK, TGF, and CS groups showing statistically 
significant decrease in expression from their corresponding week 0 values. 
The COL10A1 expression values for the BLANK group at weeks 1.5, 3, and 6; TGF 
group at weeks 3 and 6; DCC group at weeks 1.5, 3, and 6; and CS group at weeks 1.5, 3, and 6, 
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were marked as zero because the fluorescence intensities in these samples did not cross the 
threshold fluorescence. No significant differences were observed in COL10A1 expression among 
the groups at any time point (Figure 5.8F). All of the groups had negligible COL10A1expression 
at week 1.5 and beyond with statistically significant decrease in expression from their 
corresponding week 0 values.  
The IBSP expression values for the BLANK group at weeks 3 and 6, and the CS group at 
week 6, were marked as zero because the fluorescence intensities in these samples did not cross 
the threshold fluorescence. The BLANK group at week 0 had 2.1-fold (p < 0.05), 10-fold (p < 
0.05), and 1.9-fold (p < 0.05) higher IBSP expression than the expression values of the TGF, 
DCC, and CS groups, respectively (Figure 5.8G). The IBSP expression values of the TGF and 
CS group at week 0 were 4.9-fold (p < 0.05) and 5.3-fold (p < 0.05) higher than the IBSP 
expression of the DCC group, respectively. No significant differences were observed in IBSP 
expression among the groups at weeks 1.5, 3, or 6. The BLANK, TGF, and CS groups had 
negligible IBSP expression at week 1.5 and beyond with statistically significant decrease in 
expression from their corresponding week 0 values. On the other hand, the DCC group had 
negligible IBSP expression at week 3 and 6 with no statistically significant differences in its 
expression values over time. 
 
HISTOLOGY AND IMMUNOHISTOCHEMISTRY (IHC) 
Figure 5.9 represents the histological images from the BLANK, TGF, and DCC groups at week 6. 
The sections from the CS scaffolds washed off during the staining process after multiple careful 
attempts, therefore no histological and IHC images are available from the CS scaffolds. H&E 
images showed that the cells in the BLANK and TGF groups were present primarily around the 
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periphery of the microspheres, whereas cells in the DCC group were also found to have 
infiltrated the microspheres. No differences were observed in Safranin O (stains GAGs orange) 
staining intensities among the groups at week 6. Masson’s trichrome, which stains collagen dark 
blue, depicted the staining intensities to be greater in the TGF and DCC groups than in the 
BLANK group. All of the groups stained for Sudan Black, with higher staining intensities in the 
BLANK and TGF groups than in the DCC group. In addition, the spherical shape of the 
microspheres was still evident only in the DCC group. Figure 5.10 depicts the IHC images 
obtained from the BLANK, TGF, and DCC groups at week 6. All three of the groups stained 
positively for collagen I, with staining intensities in the BLANK and TGF groups being higher 
than the intensity in the DCC group. No differences in collagen II staining intensities were 
observed among the BLANK, TGF, and DCC groups. Aggrecan staining was more intense in the 
BLANK and TGF groups than in the DCC group. The aggrecan staining in the DCC group 
appeared to be distributed in clusters within the microspheres themselves, perhaps indicative of 
the encapsulated DCC itself.   
 
DISCUSSION 
The current study for the first time compared the effects of encapsulating DCC versus CS in 
promoting the chondrogenic differentiation of mesenchymal stem cells. DCC or CS could 
potentially supply the neighboring cells with raw materials (i.e., bioactive signals and building 
blocks) for differentiation along the chondrogenic lineage17, 37, 193, 226. Our previous studies have 
shown that the incorporation of DCC or CS, at concentrations of 10 or 20 wt%, in microsphere-
based scaffolds rendered the scaffolds bioactive, which further led to greater cell numbers 
compared to the “blank” (PLGA-only) controls and also enhanced matrix synthesis by the seeded 
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rBMSCs89, 172, 227. In the present study, DCC or CS were incorporated at higher concentrations 
(30 wt%) in microsphere-based scaffolds than our previous iterations of these scaffolds and the 
potential of encapsulated DCC or CS were evaluated side-by-side to influence the chondrogenic 
differentiation of rBMSCs. 
The SEM images depicted that all four types of microspheres were uniform in size, with 
average microsphere diameter ranging between 160-180 µm (Figure 5.11). The TGF, DCC, and 
CS microspheres possessed minute pores on their surface formed perhaps as a result of 
particulate leaching during solvent evaporation89, 172, 214, 227. The DCC encapsulation imparted the 
PLGA microspheres a rough appearance, differing from our prior work where PLGA 
microspheres encapsulating DCC at a concentration of 10 wt% had a smooth surface227. The 
higher concentrations of DCC encapsulated in the current study might have resulted in an uneven 
surface of the DCC microspheres. The microsphere-based scaffolds from all of the four groups 
were observed to be porous in nature with interconnected pores, as we have consistently 
observed in previous work89, 215. Additionally, it was noted that microspheres in the CS scaffolds 
had a relatively higher degree of sintering than the degree of sintering observed in the other three 
groups. Failure to observe a similar effect in the DCC group may have indicated differences in 
partitioning of CS and DCC in the polymeric microspheres that might have contributed to the 
higher extent of sintering in the CS group. The EDS maps for atomic nitrogen and sulfur 
demonstrate that TGF, DCC, and CS were uniformly distributed throughout the interior of the 
microspheres in the corresponding groups with no evidence of agglomeration at any site. The 
presence of sulfur in the TGF microspheres could be attributed to the Cysteine (C) and 
Methionine (M) amino acid residues present in TGF-β3.  
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In contrast to our previous findings172, 227, it was observed that the compressive modulus 
of CS group was significantly higher than the moduli of the TGF and DCC groups. The higher 
compressive modulus of CS scaffolds may be attributed to a higher degree of microsphere 
sintering observed in the CS group. The DCC and CS groups also had significantly higher 
porosities than the control groups. The higher porosities in the DCC and CS groups is likely 
associated with the presence of minute pores on the surface of the microspheres that imparted 
them an additional level of microporosity in addition to the macroporosity obtained from the 
microsphere sintering89.  
With regard to biochemical content, the CS groups at all time points had significantly 
higher cell numbers (i.e., DNA content) than the other three groups. Additionally, it was 
observed that the DCC group at week 0 had significantly higher cell numbers than controls at 
that time point. The higher cell numbers in the CS scaffolds is indicative of higher cell 
proliferation in these scaffolds, as CS is known to have a mitogenic effect on the proliferation of 
MSCs72, 89, 202, 237. The higher cell numbers in the DCC scaffolds at week 0 maybe attributed to 
the rough surface of microspheres that might have promoted initial cell attachment27, 126. We 
observed a similar phenomenon previously in DCC-coated microspheres where the DCC coated 
scaffold groups had higher cell numbers at week 0227. Higher concentrations of DCC used in the 
current study led to higher amounts of DCC being present on the surface of the microsphere thus, 
aiding in initial cell attachment by providing additional cell adhesion sites. The CS and DCC 
groups outperformed the other three groups in GAG and HYP contents at all time points, 
respectively. Higher amounts of GAG and HYP in the CS and DCC groups is likely ascribed to 
the inherent GAGs and collagen present in these scaffolds that decreased over time as the 
scaffolds degraded. It was noted that at week 0, the cell seeded DCC group had a significantly 
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higher HYP content than its acellular counterpart, highlighting the contribution of cell 
proliferation to matrix synthesis in the DCC scaffolds.  A major finding of the study was that the 
cellular DCC and CS groups at week 6 had significantly higher GAG contents than their 
acellular equivalents, suggestive of enhanced matrix production and/or rentention/incorporation 
by the seeded cells in the DCC and CS groups. Together, these findings suggest that CS and 
DCC encapsulation in microsphere-based scaffolds promote new cartilage-related matrix 
synthesis, and supports our previous findings of a modulatory effect of CS and DCC on 
rBMSCs89, 227.     
 It is to be noted that the expression of the osteogenic markers, RUNX2 and IBSP, 
remained low in all of the groups throughout the 6-week culture period indicating that the 
rBMSCs did not appreciably differentiate toward the osteogenic lineage in any of the scaffold 
groups, which might be a limitation with using mesenchymal stem cells that themselves have a 
tendency for exhibiting a hypertrophic phenotype218. The gene expression results for SOX9, 
COL2A1, and ACAN showed that the expression of these genes was largely suppressed in the 
DCC and CS groups at week 0 compared to the control groups at that time point, with the CS 
group outperforming the DCC group at week 0, although reassuringly the positive control TGF 
group outperformed the BLANK group in SOX9 and ACAN expression. The lower expression 
of chondrogenic markers in the DCC and CS groups early on indicated that the DCC and CS 
inhibited the expression of chondrogenic markers by creating an environment that is already high 
in cartilage-like ECM components. We observed a similar phenomenon in hydroxyapatite (HAp) 
and tricalcium phosphate (TCP) encapsulated microsphere-based scaffolds where the expression 
of osteogenic markers in MSCs was largely suppressed due to the presence of inherent minerals 
in the scaffolds61, 89. Additionally, the chondrogenic gene expression in the DCC group did not 
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increase over time, which was in contrast to the findings of some other groups utilizing cartilage 
matrix, where chondrogenic gene expression in the cartilage matrix scaffolds either was 
maintained or increased over time83, 174. Failure to observe up-regulation of the chondrogenic 
genes at later time points in the DCC group hint that the decellularization process might have 
impaired some critical cartilage matrix components required for cells to guide them toward a 
chondrogenic lineage127. Since decellularization can result in changes in cartilage matrix, we 
believe that the encapsulation of other forms of cartilage matrix (e.g. devitalized cartilage, DVC) 
might enhance the chondro-inductivity of microsphere-based scaffolds, which is a matter of 
further investigation. In our prior work, we have demonstrated the raw materials like CS in 
combination with growth factors like TGF-β3 can enhance the secretion of cartilage specific 
matrix components. Moreover, Almeida et al.3 noticed that a combination of cartilage-ECM-
derived scaffold and stimulation with TGF-β3 can induce chondrogenesis in human fat-pad-
derived stem cells, so perhaps encapsulating CS, DCC or DVC in combination with the growth 
factor may provide a synergistic effect, thus boosting the chondrogenic potential of microsphere-
based scaffolds.  
The histological images at week 6 pointed toward higher cell numbers in the BLANK and 
TGF groups than in the DCC group; however, no significant differences were observed in the 
DNA content among the three groups at week 6. The cells in the BLANK and TGF groups were 
found to be predominantly present around the periphery of the microspheres, while cells in the 
DCC group were also observed within the microsphere matrix, suggesting that the porous nature 
of DCC microspheres allowed for cell infiltration to occur within the microsphere matrix or 
perhaps there was residual DNA from the DCC itself. The Safranin-O staining intensities were 
not different among the BLANK, TGF, and DCC groups, which was consistent with no observed 
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differences in the GAG content among the three groups at that time point. The Masson’s 
trichrome images were in agreement with our HYP content results, both showing that the DCC 
group had higher collagen content than the BLANK and TGF groups at week 6. The higher net 
collagen content in the DCC group was due to the inherent collagen present in the DCC scaffolds 
as confirmed by the Masson’s trichrome staining images of the acellular DCC scaffolds (Figure 
5.12). Sudan Black staining hinted that encapsulation of DCC altered polymer degradation 
(perhaps accelerating it). The staining intensities for residual polymer were significantly higher 
in the BLANK and TGF groups than the intensity in the DCC group. PLGA microspheres 
degrade via bulk erosion where the rate-limiting step is the diffusion of water molecules into the 
microsphere core. DCC microspheres because of their porous nature might have allowed faster 
diffusion of water molecules into their core, thereby initiating polymer degradation more quickly 
than in the BLANK and TGF groups. The IHC images illustrated that the BLANK and TGF 
groups stained more intensely for collagen I and aggrecan. The gene expression results showed 
higher expression of collagen I and aggrecan in the BLANK and TGF groups than the DCC 
group at week 0; however, no significant differences in the expression of these two genes were 
observed among the groups at later time points.  
In conclusion, the results of the current study demonstrated that encapsulation of DCC 
and CS altered the morphological and structural properties of both the microspheres and the 
scaffolds. Moreover, the encapsulation of DCC and CS led to enhanced cell attachment and 
proliferation on microsphere-based scaffolds thereby, corroborating with our earlier studies 
suggesting that both DCC and CS are bioactive when incorporated into microsphere-based 
scaffolds89, 227. By providing an environment rich in GAGs and collagen, the DCC and CS 
scaffolds initially impeded the chondrogenic gene expression in rBMSCs however; biochemical 
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evidence suggested of a modulatory effect of DCC and CS on matrix synthesis by rBMSCs. 
Additionally, the differences highlighted between the DCC and CS groups by the biochemical 
content analysis and the gene expression patterns hint that rBMSCs responded differently to both 
DCC and CS encapsulated into the microsphere-based scaffolds. Although the cellular response 
did not provide compelling evidence of DCC and CS enhancing chondrogenesis in microsphere-
based scaffolds, the increased GAG content in these groups relative to acellular controls after 6 
weeks was encouraging. There is a need to further refine the technology by using even higher 
concentrations of CS and DCC, or perhaps different forms of cartilage matrix (e.g. devitalized 
cartilage), or combinations of these raw materials with TGF-β. 
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CHAPTER 6: MICROSPHERE-BASED SCAFFOLDS CARRYING OPPOSING 
GRADIENTS OF DECELLULARIZED CARTILAGE AND DEMINERALIZED BONE 
MATRIX FOR IN VIVO OSTEOCHONDRAL REGENERATION†† 
ABSTRACT 
Extracellular matrix (ECM) ‘raw materials’ such as demineralized bone matrix (DBM) and 
cartilage matrix have emerged as leading scaffolding materials for osteochondral regeneration 
due to their ability to facilitate progenitor/resident cell recruitment, infiltration, and 
differentiation without adding growth factors. Scaffolds comprised of synthetic polymers are 
robust but generally lack signals for guiding cell differentiation. We hypothesized that opposing 
gradients of decellularized cartilage (DCC) and DBM in polymeric microsphere-based scaffolds 
would provide superior osteochondral regeneration compared to polymer-only scaffolds in vivo. 
Poly(D,L-lactic-co-glycolic acid) (PLGA) microsphere-based scaffolds were fabricated, either 
with opposing gradients of DCC and DBM encapsulated (GRADIENT) or without DCC and 
DBM (BLANK control), and implanted into rabbit osteochondral defects in medial femoral 
condyles. After 12 weeks, gross morphological evaluation showed that the repair tissue in about 
30% of the implants was either slightly or significantly depressed, hinting toward rapid polymer 
degradation in scaffolds from both of the groups. Additionally, no differences were observed in 
gross morphology of the repair tissue between the PLGA and GRADIENT groups. Mechanical 
testing revealed no significant differences in model parameter values between the two groups. 
Histological observations demonstrated that the repair tissue in both of the groups was fibrous in 
nature with the cells demonstrating notable proliferation and matrix deposition activity. No 
adverse inflammatory response was observed in any of the implants from the two groups. 
                                                
††To be submitted as Gupta V, Lyne D, Laflin A, Zabel T, Barragan M, Bunch J, Pacicca D, Detamore M, 
Microsphere-Based Scaffolds Carrying Opposing Gradients Of Decellularized Cartilage And Demineralized Bone 
Matrix For In Vivo Osteochondral Regeneration, Regenerative Engineering and Translational Medicine, 2015.  
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Overall, the results emphasize the need to improve the technology in terms of altering the DBM 
and DCC concentrations, and tailoring the polymer degradation to these concentrations. 
 
INTRODUCTION 
Cartilage injuries are difficult to treat because of the limited capacity of cartilage to heal. Even 
though the osteochondral tissue consists of dissimilar tissues, cartilage and bone, it is known that 
repair of cartilage is associated with the repair of subchondral bone156. Additionally, there are 
several benefits of growing cartilage and bone within physical proximity to one another. Many 
biochemical and biomechanical cues responsible for progenitor cell commitment to the 
osteoblast or chondrocyte lineages have a high degree of interrelatedness50, 87, 191. Therefore, 
several regenerative medicine strategies for osteochondral repair are focused on regenerating 
both bone and cartilage simultaneously in a plethora of designs in which stratified and 
continuously graded designs have emerged as the frontrunners57, 155, 209. Our research group has 
shown that three-dimensional (3D) microsphere-based scaffolds with opposing gradients of 
bioactive signals can direct the differentiation of surrounding progenitor cells simultaneously and 
regionally toward osteogenesis and chondrogenesis63, 215. Moreover, we have demonstrated that 
these microsphere-based gradient scaffolds can lead to promising osteochondral repair when 
implanted in vivo in rabbits58, 65.  
In the last few years, there has been an increased interest in fabricating scaffolds from 
extracellular matrices (ECM) for regenerative medicine23, 97. For osteochondral regeneration, 
cartilage matrix and demineralized bone matrix (DBM) have widely gained attention because of 
their ability to influence resident cell behavior, such as migration, proliferation and 
differentiation.37 Both cartilage matrix and DBM allow for constructive remodeling by providing 
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tissue-specific raw materials (i.e., bioactive signals and building blocks).17 DBM is commonly 
used as a bone graft material and presently there are about 25 different DBM products 
commercially available in the market68. Cartilage matrix, on the other hand, has started to gain 
considerable attention in the last few years for cartilage regeneration3, 16, 83, 174, 204, with an 
emphasis on native tissue-derived, decellularized cartilage (DCC)226. Scaffolds derived from 
DBM and DCC have shown great promise within the field of osteochondral regeneration in part 
because of their ability to guide cell differentiation and provide raw materials for neo-tissue 
formation. However, various processing reagents used to obtain DBM or DCC often compromise 
their mechanical performance17, 37.   
The goal of the current study was to fabricate a scaffold that possesses instructive 
properties of ECM-based materials to guide cell differentiation and mechanical integrity of 
strong synthetic materials to support joint function during tissue regeneration. Furthermore, we 
have previously demonstrated that gradient microsphere-based scaffolds have the ability to 
control patterning of cell phenotype and secrete tissue-specific ECM components for promoting 
osteochondral repair58, 63, 65, 89, 169, 172, 173. Our hypothesis was that microsphere-based scaffolds 
containing gradients of DBM and DCC would lead to regionalized tissue formation when 
implanted in vivo into rabbit osteochondral defects and outperform the “blank” (no DBM or 
DCC) microsphere-based scaffolds. To test our hypothesis, we fabricated poly(D,L-lactic acid-
co-glycolic acid) (PLGA) microsphere-based scaffolds with encapsulated DCC and DBM in 
opposing gradients, and implanted them into induced femoral condyle osteochondral defects in 
rabbit knees for 12 weeks. Additionally, PLGA-only microsphere-based scaffolds were also 
implanted into the contralateral knees of each rabbits as a control.  
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MATERIALS AND METHODS 
MATERIALS 
All reagents for the decellularization process were purchased from Sigma–Aldrich (St. Louis, 
MO) unless otherwise noted. All other reagents and organic solvents utilized were of USP or 
ACS grade. PLGA (50:50 lactic acid:glycolic acid ratio, acid end group) with an intrinsic 
viscosity (i.v.) of 0.37 dL/g, was obtained from Evonik Industries (Essen, Germany). Human 
demineralized bone matrix (DBM) pellets were received from Biomet, Inc (Warsaw, IN). Two 
porcine knees from one Berkshire hog (castrated male, approximately 7-8 months old, and 
weighing 120 kg) were purchased from a local abattoir (Bichelmeyer Meats, Kansas City, KS). 
Ten New Zealand White rabbits were obtained from Harlan Laboratories (Indianapolis, IN) in 
accordance with the University of Kansas IUCAC procedures (Protocol #175-21). 
 
CARTILAGE HARVEST AND DECELLULARIZATION 
Articular cartilage was harvested from hip and knee joint surfaces and stored at -20°C. After 
freezing overnight, the cartilage was thawed and coarsely cryoground with dry ice pellets using a 
cryogenic tissue grinder (BioSpec Products, Bartlesville, OK). The dry ice was allowed to 
sublime overnight in the freezer. Decellularization of the cartilage was performed using our 
previously described method45, 225, 227. Coarse ground decellularized particles were packed into 
dialysis tubing (3500 MWCO) and stored in hypertonic salt solution (HSS) overnight at room 
temperature with gentle agitation (70 rpm). The packets were then subjected to 220 rpm agitation 
with two reciprocating washes of triton X-100 (0.01% v/v) followed by HSS to permeabilize cell 
membranes. The tissue was then treated overnight with benzonase (0.0625 KU ml-1) at 37ºC and 
overnight with sodium-lauroylsarcosine (NLS, 1% v/v) to further lyse cells and denature cellular 
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proteins. The tissue was then washed with ethanol (40% v/v) at 50 rpm and subjected to organic 
exchange resins to extract the organic solvents at 65 rpm. Afterward, the tissue was washed in 
saline-mannitol solution at 50 rpm followed by two hours of rinsing with DI water at 220 rpm. 
The tissue was removed from the packets and frozen and lyophilized. The decellularized 
cartilage (DCC) particles were further cryoground into a fine powder with a freezer-mill (SPEX 
SamplePrep, Metuchen, NJ) and then lyophilized. The DCC powder was filtered using a 45 µm 




Three different types of microspheres were fabricated for the study: (i) PLGA-only microspheres 
(BLANK), (ii) DBM encapsulated PLGA microspheres (DBM), and (iii) DCC encapsulated 
PLGA microspheres (DCC). Prior to microsphere fabrication, DBM pellets were first 
cryoground into a fine powder using the freezer-mill and then lyophilized. The DBM powder 
was filtered using a 45 µm mesh (ThermoFisher Scientific, Waltham, MA) to remove large 
particles. The DBM and DCC encapsulated microspheres were fabricated by adding 2% w/v 
DBM or 2% w/v DCC to 18% w/v PLGA dissolved in DCM, respectively. Using the PLGA-
DBM and PLGA-DCC emulsions, microspheres with mean diameters ranging from 240-270 µm 
were fabricated via our previously reported technology58, 61, 63, 65, 89, 169, 172, 173, 214, 215, 227. In brief, 
acoustic excitation produced by an ultrasonic transducer (Branson Ultrasonics, Danbury, CT), 
created regular jet instabilities in the polymer stream, thereby resulting in uniform polymer 
droplets (Figure 6.1). An annular carrier non-solvent stream of 0.5% w/v poly (vinyl alcohol) 
(PVA, 88% hydrolyzed, 25 kDa, Polysciences, Inc., Warrington, PA) in deionized water (DI 
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H2O) carried the emanated polymer droplets (i.e., microspheres) into a beaker containing the 
non-solvent solution. The microspheres were stirred for 1 h to allow the solvent to evaporate, and 
then these microspheres were filtered, rinsed and stored at -20°C. The microspheres were 
lyophilized for 48 h before further use. 
 
SCAFFOLD FABRICATION 
Gradient scaffolds (“GRADIENT” group) were fabricated using our previously established 
technology.58, 63, 65, 89, 169, 172, 173, 214, 215 Briefly, lyophilized DBM and DCC microspheres (50-100 
mg) were dispersed in DI H2O and loaded into two separate syringes. The suspensions were then 
pumped at opposing flow rates using programmable syringe pumps (PHD 22/2000; Harvard 
Apparatus, Inc., Holliston, MA) into a cylindrical plastic mold (diameter ~ 3.6 mm) having a 
filter at the bottom until a height of about 2 mm was reached. The scaffolds were 3.5-3.6 mm in 
diameter and 2 mm in height. The profile for these gradient scaffolds was linear, where the top 
one-fourth of the total height comprised of DCC microspheres (0.5 mm), then the next one-
fourth (0.5 mm) was a linear transition from DCC to DBM microspheres, and the remaining half 
(1 mm) contained only DBM microspheres (Figure 6.2). The stacked microspheres were then 
sintered with ethanol-acetone (95:5 v/v) for 55 min. The scaffolds were further lyophilized for 48 
h and sterilized with ethylene oxide for 12 h prior to animal implantation experiments. The 
control BLANK scaffolds were fabricated by packing the “blank” (PLGA-only) microspheres 
into the same molds, followed by sintering for 55 min. The BLANK scaffolds had dimensions 
similar to GRADIENT scaffolds (diameter 3.5-3.6 mm and height 2 mm). A total of two scaffold 
groups were tested in the study and were named according to the composition of microspheres 
as: BLANK and GRADIENT.  
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SURGICAL PROCEDURE 
Surgical procedures were conducted under an approved IACUC protocol at the University of 
Kansas (protocol #175-21), with a total of 10 rabbits. Following analgesic delivery, stable 
general anesthesia, and antibiotic administration, hair was shaved from area around each knee. 
Before the procedure, rabbits were provided with a lactated ringer injection or saline bolus (150-
200 cc) subcutaneously at multiple injection sites around the neck and shoulders to ensure proper 
hydration and to maintain blood pressure.  The surgical area was disinfected with alternate 
scrubs of Betadine and 70% ethanol, and then draped. Only strict aseptic techniques and sterile 
instruments were used, and the surgeons wore sterile gown, masks and head covers. All surgical 
tools, including drill, were sterilized before surgery. A medial parapatellar incision was made, 
sufficient to allow exposure of the medial condyle. The tibia was lightly pushed to displace it 
laterally to allow exposure of the medial femoral condyle. A pilot hole was drilled through the 
cartilage and the subchondral bone in the central load-bearing region of the medial condyle using 
a 1.5 mm drill. The defect was then enlarged to 3.5 mm diameter and to the depth of 2 mm using 
a 3.5 mm drill with depth gauge. The defect was then filled by press fitting one of the two 
engineered plugs, either BLANK or GRADIENT, into it (Figure 6.3). Due to differences in 
relative diameters of scaffolds and drill bits, there were some scaffolds that required excessive 
force to press-fit them into the defect, resulting in some degree of implant crumbling. We 
observed an estimate of 5% implant crumbling in the following animals: Rabbit 1 right knee and 
Rabbit 6 right knee, and 10–15% implant crumbling in Rabbit 6 left knee. After press-fitting the 
implant, the joint was then washed of debris with sterile saline, the patella and femur were 
relocated, and the articular capsule and bursae were closed with an absorbable suture, and then 
the skin was closed with a non-absorbable closure. The same procedure was performed on the 
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contralateral knee but with the alternative plug construct implanted (Table 6.1). After both 
procedures were finished, rabbits were returned to their cages. Analgesics were administered as 
needed based on pain assessment. The knee joints were allowed unconstrained movement 
postoperatively. 
 
GROSS MORPHOLOGICAL ASSESSMENT 
After 12 weeks, all implants were scored blindly by three independent co-authors based on the 
presence of repair tissue or implant at the defect site, the edge integration at the boundaries of 
newly regenerated tissue and the native cartilage, the smoothness of the repair tissue, the surface 
degree of filling at the defect site, the color of the regenerated cartilage, and the amount of repair 
tissue present relative to the total defect area. The scoring criteria are listed in Table 6.2. 
Thereafter, the joints were photographed and processed for mechanical testing or histology. 
 
MECHANICAL TESTING 
After retrieval, eight femurs (Table 6.1) were wrapped in gauze, soaked in a protease inhibitor 
solution (0.15 M NaCl; EDTA, 2 mM; benzamidine HCl, 5 mM; N-ethyl malemide, 10 mM; and 
PMSF, 1 mM) and stored at -20°C until the day of testing9. Each frozen femur was thawed at 
room temperature for 1 h in the protease inhibitor solution. Afterward, medial femoral condyles 
(MFCs) were carefully separated from the rest of the tissue with a handheld hacksaw. Each MFC 
was affixed to a stainless steel platform using cyanoacrylate adhesive, placed in a custom made 
bath and submerged in the protease inhibitor solution173. The temperature of the bath was 
maintained at 37 °C at all times during the testing. A uniaxial testing apparatus (Instron 5848 
Microtester, Canton, MA) was used for both cartilage thickness measurement and unconfined 
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indentation stress relaxation tests. A total of three sites were tested to determine the thickness, 
whereas indentation was performed only at the central region of the implant site. Thickness was 
measured via a thin needle that was inserted into the implant site perpendicularly to the specimen 
surface at a constant rate of 0.5 mm/min. The force and displacement were measured, and needle 
movement was terminated when the force reached 2 N. Specimen thickness was determined 
using a force displacement curve. A change in slope indicated the point where the needle 
contacted the subchondral bone196. For indentation stress relaxation testing, the tare-loaded (0.01 
N) implant site was subjected to 10% strain (at a ramp rate of 0.01%/s) using a solid spherical tip 
stainless steel indenter (1.5 mm diameter), and then allowed to relax for a period of 1000 s173.  
 
FINITE ELEMENT ANALYSIS 
The unconfined compression stress relaxation response of the test specimens was curve fitted 
using a finite element analyses in which cartilage was modeled as a biphasic material176. The 
porous extracellular matrix was described by a solid mixture of a neo-Hookean ground matrix 
reinforced by a continuous, random distribution of fibril bundles sustaining tension only; the 
hydraulic permeability was assumed constant7, 8, 24. The model had a total of five material 
constants: Elastic modulus (E) and Poisson’s ratio (ν) for the neo-Hookean solid, the fibril 
modulus (ksi) and the power-law exponent (β) for the spherical fiber distribution, and the 
constant hydraulic permeability (k). It was assumed a priori that β  = 2 (to produce a linear 
tensile response in the range of small strains, consistent with the known behavior of cartilage) so 
that the parameter optimization was only performed on E, ν, ksi and k7. The finite element 
analyses for curve-fitting the experimental data and modeling the contact between indenter and 
the specimen, were performed with the open-source program FEBio available in the public 
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domain162. Curve fitting was performed using FEBio’s built-in least-squares parameter 
optimization routine, based on the Levenberg-Marquardt algorithm. The contact was modeled 
using an impermeable spherical indenter with a diameter of 1.5 mm and a cylindrical disk 
(representing the tissue) of diameter of 6 mm, and 1 mm height. The model tissue diameter was 
chosen to be 4 times the indenter diameter to simulate the indentation experiment where the 
cartilage radius is much larger than the indenter radius. Due to symmetry, only a wedge of the 
geometry was modeled. The indenter produced a compressive deformation of 10% of the 
thickness. The contact interface between the indenter and the construct was assumed to be 
frictionless. In the model, the bottom of the construct was fixed to a rigid impermeable substrate. 
Fluid was assumed to escape from the free boundaries not in direct contact with the indenter173. 
The model consisted of 321 hexahedral 8-node elements and 546 nodes. The mesh was biased 
along the thickness to produce thinner elements near the top and bottom surfaces; a coarser mesh 
was also employed at the far ends along the length. FEM results were visualized using the FEBio 
Postview environment. 
 
HISTOLOGICAL AND IMMUNOHISTOCHEMICAL (IHC) ANALYSES 
Eight femurs (Table 6.1) were decalcified in 0.5N HCl with 0.1% gluteraldehyde for 9 days at 
4°C. The decalcification solution was changed every 48 h. The femurs were then washed and 
defatted in 70% and 100% ethanol for 24 h, respectively. Thereafter, the femurs were 
cryoprotected by immersion in 5% sucrose and then 10% sucrose in PBS for 2 h each, followed 
by 20% sucrose in PBS for 16 h at room temperature40. The femurs were then equilibrated in 
optimal cutting temperature embedding medium (OCT, Tissue-Tek, Torrance, CA) overnight at 
37°C and then frozen at -20°C. 10 µm thick sections were cut using a cryostat (Micron HM-550 
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OMP, Vista, CA) and stained using hematoxylin (cell nuclei) and eosin (cytoplasm); safranin-
O/fast green (glycosaminoglycans); and Sudan black for residual polymer. A modified 
O’Driscoll scoring system (Table 6.3) was used for the analysis80, 173, 185. Histological scoring 
was performed by three independent co-authors and the average scores were calculated. The 
sections from all of the implants were stained for the presence of collagen types I & II via 
immunohistochemistry (IHC). IHC for one implant in the GRADIENT group was not performed, 
as an adequate number of sections could not be obtained. Mouse monoclonal primary antibodies 
(Thermofisher Scientific, Waltham, MA) against collagen type I (1:200 dilution) and collagen 
type II (1:250 dilution) were used for IHC. Following the primary antibody, biotinylated 
secondary antibody was used followed with the ABC complex (Vector Laboratories, Burlingame, 
CA). The antibodies were visualized with the diaminobenzidine (DAB) substrate per the 




GraphPad Prism 6 statistical software (GraphPad Software, Inc., La Jolla, CA) was used to 
compare experimental groups using an unpaired t-test, where p < 0.05 was considered significant. 





Following decellularization and cryo-grinding processes, the DNA content of the native cartilage 
was reduced by 44% (p < 0.05). The GAG and hydroxyproline contents were both reduced by 
23% (p < 0.05). 
 
POSTSURGICAL COURSE 
At 2 weeks, one rabbit (with the BLANK implant in the right knee and the GRADIENT implant 
in the left knee) was euthanized prematurely due to luxation at L6-L7 caused by sudden jumping 
in the cage. At 7 weeks, another rabbit (with the BLANK implant in the left knee and the 
GRADIENT implant in the right knee) was euthanized prematurely because of chronic lameness. 
The premature euthanasia of two rabbits brought the sample number down to n = 8 for gross 
morphological analysis, n = 4 for mechanical testing, and n = 4 for histology and IHC in both the 
BLANK and GRADIENT groups. All of the other animals continued to exhibit normal 
movement during the 12-week period. 
 
GROSS MORPHOLOGICAL ASSESSMENT 
Gross signs of inflammation (swelling or reddening of the joint) or infection were not observed 
in any of the rabbits upon visual inspection of the joint surface at the time of tissue retrieval. The 
synovial fluid had a normal color. Additionally, no signs of degeneration were noted on the 
opposing joint surfaces. Figure 6.4 represents the morphological scores and the amount of repair 
tissue present at the defect site in both the BLANK and the GRADIENT groups. Figure 6.5 
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shows the representative gross morphological images of the implants receiving highest, mean, 
and lowest morphological scores in both the BLANK and the GRADIENT groups.  
The average morphological score in the BLANK group was 6.0 ± 0.5 out of a maximum 
possible score of 10 with a highest score of 8.0 while the only BLANK implant that crumbled 
during implantation received a score of 3.3. All of the rabbits that received the BLANK implants 
had more than 80% of the defect area filled with repair tissue, except for two that had 63% and 
55% of the defect area filled with the repair tissue. All of the animals receiving the BLANK 
implants (except for one) had intermediate smoothness of the repair tissue, with half of them 
showing complete edge integration with the native tissue. Six of the implants in the BLANK 
group had slightly depressed repair tissue, with one implant having completely flush and one 
having significantly depressed surface degree of filling. 75% of the animals in the BLANK 
group had translucent regenerated tissue, while the remaining 25% had an opaque appearance of 
the repair tissue.  
The GRADIENT group average morphological score was 5.2 ± 0.8 out of 10, with the 
highest score being 8.7 in the group. The GRADIENT implants that crumbled during 
implantation received average scores of 3.3 and 1.3. The percentage of repair tissue present at the 
defect site in the GRADIENT group ranged from 7-100% with an average of 61 ± 11%. No 
statistically significant differences were observed in either the average morphological scores or 
the amount of repair tissue present at the defect site between the BLANK and the GRADIENT 
groups. Almost all of the animals in the GRADIENT group showed complete integration of the 
repair tissue with the native tissue, with two animals showing partial integration and one 
showing no integration at all. 63% of the rabbits receiving the GRADIENT implant had high or 
intermediate smoothness of the repair tissue, while the remaining 37% had a rough appearance of 
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the regenerated tissue. Half of the animals in the GRADIENT group had either completely flush 
or slightly depressed regenerated tissue whereas the other half had significantly depressed repair 
tissue. All the animals in the GRADIENT group had either translucent or opaque appearance of 
the repair tissue.  
 
MECHANICAL TESTING AND FINITE ELEMENT ANALYSIS 
The elastic modulus, fiber modulus, permeability and Poisson’s ration are represented 
graphically in Figure 6.6. The average elastic moduli, obtained from curve fitting the indentation 
stress relaxation data, for the PLGA and GRADIENT groups were 250 ± 160 and kPa and 150 ± 
94 kPa, respectively. The fiber moduli for the BLANK and the GRADIENT groups were found 
to be 79 ± 21 kPa and 110 ± 27 kPa, respectively. No statistically significant differences were 
observed in the elastic and fiber moduli between the BLANK and GRADIENT groups. The 
BLANK group had an average hydraulic permeability of 1.71 ± 0.54 x 10–6 mm4/mN.s and the 
GRADIENT group had a permeability of 1.74 ± 0.79 x 10–6 mm4/mN.s. The Poisson’s ratios for 
the BLANK and GRADIENT groups were 0.18 ± 0.075 and 0.050 ± 0.028, respectively. No 
statistically significant differences were observed in the hydraulic permeabilities and Poisson’s 
ratios between the BLANK and GRADIENT groups.  
 
HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
Both the BLANK and GRADIENT groups had an average histological score close to 10 (out of a 
maximum possible 28) with the BLANK group having a mean score of 7.6 ± 0.9 and the 
GRADIENT group having a mean score of 7.4 ± 0.6 (difference not statistically significant). 
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The histological and IHC images from all of the implants in the BLANK group are 
depicted in Figure 6.7. The first column shows the images of the implant that received the 
highest histological score (10.2). No depression was observed in the regenerated tissue. The 
repair tissue possessed high cellularity with robust proliferative activity. Most of the cells in the 
defect area resembled fibrous chondrocytes. A few regions near the edges of the defect site had 
chondrocytes with lacunae; however, no columnar arrangement was observed in these 
chondrocytes. The regenerated cartilage had a thickness greater than the surrounding cartilage 
with partial bonding to the native tissue observed at both the edges of the defect site. The repair 
tissue stained slightly for Safranin-O in the areas near the edges of the defect site toward 
subchondral bone. The defect area toward the subchondral bone consisted largely of flat cells 
surrounded by loose stromal tissue and numerous blood vessels. The appearance of premature 
trabecular bone presented some evidence of subchondral bone regeneration. No adverse 
inflammatory response was observed within the defect area, although a few macrophages were 
observed in the area. The IHC images showed that the loose connective tissue present in the 
defect area stained heavily for collagen I while some collagen II staining was also observed at 
the defect edges adjacent to subchondral bone. The implant receiving the second highest 
histological score of 7.3 in the BLANK group showed significantly depressed repair tissue at the 
defect site. The regenerated tissue largely resembled fibrous tissue with most of the cells having 
a flat appearance. A few cells at the surface of the defect site appeared to have chondroblast-like 
morphology. The regenerated tissue showed severe disruptions; however, no cysts were noted in 
the repair tissue. The defect site did not stain for Safranin-O while the surrounding native tissue 
showed slight Safranin-O staining. Toward the subchondral bone region, the defect area showed 
signs of osteoblastic activity with minimal bone regeneration. No adverse inflammatory response 
	 164	
was observed in the defect area. The repair tissue stained positively for collagen I, whereas 
collagen II staining was predominantly absent from the repair tissue. The third column illustrates 
the histological and IHC images from the implant that received a histological score of 6.7 in the 
BLANK group. Although the repair tissue filled the defect space almost completely, the 
regenerated tissue appeared crumbly. Severe disruptions were noticed in the regenerated tissue. 
Most of the cells in the defect area had a flat morphology that resembled fibroblasts. Some 
chondrocyte-like cells with a few cell clusters were observed in the areas near the edges of the 
defect. In addition, light Safranin-O staining was observed near the edges of the defect site. The 
adjacent native cartilage showed some signs of degenerative changes with moderate 
hypocellularity and slight staining. No subchondral bone regeneration was observed in the defect 
area, although some blood vessels were noticed in region. The repair tissue stained positively for 
collagen I and also stained slightly for collagen II. The histological images for the implant that 
received the lowest score of 6.0 in the BLANK group showed a large chunk of native 
osteochondral tissue present at the defect site, which might have been a result of tissue 
processing during sectioning and staining. The regenerated tissue in the implant was significantly 
depressed compared to the native tissue. The cartilage at the surface of the defect area resembled 
fibrocartilage while the deeper regions showed the presence of loose connective tissue. Both the 
repair and native tissues did not stain for Safranin-O. No subchondral bone regeneration was 
observed and the defect area presented signs of mild inflammatory response with the appearance 
of some macrophages and multi-nucleated giant cells. The repair tissue stained positively for 
collagen I, while it did not stain for collagen II. 
Figure 6.8 illustrates the histological and IHC images from all the implants in the 
GRADIENT group. The defect area in the implant that received the highest histological score of 
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8.7 in the GRADIENT area was almost completely full. The repair tissue was slightly depressed 
compared to the native tissue. The regenerated tissue at the surface had lacunated chondrocytes 
with some cell clusters; however, no columnar arrangement of cells was observed. The 
regenerated cartilage was thinner than the surrounding native cartilage and no bonding was 
observed between the regenerated and native tissues. The repair tissue stained slightly for 
Safranin-O at one edge of the defect. The adjacent cartilage showed minimal signs of 
degeneration with mild hypocellularity. Although, some small blood vessels were observed in 
the bone region of the defect, no subchondral bone regeneration was observed. Additionally, a 
void area was noticed in the subchondral bone region. Minimal signs of inflammation were 
observed in the defect region as noticed by with the appearance of a few macrophages. The 
repair tissue stained positively for collagen I while only moderate collagen II staining was 
observed in the defect area. The implant receiving the second highest score, 8.0, in the 
GRADIENT group also showed depressed tissue relative to the native tissue. Most of the 
regenerated cartilage resembled fibrocartilage with the cells showing a significant amount of 
proliferative activity. Some cells at the edges had chondrocyte-like morphology and were 
arranged in isogenic groups. The regenerated cartilage had lower thickness compared to the 
native tissue and stained slightly for Safranin-O near the defect edges. In the subchondral region, 
small trabeculae were observed that suggested toward bone remodeling. No adverse 
inflammatory response was observed in the defect area. The IHC images showed that the 
regenerated tissue stained positively for collagen I, whereas no collagen II staining was observed 
in the defect area. The implant receiving a score of 6.7 in the GRADIENT group also possessed 
repair tissue that was significantly depressed compared to the native tissue. The repair tissue in 
the cartilage part of the defect area resembled fibrocartilage with the cells demonstrating good 
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proliferative activity. The regenerated cartilage was partially bonded with the native tissue on 
one side of the defect. The adjacent native cartilage showed some signs of degenerative changes 
as indicated by moderate hypocellularity in the surrounding native cartilage. The defect area 
showed no to minimal signs of subchondral bone reconstruction with mild inflammatory 
response as observed by the presence of a few giant multinucleated cells. The tissue in the defect 
area stained positively for collagen I. Slight collagen II staining was also observed in the areas 
adjacent to the defect edges. The lowest scoring implant in the GRADIENT group received a 
histological score of 6.0. The histological images showed that the repair tissue was significantly 
depressed compared to the native tissue, with the repair tissue predominantly resembling loose 
connective tissue. The subchondral bone region consisted of vascular connective tissue. 
Safranin-O staining was absent from the defect as well as the native tissue area. Due to 
inadequate number of sections obtained from the implant, IHC images are not reported for the 
implant.  
Figure 6.9 shows the Sudan Black staining images for the implants that received the 
highest and lowest histological scores in both the BLANK and GRADIENT groups. Only a few 
areas of intense staining (depicted by red arrows) were observed in all of the implants with most 
of the defect site showing none to mild staining. 
 
DISCUSSION 
The present study for the first time evaluated the in vivo response of microencapsulating 
demineralized bone matrix (DBM) and cartilage matrix in polymeric microsphere-based 
scaffolds toward osteochondral repair. Moreover, to the best of our knowledge, we are the first 
group to encapsulate DBM in microsphere-based scaffolds for the bone region of the scaffold. 
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The other groups employing microsphere-based scaffolds have banked on other calcium 
phosphates and minerals for engineering the bone tissue46, 161, 228, 255. 
From the gross morphological evaluation, it was observed that in 50% of the total 
implants (both of the groups combined) about one-fourth of the defect area was empty. 
Additionally, 5 out of the total 16 implants had either slightly or significantly depressed repair 
tissue. No statistically significant differences were observed in the BLANK and GRADIENT 
groups in the amount of defect area fill; however, the average fill area in the GRADIENT group 
was lower than the average fill area in the BLANK group. Moreover, 50% of the implants in the 
GRADIENT group had significantly depressed regenerated tissue whereas the corresponding 
number in the BLANK group was 13%. The presence of empty area and the observance of 
depressed tissue might have resulted from the rapid degradation of polymer, with even faster 
degradation occurring in the GRADIENT group. Our prior work involving gradient microsphere-
based scaffolds for osteochondral regeneration with a comparable polymer (i.v. 0.34-0.36 dL/g) 
as we have used in the current study, showed a defect fill of more than 95% in all of the implants 
at 12 weeks169. The amount of repair tissue present in defect site in the current study was about 
80% and 60% for the BLANK and GRADIENT groups, respectively. Lower amounts of repair 
tissue in the current study most likely resulted from the rapid scaffold degradation, which is a 
direct consequence of polymer degradation. It is believed that DBM and DCC encapsulation 
might have affected microsphere morphology, which might have resulted in faster degradation of 
the polymer; however, no analysis was done to assess polymer degradation, which can be a 
subject matter for subsequent studies. We have previously observed that encapsulation of raw 
materials such as chondroitin sulfate and DCC result in minute pores on the surface of PLGA 
microspheres that can accelerate polymer degradation2, 89, 172, 227. Increasing concentrations of 
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raw materials on one hand might accelerate but on the other might provide momentum to tissue 
regeneration for impeding the deleterious effects caused by rapid polymer degradation. 
Furthermore, it was observed that some of the implants crumbled during implantation that might 
have further accelerated scaffold degradation. The implants that crumbled in both of the groups 
received the lowest morphological scores, further suggesting that implant crumbling might have 
also affected scaffold degradation. The implant crumbling might have resulted due to slight 
mismatch between scaffold and defect diameters. The scaffold diameter was intentionally kept 
slightly larger than the defect diameter to allow for press-fitting of the implant169. In addition, 
variations in force applied due to the manual press-fitting approach might have caused some 
implants to crumble, which can be avoided by using an automated approach (maybe a delivery 
device) for implanting the scaffold. The average morphological scores in the BLANK and 
GRADIENT groups were similar to each other, although there were some differences observed 
in the macroscopic properties of the repair tissue between the two groups. The repair tissue in the 
GRADIENT group had better edge integration with the peripheral native tissue than the edge 
integration observed in the BLANK group. On the other hand, the repair tissue smoothness in the 
BLANK group surpassed the smoothness of the repair tissue in the GRADIENT group. 
The elastic moduli, fiber moduli, permeability, and Poison’s ratio values of the repair 
tissue in the BLANK and GRADIENT groups fell within the previously reported values of these 
parameters9, 35. No statistically significant differences were observed in any of the four model 
parameters for mechanical testing between the BLANK and GRADIENT groups. It was reported 
that the Poisson’s ratio of cartilage can be as low as 0.02 in unconfined compression, but never 
more than 0.58, 240. The Poisson’s ratio values appeared to be lower in the GRADIENT group 
than those observed in the BLANK group, indicating higher apparent compressibility of the 
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tissue and a propensity for more fluid transport in the GRADIENT group9. However, no 
statistically significant differences were observed in the Poisson’s ratios between the BLANK 
and GRADIENT groups to support that claim.  
The histological findings revealed that there were no significant differences in the 
average histological scores between the BLANK and GRADIENT groups. It should be noted that 
the histological and IHC images depict a general trend of regeneration within each group; 
however, the trend was not uniform in all of the sections, as these are representative sections 
taken from the entire defect area of the regenerated tissue. The cellular morphology observed in 
the repair tissues in both of the groups resembled those of fibroblasts with the cells 
demonstrating significant proliferative activity. The defect site in both of the groups was largely 
filled with a vascularized loose connective tissue; however, some implants showed a presence of 
a fibrocartilage layer on the top. Although the thickness of the regenerated cartilage was less than 
the thickness of the adjacent native cartilage, it was observed that the regenerated tissue was 
partially bonded with the native tissue at both sides of the defect. Some collagen II staining was 
also observed in both of the groups especially around the edges of the defect area; however, the 
regenerated tissue predominantly stained for collagen I, indicating that the regenerated cartilage 
was fibrous in nature. Additionally, both of the groups showed a mild inflammatory response in 
the subchondral bone region. The inflammatory response may have been a manifestation of 
tissue remodeling response that can have profound implications in clinical success of 
microsphere-based scaffolds154. The presence of premature bone trabeculae in some of the 
implants in both the groups also hint toward the regeneration or remodeling response in the 
defect site. However, both the BLANK and GRADIENT groups showed void areas in the 
subchondral bone region, which indicate toward rapid polymer degradation that further may have 
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led to depressed repair tissue overall in both the groups. Sudan black staining images revealed 
that the defect sites in both the groups were predominantly absent of residual polymer except for 
a few small dark-staining spots that indicated minimal leftover polymer or polymer degradation 
products. The absence of residual polymer in both the BLANK and GRADIENT groups further 
hint toward rapid polymer degradation in microsphere-based scaffolds that most likely adversely 
affected the regeneration of the tissue in the defect site.  
Overall, the results of the current study demonstrated that structural integrity of 
microsphere-based scaffolds is an important parameter than can have significant impact on the 
tissue regeneration. The degradation of the polymer in the scaffolds will play a key role in tissue 
regeneration in vivo, where extended degradation could become an obstacle to tissue 
regeneration and in contrast rapid degradation could have a deleterious effect on the regenerating 
tissue, supposedly the cause of below par regeneration observed in the current study. Thus, we 
acknowledge that there should be a more detailed look at polymer degradation as a function of 
encapsulated raw materials for subsequent in vitro and in vivo studies to identify formulations 
that more closely approximates the tissue regeneration rate in animals and humans. Additionally, 
emphasis is laid on the need to better match scaffold dimensions with defect dimensions or 
perhaps employ a scaffold delivery device that can further minimize surgeon-to-surgeon 
variations during scaffold implantation. Nevertheless, the current study hints that employing 
gradients of DBM and DCC might be beneficial for osteochondral regeneration as indicated by 
better integration of the regenerated tissue with the peripheral native tissue, thus providing a 
motivation for further refining the technology by altering the concentrations of DBM and DCC, 
and attuning polymer degradation to these concentrations.  
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CHAPTER 7: CONCLUSION 
Predecessors to this work developed microsphere-based scaffolds containing opposing 
gradients of proteins and established the feasibility of the concept for driving in vitro chondro- 
and osteogenesis, and stimulating in vivo osteochondral regeneration in rabbit osteochondral 
defects58, 63, 65, 215. Moreover, it was illustrated that a gradient in both material composition and 
encapsulated proteins can enhance secretion of tissue specific matrix proteins169, 172. Within this 
thesis, microsphere-based scaffolds encapsulating only ECM materials were developed, with the 
goal of providing the surrounding cells with raw materials (bioactive signals and building 
blocks) to facilitate their differentiation along bone and cartilage lineages. The studies within this 
thesis progressed to demonstrating the in vitro efficacy of raw material encapsulation in 
clinically relevant scaffold system, to refining composition of raw materials in homogenous 
microsphere-based scaffolds for enhancing in vitro osteogenesis and chondrogenesis, and then 
finally to evaluating the in vivo response of raw material encapsulation in gradient microsphere-
based scaffolds.  
 In vitro assessment of clinically relevant microsphere-based scaffolds fabricated using 
the raw material approach depicted that the encapsulated raw materials, CS and TCP, altered the 
microstructure of the microspheres and also influenced cellular morphologies. The mechanical 
properties of the raw material encapsulating microsphere-based scaffolds initially relied on the 
composition of the scaffolds and later on were governed by polymer degradation and newly 
synthesized ECM by the seeded cells. Additionally, raw materials had a mitogenic effect on the 
seeded rBMSCs and led to increased glycosaminoglycan (GAG), collagen, and calcium content. 
However, it was noted that the initial effects of raw material encapsulation on a per-cell basis 
might have been overshadowed by medium-regulated environment that appeared to favor 
	 172	
osteogenesis. Most importantly, the results of the study demonstrated the potential of the raw 
materials in facilitating neo-tissue synthesis in microsphere-based scaffolds and also presented 
evidence for faster maturation of rBMSCs in gradient scaffolds.  
Incorporation of TCP and HAp mixtures for enhancing osteogenesis affected the 
morphological and mechanical properties of the microsphere-based scaffolds. The microspheres 
encapsulating TCP and HAp exhibited a porous surface and possessed a deflated soccer ball-like 
shape, which further elevated the overall porosities and lowered the compressive moduli of 
scaffolds. The explicit reasons for lower compressive moduli in TCP and HAp encapsulating 
groups are currently unclear, but may relate to poor polymer healing at microsphere sintering 
junctions caused by irregularities in microsphere shape. Using a polymer with high molecular 
weight might prevent the drop in compressive moduli caused by TCP and HAp encapsulation, as 
suggested by the results of the previous study where TCP encapsulation in high molecular weight 
PLGA led to higher compressive modulus compared to PLGA-only scaffolds. Interestingly, it 
was observed that the TCP and HAp encapsulation fast-tracked the osteogenic commitment of 
cells on these scaffolds as indicated by the higher end point ECM synthesis and enhanced 
expression of osteogenic genes compared to the control formulations. Thus, future investigations 
should focus on leveraging these TCP and HAp mixtures for in vivo osteochondral regeneration 
by incorporating them into gradient scaffolds fabricated with a polymer having a degradation 
rate that closely approximates the tissue regeneration rate. 
CS and DCC encapsulation revealed that incorporation of these materials affect the 
morphological characteristics of microsphere-based scaffolds without compromising their 
mechanical integrity. The DNA content results suggested that CS and DCC encapsulation 
encouraged initial cell attachment and proliferation on these scaffolds with some biochemical 
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evidence indicating toward modulatory effect of CS and DCC on matrix synthesis by the seeded 
cells. Expression of chondrogenic genes was suppressed in the CS and DCC group at initial time 
points indicating that the cells sensed their surrounding environment, which was high in GAGs 
and collagens. To achieve the desired chondrogenic differentiation profile, subsequent studies 
should consider altering the dose of CS and DCC in microsphere-based scaffolds that could then 
be employed in vivo in a continuously graded design for osteochondral regeneration. 
The results of the in vivo study stressed the need to utilize a polymer with a 
biodegradation rate comparable to the neo-tissue formation rate. 50% of the implants had an 
average defect fill that was less than 75%, indicating that the PLGA used in the study might have 
degraded too quickly, limiting the amount of tissue regeneration in the defect area. Moreover, 
implant crumbling during implantation might have contributed to the degradation of the scaffold, 
thus suggesting the importance of better matching scaffold and defect dimensions. However, 
some benefits of the ‘raw material’ approach were noted in the microsphere-based scaffolds 
comprised of opposing gradients of DBM and DCC. The regenerated tissue in the gradient 
scaffolds integrated better with the peripheral native tissue than the repair tissue in the PLGA-
only control group. The regenerated tissue in both of the groups showed an inflammatory 
response that might suggest an immune response or of a remodeling response, which requires 
further investigation. Future studies should concentrate on investigating polymer degradation 
rate and its effect on tissue regeneration. Moreover, adjusting DBM and DCC concentrations or 
perhaps using allogeneic raw materials could achieve effective osteochondral repair. 
The evidence presented with this thesis readily demonstrates that using a raw material 
encapsulating microsphere-based scaffold approach for facilitating osteochondral regeneration is 
feasible and in many instances efficacious. In addition, emphasis is being laid on examining the 
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interplay between scaffold degradation and neo-tissue formation, where premature failure in 
scaffold mechanical properties can have a deleterious effect on the regenerating tissue and 
extended degradation in contrast could become an obstacle to tissue regeneration. Fine-tuning 
the dose of raw materials could further supplement the regenerative capacity of these raw 
material encapsulating microsphere-based scaffolds. Although higher concentrations (than the 
previous iterations) of raw materials were evaluated in this thesis, increasing concentrations of 
the raw materials with ultimately fabricating raw material-only microsphere-based scaffolds 
would bridge the gap between the ‘scaffolds’ and ‘signals’ side of the traditional tissue 
engineering triad (i.e., cells, signals, and scaffolds). As highlighted in Chapter 2, the use of 
microsphere-based scaffolds has been predominantly focused in musculoskeletal tissue 
regeneration; however, the future of microsphere-based scaffolds combined with raw material 
approach may lie in regenerating other complex types of tissue. Eventually, the idea of 
employing raw material encapsulating microsphere-based scaffolds for tissue regeneration has 
been taken from concept to design, produced encouraging results for osteochondral regeneration, 
and has opened up new avenues of research to consider and challenges to overcome. 
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Figure 2.1: Number of publications based on ‘Microsphere Scaffolds’ in tissue engineering 
and regenerative medicine 
 
Number of published articles on microsphere scaffolds in the field of tissue engineering and 
regenerative medicine since the first reported use of such scaffolds in 2002. Data represent 
search results in Web of Science database. * Results up to July 2014. 
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Figure 2.2: Microsphere fabrication methods 
 
Numerous methods are available for fabricating microspheres; however, emulsion-based 
methods are most widely used for microsphere fabrication in the tissue engineering field.
	 201	
 
Figure 2.3: Single emulsion solvent evaporation (SESE) method for microsphere 
fabrication 
 
In the SESE method, the microsphere matrix (containing either dissolved or dispersed bioactive 
molecule) is emulsified into the aqueous phase followed by microsphere hardening through 
solvent evaporation and polymer precipitation. 
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Figure 2.4: Double emulsion solvent evaporation (DESE) method for microsphere 
fabrication 
 
In DESE method, an aqueous solution of the bioactive compound is first dispersed in the matrix 
solution forming primary emulsion, which is then further emulsified to form secondary emulsion 




Figure 2.5: Emulsion gas foaming method for microsphere fabrication 
 
In the emulsion gas foaming method, an effervescent salt is dissolved in the organic phase that 
acts as a gas foaming agent, generating gas bubbles when the primary emulsion contacts the 




Figure 2.6: Emulsion microgel microsphere fabrication method 
 
Emulsion microgel fabrication involves production of micron or sub-micron sized gel spheres 
(microgels) using hydrophilic materials via ionic crosslinking, chemical crosslinking and co-




Figure 2.7: Cryopreparation method for microsphere fabrication 
 
Cryopreparation involves lowering the temperature of the DNA-containing primary emulsion 
below the freezing point of the aqueous inner phase resulting in a solid particulate suspension 





Figure 2.8: Thermally induced phase separation (TIPS) for microsphere fabrication 
 
In thermally induced phase separation method, a solvent with a low boiling point that easily 
sublimes is used. Solvent dissolved matrix material (usually a polymer) droplets are either 
preformed via an emulsion or directly dropped (via a syringe or sprayed through a nozzle) into 




Figure 2.9: ProLease process for microsphere fabrication 
 
In the ProLease process, the polymer/active agent mixture is atomized into a vessel containing a 
liquid non-solvent, alone or frozen and overlaid with a liquefied gas, at a temperature below the 
freezing point of the polymer/active agent solution. The atomized droplets freeze into 
microspheres upon contacting the cold liquefied gas, then sink onto the frozen non-solvent layer. 
The frozen non-solvent is then thawed. As the non-solvent thaws, the microspheres that are still 
frozen sink into the liquid non-solvent. The solvent in the microspheres then thaws and is slowly 




Figure 2.10: Precision particle fabrication (PPF) method for microsphere fabrication 
 
In PPF, a solution containing the microsphere matrixis passed through a small nozzle to form a 
smooth cylindrical jet. A piezoelectric transducer driven by a wave generator at a frequency 
tuned to match the flow rate and the desired drop size vibrates the nozzle. The mechanical 
excitation launches a wave of acoustic energy along the liquid jet generating periodic instabilities 
that, in turn, breaks the liquid jet into a train of uniform droplets. An annular flow of a non-
solvent phase around the matrix jet is employed that is pumped at a linear velocity greater than 
that of the matrix stream. The frictional contact between the two streams generates an additional 
downward force that effectively pulls the microsphere solution away from the orifice of the 
nozzle. The microsphere matrix stream is accelerated by this force and, therefore, thinned to a 




Figure 2.11: Schematic for flame spheroidization apparatus142 
 
In flame spheroidization, the particles pass into the flame and travel along the flame axis. The 
particles undergo spheroidization due to surface tension forces and are then collected in the glass 








Figure 3.1: Scanning electron micrographs of acellular microsphere-based scaffolds 
 
(A) PLGA, (B & D) CS, (C & E) TCP, and (F) GRADIENT at the CS (white arrow)-TCP (blue 
arrow) transition region. The images reveal the distinct morphological features of the 
microspheres in different scaffold groups. Note the porous nature of CS microspheres and rough 





Figure 3.2: Cellular morphology of rBMSCs seeded on microsphere-based scaffolds 
 
 (A) PLGA, (B) CS, (C) TCP, and (D) GRADIENT groups. Note the differences in cellular 
morphology in different scaffold groups at day 10 (week 1.5). Flat cells were observed in the CS 
group whereas cluster forming cells were observed in the TCP group. The GRADIENT group 




Figure 3.3: Compressive elastic modulus 
 
(A) Acellular constructs at week 0. (B) Cellular constructs at week 6. Both the acellular and cell 
seeded TCP scaffolds had significantly higher modulus. All values are expressed as the average 
+ standard deviation (n = 3-5). The TCP group (both acellular and cellular) had significantly 
higher modulus than the other groups. *significant change over the other three 
groups, %significant change over the CS group (p < 0.05). PLGA constructs at week 6 are not 




Figure 3.4: Total DNA content as measured in the microsphere-based scaffolds 
 
The CS, TCP and GRADIENT groups had significantly higher DNA content than the PLGA 
group at week 6. All values are expressed as the average + standard deviation (n = 3-5). The CS 
group at week 6 had significantly higher cell numbers compared to the other groups. 
@significant change over week 0 value, #significant change over its value at previous time point, 
*significant change over the PLGA group at same time point and $significant change over the 




Figure 3.5: GAG content as measured in the microsphere-based scaffolds 
 
(A) Total GAG content in micrograms per construct. (B) Normalized GAG content in 
micrograms per micrograms DNA. The CS group had significantly higher net GAG content than 
the other three groups at week 6. All values are expressed as the average + standard deviation (n 
= 3-5). The CS group at week 6 surpassed the other three groups in net GAG content. 
@significant change over week 0 value, #significant change over its value at previous time point, 
*significant change over the PLGA group at same time point, $significant change over the TCP 
and GRADIENT groups at same time point, and &significant change over the TCP group at 




Figure 3.6: HYP content as measured in the microsphere-based scaffolds 
 
(A) Total HYP content in micrograms per construct. (B) Normalized HYP content in micrograms 
per micrograms DNA. The CS and GRADIENT groups had significantly higher net HYP content 
than the PLGA group at weeks 3 and 6. All values are expressed as the average + standard 
deviation (n = 3-5). The CS and GRADIENT groups at week 6 had significantly higher net HYP 
content than the other two groups. @significant change over week 0 value, #significant change 
over its value at previous time point, *significant change over the PLGA group at same time 
point, &significant change over the TCP group at same time point, and %significant change over 




Figure 3.7: Calcium content as measured in the microsphere-based scaffolds 
 
(A) Total calcium content in micrograms per construct. (B) Normalized calcium content in 
micrograms per micrograms DNA. The PLGA group had significantly higher normalized 
calcium content than the other three groups at weeks 3 and 6. All values are expressed as the 
average + standard deviation (n = 3-5). The CS and GRAIDENT groups at week 6 had 
significantly higher net calcium content than the other two groups. @significant change over 
week 0 value, #significant change over its value at previous time point, *significant change over 
the PLGA group at same time point, $significant change over the TCP and GRADIENT groups 
at same time point, &significant change over the TCP group at same time point, ^significant 
change over the GRADIENT group at same time point, and %significant change over the CS 




Figure 3.8: ALP activity in micromolar pNP released per micrograms DNA per minute 
 
The TCP and GRADIENT groups had significantly higher ALP activities than the PLGA group 
at week 0. All values are expressed as the average + standard deviation (n = 3-5). The TCP and 
GRADIENT groups at week 0 had significantly higher ALP activities than the activities in the 
other two groups. @significant change over week 0 value, *significant change over the PLGA 






Figure 3.9. Relative gene expression 
 
All values are expressed as the average + standard deviation (n = 3-5). The GRADIENT group 
had significantly higher expression of ACAN and SPP1 than the PLGA group at week 1.5. (A) 
SOX9 expression, (B) COL2A1 expression, (C) ACAN expression, (D) COL1A1 expression, (E) 
RUNX2 expression, (F) BGLAP expression, (G) SPP1 expression, and (H) IBSP expression. The 
GRADIENT group at week 1.5 outperformed the other three groups in ACAN and COL1A1 
expression. @significant change over week 0 value, #significant change over its value at 
previous time point, *significant change over the PLGA group at same time point, $significant 
change over the TCP and GRADIENT groups at same time point, ?significant change over week 
1.5 value, %significant change over the CS group at same time point, &significant change over 
the TCP group at same time point, and ^significant change over the GRADIENT group at same 




Figure 3.10: Microsphere size distribution graph 
 





Figure 4.1: Size distribution graph for all four types of microspheres used in the study 
 
All of the microspheres were uniform in size with average microsphere diameter ranging 




Figure 4.2: Scanning electron micrographs of microspheres 
 
BLANK (PLGA-only), BMP (PLGA with BMP-2 encapsulated), TH73 (PLGA with 30 wt% 
TCP/HAp 7:3), and TH11 (PLGA with 30 wt% TCP/HAp 1:1) microspheres. The images reveal 
the distinct morphological features of the microspheres used in different scaffold groups; note 
the porous nature of the surface of the BMP microspheres, and the deviation from the perfect 




Figure 4.3: Scanning electron micrographs (left column) and energy dispersive spectral 
maps of cryo-fractured microspheres for atomic calcium (Ca), nitrogen (N), and 
phosphorous (P) 
 
BLANK (PLGA-only), BMP (PLGA with BMP-2 encapsulated), and TH11 (PLGA with 30 wt% 
TCP/HAp 1:1). Note the uniform distribution of nitrogen in BMP microspheres and of calcium 




Figure 4.4: Scanning electron micrographs of acellular microsphere-based scaffolds 
 
BLANK (PLGA-only), BMP (PLGA with BMP-2 encapsulated), TH73 (PLGA with 30 wt% 
TCP/HAp 7:3), and TH11 (PLGA with 30 wt% TCP/HAp 1:1) scaffolds. All of the scaffolds 




Figure 4.5: Average compressive moduli of elasticity of acellular microsphere-based 
scaffolds at week 0 
 
All values are expressed as the average + standard deviation (n = 6). The TCP/HAp groups had 
significantly lower moduli than the BLANK and BMP controls. *significant difference from the 
BLANK negative control group, @significant difference from the BMP positive control group, 




Figure 4.6. Average porosities of different scaffold groups 
 
All values are expressed as the average + standard deviation (n = 6). The TCP/HAp groups had 
significantly higher porosities than the BLANK and BMP controls. *significant difference from 
the BLANK negative control group, @significant difference from the BMP positive control 




Figure 4.7: Total DNA content as measured in the microsphere-based scaffolds 
 
All values are expressed as the average + standard deviation (n = 6). The TCP/HAp groups had 
significantly lower DNA content than the BLANK and BMP controls at week 0, while no 
significant differences were observed among the groups at later time points. *significant 
difference from the BLANK negative control group at same time point, @significant difference 
from the BMP positive control group at same time point, and #significant change from its value 





Figure 4.8: HYP content as measured in the microsphere-based scaffolds  
 
(A) Total HYP content in micrograms per construct. (B) Normalized HYP content in micrograms 
per microgram of DNA. All values are expressed as the average + standard deviation (n = 6). 
The TCP/HAp groups had significantly higher normalized HYP content than the BLANK and 
BMP controls at week 6. *significant difference from the BLANK negative control group at 
same time point, @significant difference from the BMP positive control group at same time 
point, &significant difference from the TCP/HAp 1:1 group at same time point, #significant 





Figure 4.9: ALP activity in ‘Glycine Units’ per micrograms DNA  
 
Glycine Unit refers to the amount of enzyme causing the hydrolysis of one micromole of pNPP 
per minute at pH 9.6 and 25°C (glycine buffer). All values are expressed as the average + 
standard deviation (n = 6). The TCP/HAp groups outperformed the BLANK and BMP controls 
in ALP activity at week 6. *significant difference from the BLANK negative control group at 
same time point, @significant difference from the BMP positive control group at same time 
point, &significant difference from the TCP/HAp 1:1 group at same time point, #significant 





Figure 4.10: Total calcium content as measured in the microsphere-based scaffolds 
 
The calcium contents of the TCP/HAp 7:3 and TCP/HAp 1:1 constructs (both cellular and 
acellular) at week 0 are not reported because of inadequate extraction of calcium from these 
scaffolds. All values are expressed as the average + standard deviation (n = 6). The TCP/HAp 
7:3 group had significantly higher calcium than the TCP/HAp 7:3 [Acellular] group at week 6. 
@significant difference from the BMP positive control group at same time point, $significant 
difference from the TCP/HAp 7:3 group at same time point, #significant change from its value at 





Figure 4.11: Relative gene expression 
 
All values are expressed as the average + standard deviation (n = 6). The gene expression of the 
TCP/HAp groups was lower compared to that of the BLANK and BMP controls initially; 
however, it was higher at later time points. *significant difference from the BLANK negative 
control group at same time point, @significant difference from the BMP positive control group 
at same time point, $significant difference from the TCP/HAp 7:3 group at same time point, & 
significant difference from the TCP/HAp 1:1 group at same time point, # significant change from 
its value at week 0, ^ significant change from its value at week 1.5, and % significant change 




Figure 4.12. Histological staining of cell-seeded microsphere-based constructs at week 6 
 
BLANK, BMP, TH73 (TCP/HAp 7:3), and TH11 (TCP/HAp 1:1) scaffolds were stained for 
H&E (A-D), Masson’s trichrome (E-H), Alizarin red (I-L), von Kossa (M-P), and Sudan black 
(Q-T). The TCP/HAp groups showed deposits of collagen (indicated by arrows), while no such 




Figure 4.13: Alizarin Red and von Kossa staining images for acellular TCP/HAp 7:3 
scaffolds and TCP/HAp 1:1 scaffolds at week 6 
 
High staining intensities in the TCP/HAp groups indicate toward high mineral content remaining 




Figure 4.14 Image of acellular scaffolds in culture (week 4) depicting macroscopic changes 
in scaffold size and color changes in culture medium among different groups 
 
The culture medium in the acellular BLANK and BMP scaffolds became acidic more rapidly 




Figure 4.15: Immunohistochemical staining of microsphere-based constructs at week 6  
 
BLANK, BMP, TH73 (TCP/HAp 7:3), and TH11 (TCP/HAp 1:1) scaffolds were stained for 
Collagen I (A-D). Images of negative controls (primary antibody omitted) are also shown (E-H). 
Collagen I staining was more intense in the BMP and TCP/HAp 1:1 groups than the staining in 





Figure 5.1: Scanning electron micrographs (left column) and energy dispersive spectral 
maps (center and right columns) of cryo-fractured BLANK microspheres for atomic 
nitrogen (N) and sulfur (S) 
 
Both nitrogen and sulfur were essentially absent from the interior of the BLANK microspheres. 




Figure 5.2: Scanning electron micrographs of microspheres (left column) and scaffolds 
(right column)  
 
BLANK (PLGA-only), TGF (PLGA with TGF-β3 encapsulated), DCC (PLGA with 30 wt% 
DCC), and CS (PLGA with 30 wt% CS) microspheres and scaffolds. The images reveal the 
distinct morphological features of the microspheres and scaffolds; note the porous nature of the 
surface of the TGF microspheres, rough surface of DCC microspheres, and relatively greater 




Figure 5.3: Scanning electron micrographs (left column) and energy dispersive spectral 
maps (center and right columns) of cryo-fractured microspheres for atomic nitrogen (N) 
and sulfur (S)  
 
TGF (PLGA with TGF-β3 encapsulated), DCC (PLGA with 30 wt% DCC), and CS (PLGA with 
30 wt% CS) microspheres. Note the uniform distribution of nitrogen and sulfur in the TGF, DCC 




Figure 5.4: Average compressive moduli of elasticity of acellular microsphere-based 
scaffolds at week 0  
 
All values are expressed as the average + standard deviation (n = 6). The CS group had a 
significantly higher modulus than the TGF and DCC groups. @significant difference from the 





Figure 5.5: Average porosities of different scaffold groups 
 
All values are expressed as the average + standard deviation (n = 6). Both the DCC and CS 
groups had higher porosities than the BLANK and TGF groups *significant difference from the 
BLANK group, @significant difference from the TGF group, and $significant difference from 




Figure 5.6: Total DNA content in different scaffold groups  
 
All values are expressed as the average + standard deviation (n = 6). The CS group had the 
highest DNA content at all time points by at least a factor of 2. *significant difference from the 
BLANK group at same time point, @significant difference from the TGF group at same time 
point, $significant difference from the DCC group at same time point, and #significant difference 





Figure 5.7: Total GAG content (A) and HYP content (B) in different scaffold groups 
 
All values are expressed as the average + standard deviation (n = 6). The DCC and CS groups 
had significantly higher GAG content than their acellular counterparts at week 6. The DCC 
group at week 0 also had significantly higher HYP content than the DCC [Acellular] group. 
*significant difference from the BLANK group at same time point, @significant difference from 
the TGF group at same time point, $significant difference from the DCC group at same time 
point, +significant difference from the DCC [Acellular] group at same time point, ?significant 
difference from the CS [Acellular] group at same time point, #significant difference from its 




Figure 5.8: Relative gene expression. (A) SOX9 expression, (B) COL2A1 expression, (C) 
ACAN expression, (D) COL1A1 expression, (E) RUNX2 expression, (F) COL10A1 
expression, and (G) IBSP expression 
  
All values are expressed as the average + standard deviation (n = 6). The TGF positive control 
group had higher expression whereas the DCC group had lower expression of chondrogenic 
signals at week 0. *significant difference from the BLANK group at same time point, 
@significant difference from the TGF group at same time point, &significant difference from the 
CS group at same time point, #significant difference from its value at week 0, and ^significant 




Figure 5.9: Histological staining images of cell-seeded microsphere-based constructs at 
week 6 
 
BLANK, TGF, and DCC scaffolds were stained for H&E, Safranin-O, Masson’s trichrome, and 
Sudan Black. No images could be obtained from the CS group as the sections washed off the 
slides during the staining process. The Sudan Black staining intensities for residual polymer were 




Figure 5.10: Immunohistochemical staining images of microsphere-based constructs at 
week 6 
 
BLANK, TGF, and DCC were stained for collagen I, collagen II, and aggrecan. No images could 
be obtained from the CS group as the sections washed off from the slides during the staining 
process. The BLANK and the TGF group stained more intensely for aggrecan than the DCC 






Figure 5.11: Size distribution graph for all four types of microspheres used in the study  
 
All of the microspheres were uniform in size with average microsphere diameter ranging 




Figure 5.12: Safranin-O (A) and Masson’s trichrome (B) staining images for acellular DCC 
scaffolds at week 6  
 




Figure 6.1: A schematic representation of microsphere fabrication process  
 
Demineralized bone matrix (DBM) or decellularized cartilage (DCC) encapsulating poly(D,L-





Figure 6.2: A schematic of scaffold fabrication process 
 
Demineralized bone matrix (DBM) or decellularized cartilage (DCC) encapsulating poly(D,L-
lactic-co-glycolic acid) (PLGA) microspheres were assembled to form continuously graded 




Figure 6.3: Implant placed in a defect in the medial femoral condyle (photo shows right 
knee)  
 




Figure 6.4: Gross morphological scores of retrieved joints 12 weeks post-implantation  
 
(A) The average morphological score in the BLANK and GRADIENT groups, (B) the average 
percentage of repair tissue present at the defect site in the BLANK and GRADIENT groups, (C) 
the scatter plot showing total morphological score distribution in the BLANK and GRADIENT 
groups, and (D) the scatter plot showing amount of repair tissue present in the defect site in the 
PLGA and GRADIENT groups. All values are expressed as the average + standard deviation (n 
= 8). The maximum possible score was 10. No significant differences in gross morphological 
scores and amount of repair tissue present were observed between the two groups. The average 
morphological score in the BLANK group was 6.0 ± 0.5 with a highest score of 8.0, while the 





Figure 6.5: Representative images for gross morphology of the BLANK and GRADIENT 
groups at 12 weeks post-implantation  
 
The top row represents images from the implants that received the highest morphological score 
(BLANK – 8, GRADIENT – 8.7). The middle row represents images from the implants that 
received the mean morphological score (BLANK – 6, GRADIENT – 5.2). The bottom row 
represents images from the implants that received the lowest morphological score (BLANK – 3.3, 
GRADIENT – 1.3). The BLANK group performed better in percent defect fill while the 




Figure 6.6: Mechanical testing results of repair tissue in the retrieved joints from the 
BLANK and GRADIENT groups at 12 weeks post-implantation  
 
(A) Elastic modulus, (B) Fiber modulus, (C) Permeability, and (D) Poisson’s ratio. All values are 
expressed as the average + standard deviation (n = 4). No significant differences in any of the 
four model parameter values were observed between the two groups. The Poisson’s ratio for the 




Figure 6.7: Histological and immunohistochemical (IHC) staining images for the BLANK 
implant along with their histological scores on top  
 
First column represents images from the implant that received the highest histological score 
(10.2); second column represents images from the implant that received the second highest 
histological score (7.3); third column represents images from the implant that received the third 
highest histological score (6.7); and fourth column represents images from the implant that 
received the lowest score (6.0) in the BLANK group. The sections were stained for hematoxylin 
and eosin; safranin-O; collagen I; and collagen II. Negative controls for IHC were also run with 
the primary antibody omitted. The boxes in the top row outline the defect area. The regenerated 
tissue in the BLANK group was predominantly fibrous in nature with some evidence of cartilage 





Figure 6.8: Histological and immunohistochemical (IHC) staining images for the 
GRADIENT implants along with their histological scores on top  
 
First column represents images from the implant that received the highest histological score 
(8.7); second column represents images from the implant that received the second highest 
histological score (8.0); third column represents images from the implant that received the third 
highest histological score (6.7); and fourth column represents images from the implant that 
received the lowest score (6.0) in the GRADIENT group. The sections were stained for 
hematoxylin and eosin; safranin-O; collagen I; and collagen II. Negative controls for IHC were 
also run with the primary antibody omitted. The boxes in the top row outline the defect area. The 
repair tissue was predominantly fibrous in nature with some evidence of cartilage repair. The 





Figure 6.9: Sudan black staining images for the implants that received the highest and 
lowest histological scores in both the BLANK and GRADIENT groups 
 
The defect sites in both of the groups demonstrated mild staining overall with a few dark-
staining spots (arrows). Scale bars: 500 µm. 
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Table 2.1: Notable controlled release applications of microspheres in tissue engineering 
scaffolds 
 
Reference Microsphere Material 
Encapsulated 
Factor Scaffold Matrix Application 
Lee et al. 143, 144 Chitosan TGF-β1 Collagen I and 
chitosan 
CTE 
Royce et al. 198 PLGA FGF-1 Fibrin - 
DeFail et al. 52 PLGA TGF-β1 PEG CTE 
Wei et al. 248 PLGA PDGF-BB PLLA PTE 







Jaklenec et al. 
111 
PLGA IGF-I & TGF-
β1 
PLGA CTE 
Kempen et al. 
129, 130 
PLGA BMP-2 Gelatin & PPF BTE 
Lee et al. 147 PLGA bFGF PCL Smooth muscle 
regeneration 
Bing et al. 148 PLGA BMP-2 PUR BTE 
Wang et al. 244 PLGA & silk BMP-2 & IGF-
I 
Alginate OTE 
Francis et al. 78 P(3HB) Gentamycin Bioglass BTE 
Ju et al. 119 PLGA Dexamethasone Collagen I - 
Liu et al. 153 Ethyl cellulose Ceftazidime HA/PUR BTE 
Brown et al. 31 PLGA BMP-2 PUR BTE 





Lee et al. 145, 146 PLGA BMP-2 PPF/DEF BTE 
Xufeng et al. 
182 
Chitosan BMP-2 nHAC/PLLA BTE 





Son et al. 219 PLGA Dexamethasone HA BTE 
De Boer et al. 
48 
PLGA NGF & GDNF  NTE 
Reyes et al. 194 PLGA PDGF, TGF-β1 
& VEGF 
TCP BTE 
Soran et al. 220 Alginate BMP-6 Chitosan PTE 
Wang et al. 241 Gelatin BMP-2 & ALP Gelatin BTE 
Lupu-Haber et 
al. 159 
PLGA BMP-2 ZrO2 BTE 
Meng et al. 146 P(3HB) Tetracycline Bioglass BTE 
Wang et al. 243 Chitosan ADM PLGA BTE 
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TGF-β1, transforming growth factor-beta 1; CTE, cartilage tissue engineering; PLGA, poly(D, L-
lactic-co-glycolic acid); FGF-1, fibroblast growth factor-1; PEG, poly(ethylene glycol); PDGF-
BB, platelet-derived growth factor-BB; PLLA, poly(L-lactic acid); PTE, periodontal tissue 
engineering; P4VN, poly(4-vinyl pyridine); BMP-2, bone morphogenic protein-2; BMP-7, bone 
morphogenic protein-7; BTE, bone tissue engineering; IGF-I, insulin growth factor-I; PPF, 
poly(propylene fumarate); bFGF basic fibroblast growth factor; PCL, polycaprolactone; PUR, 
polyurethane; OTE, osteochondral tissue engineering; P(3HB), poly(3-hydroxybutyrate); HA, 
hydroxyapatite; NTE, nerve tissue engineering; DEF, diethyl fumarate; nHAC, 
nanohydroxyapatite/collagen; OPF, oligo [(polyethylene glycol) fumarate]; NGF, nerve growth 
factor; GDNF, glial cell derived neurotropic factor; VEGF, vascular endothelial growth factor; 

































al. 25, 26  SESE PLAGA 
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et al. 166, 
167 











et al. 178 DESE PLGA 
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Kim et al. 
135 SESE PLGA 
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184 







Park et al. 
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Lv et al. 
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Shin et al. 
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Das et al. 
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Jeon et al. 
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SESE, single emulsion solvent evaporation; PLAGA, poly(lactide-co-glycolide); BTE, bone 
tissue engineering; PLG, poly(D,L-lactide-co-glycolide); HA, hydroxyapatite; CTE, cartilage 
tissue engineering; DESE, double emulsion solvent evaporation; PLGA, poly(D,L-lactic-co-
glycolic acid); NTE, neural tissue engineering; RA, retinoic acid; CTP, calcium titanium 
phosphate; BMSCs, bone marrow stromal cells; ATE, adipose tissue engineering; STE, skin 
tissue engineering; CaP, calcium phosphate; PLCL, poly(L-lactide-co-e-caprolactone); PHBV, 
poly(3-hydroxybutyrate- co-3-hydroxyvalerate); LTE, liver tissue engineering; VTE, vascular 
tissue engineering; bFGF, basic fibroblast growth factor; HGF, hepatocyte growth factor; 
hUCVECs, human umbilical coed vein endothelial cells; PPhos, polyphosphazenes; IGF-I, 
insulin growth factor-I; TGF-β1, transforming growth factor-beta 1; PCL, poly(ε-caprolactone); 
BSA, bovine serum albumin; MTE, muscle tissue engineering; PLLA, poly(L-lactide); HEPM, 
human embryonic palatal mesenchymal cells; PPF, precision particle fabrication; OTE, 
osteochondral tissue engineering; BMP-2, bone morphogenic protein; TGF-β3, transforming 
growth factor-beta 3; UCMSCs, umbilical cord mesenchymal stromal cells; Dex, 
dexamethasone; AA, ascorbic acid; GP, β-glycerophosphate; ITE, interfacial tissue engineering; 
CaCO3, calcium carbonate; TiO2, titanium dioxide; CA, cellulose acetate; EC, ethyl cellulose; 
CS, chondroitin sulphate; BG, bioactive glass; EGF, epidermal growth factor; TPG, titanium 
fabrication (Saos-2) 
Hu et al. 
99 SESE PLGA 
Inject






















al. 228 SESE PLGA 
Sinter
ed Heat BTE FHA 
Fibroblasts In 
vitro 
Xu et al. 
255 SESE PLGA 
Sinter





Table 3.1: GAG content measured over time in acellular scaffolds from the CS and 




Week 0 Week 3 Week 6 
CS 17.4 ± 9.4 15.9 ± 5.0 16.5 ± 3.8 
GRADIENT 18.4 ± 23.9 9.3 ± 11.3 4.4 ± 2.5 
 
All values are expressed as the average ± standard deviation (n = 3). 
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Table 3.2: Calcium content measured over time in acellular scaffolds from the TCP and 




Week 0 Week 3 Week 6 
TCP 13.8 ± 19.3 3.3 ± 0.9 2.7 ± 2.5 
GRADIENT 7.7 ± 3.7 6.9 ± 1.3 17.7 ± 6.5 
 
All values are expressed as the average ± standard deviation (n = 3). 
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Table 3.3: Genes used for RT-qPCR analysis 
 




SRY (sex determining 
region Y)-box 9 
SOX9 Rn01751069_mH 
Collagen type II COL2A1 Rn01751069_mH 
Aggrecan ACAN Rn00573424_m1 













Table 3.4: Average porosities of different scaffold groups  
 
Group Average Porosity (%) 
PLGA 21.0 ± 6.8 
CS 49.6 ± 4.4* 
TCP 21.6 ± 6.8 
GRADIENT 18.4 ± 4.6 
*significantly higher than the other three groups (p < 0.05) 
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Table 3.5: The dimensions of the constructs used for mechanical testing  
 
Group Week 0 (Acellular) Week 6 (Cellular) Diameter (mm) Height (mm) Diameter (mm) Height (mm) 
PLGA 4 ± 0 6.5 ± 0.7 4 ± 0 6.8 ± 0.3 
CS 3.9 ± 0.1$ 6.3 ± 0.9 5.7 ± 0.1*$ 10 ± 1*$ 
TCP 4.1 ± 0.2 6.4 ± 0.2 3.8 ± 0.1* 6.3 ± 1.0 
GRADIENT 4.1 ± 0.2 6.8 ± 0.2 4.4 ± 0.2*$ 7.6 ± 0.5 
 
All values are expressed as the average ± standard deviation (n = 3-5). *significant difference 
from its Week 0 value and $significant difference from PLGA group at that time point (p < 0.05). 
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Table 4.1: Genes used for RT-qPCR analysis 
 
Gene Symbol TaqMan Assay ID 
Glyceraldehyde 3-
phosphate dehydrogenase GAPDH Rn01775763_g1 
Collagen type I COL1A1 Rn01463848_m1 
Runt-related transcription 
factor 2 RUNX2 Rn01512298_m1 
Bone gamma- 
carboxyglutamate protein BGLAP Rn00566386_g1 
Integrin-binding 
sialoprotein IBSP Rn00561414_m1 
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Table 5.1: Genes used for RT-qPCR analysis 
 
Gene Symbol TaqMan Assay ID 
Glyceraldehyde 3-
phosphate dehydrogenase GAPDH Rn01775763_g1 
Collagen type I COL1A1 Rn01463848_m1 
Collagen type II COL2A1 Rn01751069_mH 
Collagen type X COL10A1 Rn01408029_g1 
Aggrecan ACAN Rn00573424_m1  
SRY (sex determining 
region Y)-box 9  SOX-9 Rn01751069_mH  
Runt-related transcription 
factor 2 RUNX2 Rn01512298_m1 
Integrin-binding 




Table 6.1: List of implant received by each animal and the type of analysis performed for 
the implants 
 
Animal ID Left Knee Right Knee Time Analysis 
Rabbit 1 PLGA GRADIENT 12 weeks Morphology & Histology 
Rabbit 2 PLGA GRADIENT 12 weeks Morphology & Histology 
Rabbit 3 PLGA GRADIENT 12 weeks Morphology & Mechanical 
Rabbit 4a PLGA GRADIENT 12 weeks Euthanized prematurely 
Rabbit 5 PLGA GRADIENT 12 weeks Morphology & Mechanical 
Rabbit 6 GRADIENT PLGA 12 weeks Morphology & Histology 
Rabbit 7 GRADIENT PLGA 12 weeks Morphology & Histology 
Rabbit 8 GRADIENT PLGA 12 weeks Morphology & Mechanical 
Rabbit 9 GRADIENT PLGA 12 weeks Morphology & Mechanical 
Rabbit 10b GRADIENT PLGA 12 weeks Euthanized prematurely 
a Euthanized prematurely because of chronic lameness 




Table 6.2: Morphology scoring parameters for the regenerated tissue and associated 
numeric score 
 
Repair tissue or implant present at the 
defect site 
• Full – 2 
• Partial – 1 
• None – 0 
Edge integration (new tissue relative to 
native 
cartilage) 
• Full – 2 
• Partial – 1 
• None – 0 
Smoothness of repair surface 
• Smooth – 2 
• Intermediate – 1 
• Rough/Missing – 0 
Cartilage surface degree of filling 
• Flush – 2 
• Slight depression – 1 
Depressed/Overgrown – 0 
Color of cartilage (opacity /translucency of 
repair tissue) 
• Translucent – 2 
• Opaque – 1 
• Missing – 0 
Amount of repair tissue relative to total 




Table 6.3: Histology scoring parameters and associated numerical score 
 
Cellular morphology • Hyaline Cartilage – 4 
• Mostly hyaline cartilage 
– 3 
• Mixed hyaline and 
fibrocartilage – 2 
• Mostly fibrocartilage – 
1 
• Some fibrocartilage and 
mostly nonchondrocytic 
cells – 0 
Safranin-O staining • Normal or nearly 
normal – 3 
• Moderate – 2 
• Slight – 1 
• None – 0 
Structural characteristics • Normal – 2 
• Slight disruption, 
including cysts – 1 
• Severe disintegration, 
disruptions – 0 
Thickness • Similar to surrounding 
cartilage – 3 
• Greater than 
surrounding cartilage – 
2 
• Less than surrounding 
cartilage – 1 
• No cartilage – 0 
Bonding • Bonded at both ends of 
graft – 2 
• Bonded at one end or 
partially at both ends – 
1 
• Not bonded – 0 
Reconstruction of 
subchondral bone 
• Normal or reduced 
subchondral bone 
reconstruction – 2 
• Minimal subchondral 
bone reconstruction – 1 
• No subchondral bone 
reconstruction – 0 
Degenerative changes: graft • Normal cellularity – 2 
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Chondrocyte clustering • No clusters – 2 
• < 25% of the cells 1 
• 25-100% of the cells – 0 
Degenerative changes: 
adjacent cartilage 
• Normal cellularity, no 
clusters, normal staining 
– 3 
• Normal cellularity, mild 
clusters, moderate 





staining – 1 
• Severe hypocellularity 
and degeneration, poor 
or no staining – 0 
Strucutral integrity of 
regenerated cartilage 
• Normal – 2 
• Slight disruption, 
including cysts – 1 
• Severe disintegration 
disruptions – 0  
Inflammatory response in 
subchondral bone 
• None/mild – 2 
• Moderate – 1 
• Severe – 0  
Maximum possible score – 28 
 
